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 Nature has evolved myriad biocatalytic tools for selective synthesis. The three-
dimensional architecture of an enzyme active site enables the direct construction of new bonds 
with exquisite site-, chemo-, and stereo-selectivity. Seeking to take advantage of these 
characteristics, researchers have leveraged biocatalysts for the rapid synthesis of natural products 
and complex molecules, developing sustainable methods to address long-standing challenges in 
synthetic chemistry. In recent years, this approach has been expanded to combine chemo- and 
biocatalytic methods in a single vessel, enabling transformations of increasing complexity to occur 
in a streamlined process. This thesis describes the development of novel, one-pot chemoenzymatic 
methods for the synthesis of complex molecules and natural products. Specifically, this work 
leveraged non-heme iron (NHI) alpha-ketoglutarate-dependent enzymes to access reactive ortho-
quinone methide (o-QM) and radical intermediates for the construction of chroman and tropolone 
natural products. These studies provide a platform for the development of NHI enzymes as scalable 
and selective catalysts for the synthesis of complex molecules. 
 The described research involved the development NHI enzymes CitB and ClaD to perform 
selective benzylic C–H hydroxylation of ortho-phenolic compounds. This biocatalytic method 
offered numerous advantages over small molecule oxidants, which often exhibit poor site- and 
chemo-selectivity for benzylic hydroxylation reactions. In comparison, CitB and ClaD provided 





achieve selective catalysis. The substrate scope of this transformation was evaluated for these 
biocatalysts and a scalable reaction platform was developed for this transformation, demonstrating 
the ability of NHI enzymes to serve as sustainable and selective catalysts for benzylic C–H 
hydroxylation. The products of this selective oxidation were fully characterized and were shown 
to serve as reactive precursors for the formation of o-QMs in a one-pot process. Compared to 
traditional synthetic approaches to one-pot o-QM generation, a biocatalytic route offers the 
advantage of selective oxidation, leading to controlled generation of the reactive o-QM 
intermediate. These intermediates were elaborated in one-pot, modular chemoenzymatic fashion 
through 1,4-addition and [4+2] cycloaddition reactions demonstrating the synthetic utility of this 
approach for synthesizing complex scaffolds. Overall, this biocatalytic reaction platform offered 
an improved selectivity profile over traditional oxidative approaches to o-QM synthesis,  enabling 
facile one-pot benzylic oxidation and functionalization in a scalable reaction format. 
 A second focus of this work involved the chemoenzymatic synthesis of 7-membered 
aromatic compounds known as tropolones. Efficient synthetic access to this structurally-diverse 
class of metabolites represents a significant challenge to the development of novel tropolone 
pharmaceuticals. To address this hurdle, NHI enzymes XenC and TropC were leveraged for their 
native ring expansion function to develop an efficient one-pot, two-enzyme reaction for the 
synthesis of substituted tropolones. Reactions with XenC were leveraged in the efficient 
chemoenzymatic synthesis of a variety of non-natural tropolones including the deoxygenated form 
of tropolone natural product epolone B. The reactivity of a putative Diels-Alderase was also 
explored in this reaction, providing a potentially selective route to the synthesis of bioactive 





expansion reaction performed by NHI enzyme TropC and provided evidence of a radical-based 
reaction through structural characterization of the enzyme, as well as mutagenesis and 
computational analysis. These observations led to a revised proposal for fungal tropolone 





Chapter 1: One-pot Chemoenzymatic Reaction Sequences for Complex Molecule Synthesis 
 
Adapted with permission from Doyon, T. J. & Narayan, A. R. H. Synthetic utility of one-pot 
chemoenzymatic reaction sequences. Synlett 2020, 31, 230-236. Copyright © 2020 Georg Thieme 
Verlag KG, Rüdigerstraẞe. 
 
1.1 Introduction 
 Groundbreaking discoveries in protein engineering and the development of non-native 
enzymatic reactions, coupled with an ever-expanding database of natural protein sequences, have 
positioned biocatalysis to be increasingly impactful in synthetic chemistry.1-3 In particular, 
chemoenzymatic cascades and one-pot reaction sequences are powerful tools for the efficient 
synthesis of chemical building blocks, natural products, and pharmaceutical agents.1-3 These 
reaction sequences are often inspired by Nature's methods for generating natural products, wherein 
multiple transformations are performed in a single vessel (for example, a cell) to quickly generate 
molecular complexity. Biocatalysis can provide an array of advantages over traditional synthetic 
methods, offering improved site-, stereo-, and chemoselectivity, in addition to mild reaction 
conditions.1-6 Chemoenzymatic, one-pot reaction sequences combine the benefits of biocatalytic 
methods with the potential to perform multiple transformations in a single reaction vessel with 
high specificity.1-3 In contrast to many traditional synthetic transformations, chemoenzymatic 





Using enzymes, transformations that 
traditionally require incompatible reaction 
conditions can often be performed in a single 
vessel without issue. Efforts combining 
traditional chemical methods and biocatalytic 
reactions are currently underexploited. 
However, such hybrid strategies have the 
potential to expand the repertoire of 
transformations to access previously 
inaccessible chemical space that cannot be 
achieved with biocatalysis or chemocatalysis alone. 
 Chemoenzymatic processes have been applied to the synthesis of an array of high-value 
molecules, including bioactive natural products, drugs and pharmaceutical intermediates, such as 
cholesterol-lowering Lipitor® (atorvastatin), and the diabetes control drug Januvia® (sitagliptin).4-
6 A variety of enzyme classes have been used in cascade or sequential one-pot processes including 
oxygenases, halogenases, oxidases, reductases, decarboxylases and lipases among others.4-5 These 
reactions are designed to operate in a complementary fashion, where a chemical step generates a 
substrate for a subsequent enzymatic reaction, or a chemical step is used to modify the product of 
an enzymatic process (Figure 1.1). In order to optimize reaction conditions, chemoenzymatic one-
pot reactions have featured a diverse array of approaches.7-8 Reaction processes can occur in a 
cascade, or tandem format in which all reagents and catalysts are added to a single mixture and 
both the chemical and biocatalytic transformations are allowed to proceed simultaneously.7-8 In 
contrast, some chemoenzymatic one-pot processes feature a modular or stepwise approach in 
Figure 1.1. One-pot chemoenzymatic 
transformations.  
A. Biocatalyst-generated products are 
modified through a chemical reaction. B. 
Chemically-modified substrates undergo a 
second biocatalytic transformation. S = 






which one reaction is allowed to proceed to 
completion prior to the addition of reagents or 
initiators for a second transformation. Such 
strategies are often used to circumvent 
compatibility challenges between chemo- and 
biocatalytic reactions.7-8 An additional 
category of chemoenzymatic transformation 
includes cooperative systems in which 
conversion of a starting material to a reactive 
intermediate is a reversible process (Figure 
1.2).8 This process generates a substrate for an 
irreversible downstream reaction that, in turn, 
improves flux through the cascade to deliver 
products. Examples of each type of reaction 
platform are featured throughout this chapter. 
 Challenges in the construction of 
compatible chemoenzymatic one-pot reaction platforms have involved the creative development 
of novel processes to overcome these limitations. For example, chemocatalytic reactions can be 
difficult to adapt to the aqueous reaction conditions required for many biocatalytic reactions.7-8 
Chemical catalysts may be sensitive to water-induced catalyst poisoning or generate unwanted side 
products through alternative reaction pathways. On the other hand, biocatalysts may perform 
poorly under non-aqueous environments or under the increased temperatures required for several 
chemocatalytic reactions.7-8 Furthermore, biocatalysts may undergo denaturation in the presence 
Figure 1.2. Types of one-pot 
chemoenzymatic transformations.  
A. Cascade or tandem reaction in which both 
reactions are performed simultaneously. B. 
Modular or stepwise approach in which 
chemical and biocatalytic steps are separated 
temporally but occur in the same vessel. C. 
Cooperative system in which a reversible 
reaction generates substrate for an irreversible 
downstream reaction. S = enzyme substrate, P 






of some chemical reagents. To overcome these challenges, several novel chemoenzymatic reaction 
platforms have been developed, including reactions using cosolvents, biphasic systems, 
supramolecular reaction scaffolds, encapsulated enzyme techniques and the use of deep eutectic 
solvents.7-8 These reaction systems have been leveraged for a plethora of chemoenzymatic 
systems, enabling the coupling of previously incompatible chemical and biocatalytic processes and 
broadening the scope of possible transformations that can be performed using a chemoenzymatic 
process. Transformations utilizing chemoenzymatic strategies are highlighted within this chapter, 
demonstrating the ways in which these advancements have resulted in a complete renaissance in 
the organic synthesis of complex molecule.7-8 
1.2 Chemoenzymatic one-pot sequences 
Aldol reactions paired with enzymatic processes 
 Aldol reactions are a key transformation in the synthesis of new C–C bonds. These 
reactions often occur at room temperature and can be catalyzed asymmetrically using sustainable 
organocatalysts. As a result, these transformations are particularly amenable to integration with 
biocatalytic processes. In one example, Gröger and coworkers designed chemoenzymatic 
sequences for the one-pot stereo-divergent synthesis of enantioenriched 1,3-diols and 
demonstrated the concept of enzyme-catalyzed modification of a chemically-generated product.9 
After an initial organo-catalyzed asymmetric aldol reaction (1.1 to 1.3, Figure 1.3A), the resulting 
ketone (1.2) was reduced stereo-specifically by a nicotinamide adenine dinucleotide phosphate 
hydride (NADPH)-dependent alcohol dehydrogenase (ADH). By selecting an appropriate aldol 
catalyst and ADH, the configuration of each stereocenter could be controlled. This allowed access 





enantio- and diastereoselectivity. In comparison, traditional synthetic approaches to selectively 
access each of the possible stereoisomers require numerous steps and are typically accomplished 
by modular asymmetric synthesis of each stereocenter using transition metal-catalyzed 
processes.10-11 Aoki and coworkers developed a similar one-pot stereodivergent synthesis of 
enantioenriched 1,3-diols through a Zn-catalyzed enantioselective aldol reaction, followed by an 
analogous enantioselective reduction with complementary NADPH-dependent ADHs (1.6-1.8, 
Figure 1.3B).12 These conditions offered improved enantioselectivity in the aldol step, translating 
to improved diastereomeric ratios of products following the enzyme-catalyzed reduction. Such 
examples also highlight the utility of cascade biocatalysis for performing enantioselective 




Figure 1.3. Stereodivergent chemoenzymatic one-pot synthesis of 1,3-diols.  
A. Organo-catalyzed asymmetric aldol reaction paired with stereoselective reduction using 






Chemoenzymatic cyclization cascades 
 Chemoenzymatic one-pot reactions offer significant advantages for the selective oxidation 
of molecules, particularly for those with redox-sensitive functional groups. The ability to perform 
selective oxidations without protecting group manipulations allows for one-pot cascade sequences 
that would be challenging using traditional synthetic methods alone. The opportunities afforded 
by selective biocatalytic functionalization has inspired new routes to synthetically challenging 
target molecules. For example, the Turner group has pioneered a number of chemoenzymatic 
processes for the selective synthesis of nitrogen-containing heterocycles. They have established a 
variety of approaches, including the chemoenzymatic kinetic resolution of cyclic amines and 
cascades for cyclization to form an imine, followed by selective reduction using imine reductases 
(Figure 1.4A).13-16 These methods enabled facile access to enantioenriched amine scaffolds that 
Figure 1.4. Chemoenzymatic one-pot syntheses of cyclic amines.  
A. Imine condensation paired with asymmetric imine reduction. B. NHI dioxygenase-catalyzed 
oxidation and cyclization paired with chemical imine reduction. C. Application of 1.19 to the 
synthesis of cavinafungin B. D. Comparison of chemoenzymatic approach to traditional 





are key components of natural products and pharmaceuticals, demonstrating that such syntheses 
can be performed in a direct and highly selective manner.13-16 
 Utilizing an amine cyclization technique, Renata and coworkers recently developed a one-
pot chemoenzymatic method that proceeded through an intermediate imine to generate L-proline 
derivatives (1.16-1.22), a motif common to a number of acyldepsipeptide antibiotics (Figure 
1.4B).17 Their approach leverages the ability of GriE, an α-ketoglutarate-dependent non-heme iron 
dioxygenase, to perform two successive C–H oxidations on the terminal methyl group of L-leucine, 
to generate an aldehyde intermediate.17 In situ intramolecular condensation to form imine 
intermediate 1.17 is followed by borazane reduction to afford L-proline derivatives 1.19-1.22 in 
good yields. Renata and coworkers subsequently applied the chemoenzymatic synthesis of proline 
derivative 1.19 for the first total synthesis of the antiviral lipopeptide natural product cavinafungin 
B (1.15).18 This method demonstrates the efficiency of performing complementary 
chemoenzymatic transformations in one-pot without the need for isolation of reaction 
intermediates.17 In comparison, an established synthetic route to access 4-methylproline (1.19) 
involves multiple steps, including protection of L-4-hydroxyproline (Figure 1.4D, 1.23-1.24), 
oxidation to the corresponding ketone (1.24-1.25), olefination with Petasis reagent (1.25-1.26), 
hydrogenation with Crabtree's catalyst (1.26-1.27) and, finally, global deprotection to yield 1.19 
with moderate diastereomeric ratios.19 Thus, the chemoenzymatic approach employing GriE 







Chemoenzymatic cross-coupling transformations 
Figure 1.5. Chemoenzymatic one-pot cross-couplings paired with enzymatic reductions. 
A. Suzuki-Miyaura cross-coupling reaction paired with asymmetric KRED-catalyzed 
reductions. B. Suzuki-Miyaura cross-coupling reaction paired with asymmetric KRED-
catalyzed reductions. C. Liebeskind-Srogl cross-coupling paired with asymmetric biocatalytic 
reductive amination and KRED-catalyzed reduction. D. Ni-catalyzed cross-coupling paired 





 Significant effort has been devoted to the development of high utility chemoenzymatic 
sequences. For example, the combination of transition metal-catalyzed and biocatalytic reactions 
in a single vessel allows chemists to perform transformations that are generally not possible using 
biocatalysts alone. In some cases, cross-coupling reactions can be used to generate substrates in 
situ for a biocatalyst, or they can be leveraged for further diversification of an enzyme product.7, 
20-23 Innovative work by Gröger and coworkers demonstrated that palladium-catalyzed cross-
couplings could be paired in a modular fashion with the asymmetric reduction of aryl ketones for 
the generation of enantioenriched biaryl benzylic alcohols (1.30 and 1.34, Figure 1.5A and 1.5B).20 
Either of the desired enantiomers could be accessed using complementary ADHs, giving products 
with the targeted configuration with nearly perfect selectivity and in good yields.20 This was the 
first demonstration of a cross-coupling reaction used in a one-pot fashion with a biocatalytic 
reaction, expanding the scope of transformations that are possible through chemoenzymatic 
processes and inspiring future innovation in combining transition-metal catalysis and biocatalysis.  
 Since these initial studies by the Gröger group, other cross-coupling reactions have been 
developed that leverage highly selective enzyme-mediated reductions to synthesize more complex 
targets.24 For example, the Mihovilovic group has innovated in this area, expanding the cross-
coupling portion of this modular reaction to include the Liebeskind-Srogl (L-S) reaction, which 
couples boronic esters and thioesters in a palladium-catalyzed process (Figure 1.5C, 1.35-1.39).24 
They combined this transformation with downstream reductive reactions, including in-situ KRED- 
and transaminase-catalyzed diversification of the resulting ketone. As with the reactions developed 
by the Gröger group, these one-pot cascade processes were highly successful, boasting moderate 
to good yields and high levels of enantioselectivities.24 Similarly, the Garg group applied this 





by enantioselective reduction using an engineered ketoreductase to deliver enantioenriched, biaryl 
alcohols in moderate to good yields (see Figure 1.5D, 1.44-1.48).25 
 Cross-coupling reactions have also been applied in the modification of enzyme-generated 
products. In particular, Suzuki-Miyaura and Heck reactions have been used to diversify the 
products of engineered flavin-dependent halogenases (Figure 1.6A). The Micklefield group has 
leveraged this type of approach for the site-selective one-pot synthesis of biaryls and aryl-indoles 
(see 1.49-1.53).26 Using a molecular weight cutoff device to effectively compartmentalize their 
chosen halogenase, they coupled site-selective bromination with palladium-catalyzed cross-
coupling reactions in an aqueous medium, allowing for the generation of cross-coupled species in 
moderate to good yields.26 They reported that compartmentalization of their enzyme led to 
improved yields in the cross-coupling reactions and improved flux through this cascade reaction.26 
As an alternative to the compartmentalized one-pot chemoenzymatic approach, the Lewis group 
Figure 1.6. One-pot enzymatic halogenation paired with cross-coupling reactions.  
A. Compartmentalized enzymatic halogenation paired with Suzuki-Miyaura cross-couplings. B. 





has also reported a halogenase/cross-coupling sequence in which the crude extract of a biocatalytic 
halogenation reaction was used directly in palladium-catalyzed cross-coupling transformations.27 
 Sewald and coworkers took a modular approach to the Heck coupling of styrene with 
unprotected tryptophan, performing a stepwise, enzyme-catalyzed bromination by using a 
combination of an immobilized flavin-dependent halogenase and a reductase, followed by 
palladium-catalyzed Heck coupling at elevated temperatures (Figure 1.6B, 1.54-1.56).28 This 
reaction resulted in the streamlined synthesis of modified tryptophans in moderate yield without 
the need for protection or deprotection procedures.28 Overall, these procedures provide a site-
selective and highly efficient method for the diversification of aryl species in a one-pot process. 
Such processes also demonstrate that challenges in compatibility between enzymatic and 
transition-metal catalyzed processes could be overcome through the creative application of 
biochemical tools, such as inexpensive and reusable molecular weight cutoff devices.26 
 
Ruthenium-catalyzed metathesis paired with enzyme processes 
 One limitation in the development of one-pot chemoenzymatic processes is the frequent 
incompatibility of conditions for the chemocatalytic and biocatalytic reactions.8, 21-23 For example, 
some biocatalysts are highly sensitive to organic solvents, while many chemical catalysts cannot 
operate in aqueous or aerobic conditions. These contradictory requirements can make some 
desirable chemoenzymatic transformations logistically difficult or impossible.8 However, recent 
innovations have enabled the combination of otherwise incompatible transformations.8 In one 
example, Hartwig and Zhao developed a tandem chemoenzymatic reaction for the conversion of 
simple alkenes to substituted, enantioenriched epoxides through an initial olefin metathesis with 





Figure 1.7A and 1.7B).21-22 In this case, the seemingly incompatible processes could be 
accomplished in a common reaction vessel by using a biphasic system of isooctane and aqueous 
buffer.21-22 This solution was effective, generating enantioenriched epoxides in yields that were 
often greater than those achieved for each standalone reaction.21-22 This increase in yield is likely 
the result of a change in equilibrium for the metathesis reaction caused by the consumption of the 
metathesis product in the subsequent biocatalytic reaction, an example of a cooperative 
chemoenzymatic cascade process.22 Similarly, Turner and Castagnolo developed a system for the 
Figure 1.7. Ruthenium-catalyzed metathesis reactions paired with biocatalytic processes. 
A. Biphasic Hoveyda-Grubbs II-catalyzed metathesis combined with enzymatic epoxidation. 
B. Hoveyda-Grubbs II- catalyzed metathesis combined with enzymatic epoxidation. C. Grubbs 
II-catalyzed cyclization paired with enzymatic oxidation to form pyrroles. D. Grubbs II-





chemoenzymatic synthesis of substituted pyrroles (Figure 1.7C).23 This reaction sequence featured 
an olefin metathesis mediated by the second generation Grubbs catalyst, followed by monoamine 
oxidase-D5 (MAO-D5)-catalyzed oxidation to generate pyrrole products (see 1.66-1.68). This 
method used whole cells containing the biocatalyst as an alternative to purified protein or crude 
cell lysate, providing a simple and scalable platform for the oxidation of the cyclic amine to the 
final pyrrole product.23 Traditional methods for this oxidation require stoichiometric oxidants, such 
as hypervalent iodide,29 or transition-metal catalysts with TEMPO.30 In comparison, the 
biocatalytic process presented here is selective for the oxidation of amines and uses molecular 
oxygen as the stoichiometric oxidant. Thus, this biphasic chemoenzymatic system provides several 
advantages over traditional approaches to pyrrole synthesis.23 Following the development of this 
system, the Castagnolo group was able to apply this same chemoenzymatic reaction process to the 
synthesis of substituted furans, using a commercially-available laccase and TEMPO in a biphasic 
medium to oxidize the 2,5-dihydrofuran up to the aromatic furan (see 1.69-1.71).31 Catalytic 
TEMPO was required to initiate electron-transfer to the laccase system, as molecular oxygen alone 
was not enough to catalyze the laccase-mediated oxidation.31 
 
Copper-catalyzed chemoenzymatic transformations 
 Copper-catalyzed processes have been widely utilized for biorthogonal transformations in 
chemical biology. For example, the copper-catalyzed [3+2] addition between alkynes and azides–
known as "click" chemistry–has enabled small molecule-based tagging of biological molecules, 
including proteins, nucleic acids and other targets in aqueous media and under biologically-
relevant conditions.32-33 As a result of this compatibility with aqueous conditions, the combination 





For example, Omori and coworkers developed a cascade reaction that combined a stereoselective 
enzyme-catalyzed reduction of azide-containing ketone 1.72 with a copper-catalyzed click reaction 
with various alkyne partners (Figure 1.8A, 1.72-1.74).34 The ketoreductase activity demonstrated 
in this cascade was developed using a known reaction between ketones and reductase-producing 
endophytic bacteria that reside in the root of carrots (D. carota).34 The transformation provided an 
Figure 1.8. Copper-catalyzed reactions paired with biocatalytic processes.  
A. Enzymatic reduction of ketones by endophytic bacteria in carrot roots paired with “click” 
reactions. B. Enzymatic asymmetric epoxide opening paired with “click” reactions. C. 
Biocatalyst-mediated decarboxylation, followed by Cu-catalyzed reduction. D. Cu-catalyzed 





inexpensive, scalable and renewable source of reductase that proved compatible with downstream 
copper-catalyzed "click" reactions. This one-pot transformation delivered enantioenriched 
benzylic alcohols functionalized with diverse triazoles in moderate to good yields and excellent 
enantioselectivities.34 Another one-pot chemoenzymatic reaction using "click" chemistry was 
coupled with the kinetic resolution of racemic epoxides.35 Feringa and coworkers showed that 
halohydrin dehalogenase HceC from Agrobacterium radiobacter could stereoselectively deliver 
nucleophilic azide to epoxides in a non-native reaction, resulting in the formation of 
enantioenriched benzylic alcohols possessing azide functionalization (see Figure 1.8B, 1.75-
1.78).35 Copper-catalyzed "click" reactions were simultaneously used to further diversify this 
scaffold to generate chiral α-hydroxy-triazoles (such as 1.78) with moderate to good yields and 
enantioselectivities.35 These transformations take advantage of the compatibility of "click" 
chemistry with biological molecules, leveraging these reactions for the rapid synthesis of diverse 
scaffolds from simple precursors. 
 Chemoenzymatic processes that utilize copper-catalyzed reactions are not limited to 
"click" chemistry. Biocompatible transformations involving copper-mediated reductions and 
cross-couplings have also been recently reported. For example, Kourist and coworkers coupled a 
one-pot enzyme-catalyzed decarboxylation with a copper-catalyzed alkene reduction to produce 
enantioenriched 2-methylalkanoic acids (Figure 1.8C, 1.79-1.81).36 Engineered arylmalonate 
decarboxylases (AMDases) catalyzed the initial decarboxylation reaction resulting in the 
formation of an enantioenriched β,γ-unsaturated carboxylic acid (1.80).36 Previous directed 
evolution campaigns provided the authors with available AMDase variants that could catalyze the 





diimide reduction of the β,γ-unsaturated carboxylic acid 1.80 resulted in the formation of the fully 
saturated product with fair to excellent yields and enantioselectivities.36  
 Copper-mediated cross-coupling reactions have also been used in conjunction with 
enzymatic processes.37 Schwaneberg and coworkers recently developed a chemoenzymatic 
synthesis of bis-benzofuran 1.86 using a copper-catalyzed Sonogashira reaction, coupled with a 
P450-mediated oxidation/formaldehyde elimination reaction to generate a dimerized product.37 
This cascade takes advantage of the ability of P450BM3 to perform a site-selective C–H oxidation 
reaction on methyl groups attached to heteroatoms, effectively demethylating the substrate through 
the loss of formaldehyde.37 The hydroxymethyl-amine intermediate 1.84 serves as an electrophile 
for nucleophilic dimerization with loss of formaldehyde to form the product bis-benzofuran 1.86 
in a one-pot process. Schwaneberg and coworkers developed a water-compatible Sonigashira 
reaction through comparative screening of ligands, with copper scorpionate serving as the ideal 
system for this transformation and providing the cyclized benzofuran product in quantitative 
yield.37 When combined in a one-pot process with P450BM3, the dimerized furan was synthesized 
in good yield over two steps.37 These reactions illustrate that copper-dependent processes can be 
combined in a direct manner with biocatalysts to streamline synthetic routes and to perform 
complex, selective transformations in a single vessel, broadly expanding the scope of accessible 
chemoenzymatic processes. 
 
Chemoenzymatic transformations using supramolecular complex chemistry 
 Synthetic chemists have long sought ways to mimic the selectivity profiles of enzyme 
catalysts. In an enzyme, the three-dimensional architecture often dictates the reactivity of a 





inspiration from Nature, chemists have sought to control the site- and stereoselectivity of a reaction 
by mimicking the constraints of an enzyme active site. One way of achieving such selectivity is 
through the use of supramolecular scaffolds containing reactive transition-metal complexes.38 This 
species, known as a host-guest complex, provides a defined three-dimensional cavity in which the 
substrate can react with a metal catalyst, influencing both the reaction rate and stereochemical 
outcome of a particular transformation through cavity-substrate interactions.38 These complexes 
also serve to sequester reactive transition-metal species, preventing catalyst degradation and side 
reactions from occurring.38-39 Furthermore, supramolecular complexes often assist with 
solubilization of metal complexes containing hydrophobic ligands, generating a water-soluble 
catalyst mixture.38-39 These characteristics make supramolecular complexes particularly amenable 
to one-pot chemoenzymatic reactions, as metal sequestration prevents biocatalyst destruction and 
allows for reduced biocatalyst loading.38-39  
 Toste and coworkers developed a gallium-based supramolecular scaffold that contained a 
Au(I)-phosphine complex capable of performing hydroalkoxylation of allenes (Figure 1.9A).39 
This reaction was paired in a one-pot cascade with enantioselective hydrolysis of allene 1.87 to 
generate the enantioenriched free alcohol 1.88.39 Gold-catalyzed cyclization of 1.88 in situ 
generated substituted tetrahydrofuran 1.89 in moderate diastereoselectivity. Toste and coworkers 
demonstrated that the use of an un-sequestered Au(I)-complex in the presence of a lipase was 
deleterious to enzyme activity.39 Au(I)-complexes are particularly reactive with thiol-containing 
molecules, such as cysteine residues in enzymes, resulting in enzyme degradation. Thus, a gold-
catalyzed process would not have been feasible without the use of a host-guest complex, enabling 





 Toste and coworkers also demonstrated that a ruthenium-catalyzed process could be 
developed using a host-guest complex (Figure 1.9B).39 This cascade reaction commenced with an 
initial Ru(II)-catalyzed isomerization of allylic alcohol 1.90, followed by reduction of the resulting 
isopropanal (1.91) using an alcohol dehydrogenase (ADH) to produce isopropanol (1.92).39 
Sequestration of the ruthenium complex again prevented side reactivity with the biocatalyst in this 
one-pot cascade, delivering isopropanol in a 61% yield.39 This method provides a means by which 
enzymatic and transition-metal processes can perform concurrent catalysis with reduced 
biocatalyst degradation, resulting in more sustainable reaction conditions and direct synthesis of 
desired products.39 
 
Photocatalytic one-pot chemoenzymatic reactions 
 In recent years, photocatalytic systems have enabled highly efficient transformations, 
particularly when used to mediate transition-metal catalyzed redox processes for catalyst 
Figure 1.9. One-pot supramolecular complex chemistry paired with enzymatic reactions. 
A. Biocatalytic kinetic resolution of γ-acylated allenes paired with Au-catalyzed 
hydroalkoxylation. B. Ru-catalyzed isomerization of α,β-unsaturated alcohols paired with 





regeneration.40-41 While numerous small molecule catalytic processes have been combined with 
biocatalysts in a one-pot process, photochemical reactions have been generally underexplored in 
chemoenzymatic cascade reactions. However, the mild conditions employed for numerous 
photochemical methods make these reactions highly amenable for combination with biocatalytic 
processes.40-41 In addition, photocatalytic processes are typically more sustainable than traditional 
small-molecule catalysis, requiring relatively low catalyst loading and avoiding stoichiometric use 
of chemical reductants for catalyst turnover.40-41 Organic photocatalysts have also been used in 
place of transition-metal complexes and many, such as flavin mononucleotide (FMN), are derived 
from bio-renewable sources, improving the sustainability profile of the reaction.40 
 Hartwig, Zhao and coworkers developed a cooperative photo-chemoenzymatic method for 
the stereoconvergent reduction of alkene mixtures using ene-reductases (ERs) (Figure 1.10A).40 
Numerous ERs have been characterized and shown to catalyze the reduction of only the E-isomer 
Figure 1.10. Photocatalytic reactions paired with enzymatic reactions.  
A. Photocatalytic alkene isomerization paired with asymmetric biocatalytic alkene-






of alkenes.42 Hartwig and Zhao designed a cooperative chemoenzymatic cascade reaction in which 
photocatalytic isomerization of alkenes would generate substrates for biocatalytic reduction by 
ERs (1.93-1.95).40 The photoisomerization reaction could be carried out with FMN or using an 
iridium photocatalyst in the presence of blue LED lights. This reaction design "funnels" mixtures 
of isomeric alkenes in a reversible photoisomerization reaction toward formation of E-isomer 
substrates that could be accepted as substrates by ERs for non-reversible reduction, leading to the 
stereoconvergent synthesis of enantioenriched benzylic alkyls in moderate to excellent yields and 
high enantioselectivities.40  
 In another example, Castagnolo and coworkers designed a one-pot chemoenzymatic route 
featuring a photocatalytic thio-Michael reaction paired with KREDs to access enantioenriched 1,3-
mercaptoalkanols (Figure 1.10B).41 A ruthenium photocatalyst was utilized under visible light 
conditions to couple various thiols and α,β-unsaturated ketones to form 1,3-mercaptoketones (see 
1.97) as substrates for R- or S-selective KREDs.41 This cascade resulted in the direct generation of 
volatile sulfur compounds (VSCs), such as 1.98, that are commonly used in food flavoring.41 
Enantiomers of VSCs can be distinguished through olfactory senses, as one enantiomer often has 
a pleasant smell or taste, while the other is unpleasant.41 As a result of olfactory distinction, precise 
enantioselective control over the synthesis of VSCs is critical for producing the desired effects. 
This chemoenzymatic approach provides a sustainable and highly selective platform for VSC 
synthesis with a variety of thiol and ketone functionalities, leading to improved control over 
olfactory characteristics. 
 





 Aldehydes and ketones have long been utilized as an important synthetic handle in the 
synthesis of complex molecules. In order to take advantage of the synthetic utility of this group, 
several one-pot chemoenzymatic methods have drawn on the generation and functionalization of 
an aldehyde as a key step in the reaction sequence.43-45 In these examples, the aldehyde or ketone 
serves as an intermediate in further diversification of the molecule of interest through a one-pot 
cascade. For example, Gröger and coworkers developed a chemoenzymatic cascade that 
commences with a Wacker oxidation of styrenes, followed by enantioselective reduction using an 
alcohol dehydrogenase (ADH) to deliver the corresponding benzylic alcohol in moderate yields 
and excellent enantioselectivity (Figure 1.11A, see 1.100-1.102).43 This synthesis allows for direct, 
one-pot access to chiral benzylic alcohols from commercially-available styrenes.  
 Faber and coworkers also developed a modular chemoenzymatic reaction to generate 
benzylic alcohols (Figure 1.11B).44 Galactose oxidase from Fusarium NRRL 2903, together with 
horseradish peroxidase and the reductant 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) 
diammonium salt (ABTS) to degrade hydrogen peroxide, catalyzes chemoselective oxidation of 
primary benzylic alcohols to the corresponding benzaldehyde (1.104).44 Following enzymatic 
generation of the aldehyde in situ, an indium-catalyzed allylation was performed to generate 
racemic substituted benzylic alcohols (1.105).44 These methods provide a direct synthesis of 
benzylic alcohols from commercial starting materials in a one-pot fashion, illustrating the 
advantages of chemoenzymatic methods in catalyzing chemo- and stereoselective chemical 
transformations. 
 In addition to serving as synthetic handles for aldol reactions, aldehydes can also be 
modified through the condensation of hydroxylamine to form an aldoxime.45 These compounds 





rearrangement, reduced directly to form amines, or dehydrated to form nitriles.45 Molinari and 
coworkers developed a chemoenzymatic one-pot procedure for the synthesis of aldoximes using 
whole-cell biotransformations with acetic acid bacteria (Figure 1.11C).45 A strain of 
Gluconobacter oxydans was used to perform oxidation of 2-phenylethanol (1.106) to 2-
Figure 1.11. Chemoenzymatic one-pot synthesis and modification of aldehydes and 
ketones. A. Pd-catalyzed Wacker oxidation paired with asymmetric biocatalytic reduction. B. 
Biocatalytic oxidation of benzylic alcohols paired with chemical allylation. C. Biocatalytic 
oxidation of alcohols paired with amine condensation to generate aldoximes. D. Pyridoxal 





phenylacetaldehyde (1.107). The aldehyde species generated in situ then underwent a condensation 
reaction with hydroxylamine to directly produce oxime 1.108.45 This process was optimized for 
biocatalyst loading, reaction temperature, and hydroxylamine loading to generate aldoximes, such 
as 1.108, in good yield.45 This one-pot procedure demonstrates the ability of chemoenzymatic 
processes to directly generate synthetic handles for the streamlined synthesis of complex 
molecules. Furthermore, acetic acid bacteria are widely used in industrial fermentation processes, 
providing a highly scalable biotransformation for the direct synthesis of aldoximes. 
 Stereoenriched 2-aminoalcohols are a common motif in a wide variety of pharmaceuticals 
and their derivatives.46 The development of small molecule-based methods which provide access 
to all of the possible stereoisomers is challenging, owing to the requirement for extensive catalyst 
development for each desired transformation. Hyster and colleagues recently developed a one-pot 
chemoenzymatic approach to address these challenges, featuring pyridoxal phosphate (PLP)-
catalyzed racemization of the α-amino stereocenter, followed by stereoselective reduction by 
KREDs to deliver all four possible stereocenters in an enzyme-dependent fashion (Figure 1.11D).46 
The use of PLP in this reaction sequence reduces the pKa of the α-amino proton by many orders 
of magnitude, allowing deprotonation to proceed at near-physiological pH and enabling 
concomitant use of KREDs in a one-pot kinetic resolution process (see 1.109-1.110). In addition, 
numerous screened KREDs exhibited both enantio- and diastereoselectivity in the reduction 
process, leading to the selective synthesis of all possible α-aminoalcohols (see 1.110-1.111).46 
 
Chemoenzymatic processes using lipases 
 Lipases are critical metabolic enzymes for the hydrolysis of lipids to form free fatty acids, 





highly efficient biocatalysts for scalable industrial processes.47 In particular, these enzymes can be 
leveraged as enantioselective hydrolytic biocatalysts, delivering a particular stereoisomer 
selectively by allowing the simple kinetic resolution or dynamic kinetic resolution (DKR) of a 
racemic mixture.48  
 Bisogono and coworkers developed a novel chemoenzymatic multicomponent reaction 
(MCR) for the synthesis of β-thioketones (Figure 1.12A).49 A β-haloketone (1.112) was combined 
with a thioketone salt (1.114) and an alkyl halide (1.113) under basic conditions to directly form 
the acylated vinylogous thiol 1.115.49 Following the addition of Tris buffer, the commercially-
available lipase B from Candida antarctica (CAL-B) was used to hydrolyze the acyl group to 
Figure 1.12. Lipase-catalyzed chemoenzymatic transformations.  
A. Multicomponent reaction (MCR) paired with lipase-catalyzed diacylation. B. Lipase-
catalyzed kinetic resolution of α-hydroxyalkynes paired with in situ Mitsonobu reaction in the 






generate β-thioketones, such as 1.116, in good yields.49 This one-pot process represents a rare use 
of MCR within the context of a chemoenzymatic platform and demonstrates the ability of CAL-B 
to work within complex reaction mixtures. In addition, this reaction can be performed on a gram 
scale to generate large quantities of β-thioketone products.49 
 Faber and coworkers also leveraged CAL-B for the selective synthesis of complex 
molecules (Figure 1.12B).50 In particular, they aimed to develop a chemoenzymatic synthesis of 
the acetylenic natural product panaxytriol (1.120), which has been employed in traditional 
Japanese medicine for a variety of maladies and has documented anti-cancer activities.50 They 
sought to stereoselectively construct allylic alcohol fragment 1.119 through CAL-B-catalyzed de-
acylation of racemic acylated material (1.117).50 Kinetic resolution using CAL-B resulted in a 
selective synthesis of 1.118 with the R-conformer generated by the enzyme in the native reaction. 
However, the natural product configuration is S at this stereocenter, requiring a stereoinversion 
step achieved by performing an in situ Mitsonobu reaction on alcohol 1.118.50 This final step 
generated the required stereochemistry for the allylic alcohol fragment which was carried forward 
in the total synthesis of panaxytriol (1.120).50 
 β-amino acids are critical synthetic building blocks in the construction of pharmaceuticals 
and natural products.51 Therefore, methods to build these molecules stereoselectively, sustainably 
and on an industrial scale are vital to the efficient synthesis of drug molecules containing these 
moieties. Gröger and coworkers sought to develop a one-pot chemoenzymatic route for the 
synthesis of β-amino acids, taking advantage of the stereo-specific nature of the lipase CAL-B to 
achieve the selective synthesis of a single enantiomer (Figure 1.12C).52 Their cascade commenced 
with Michael addition of benzylamine (1.122) to an α,β-unsaturated ester (1.121), generating the 





aminolysis of the R-enantiomer of the β-amino acid, leaving the S-enantiomer untouched as the 
product (1.124).52 This kinetic resolution step could be repeated to achieve good conversion of the 
S-enantiomer with excellent enantioselectivity. The immobilized enzyme could also be efficiently 
recycled up to four times, demonstrating the sustainability of this system for the synthesis of chiral 
building blocks.52 
 
Chemoenzymatic modification of nitrogen-containing compounds 
 Nitrogen-containing compounds are key components of pharmaceuticals and natural 
products.53 Novel methods for modification of these compounds are critical for the development 
of efficient synthetic routes. Toward this end, chemoenzymatic processes possess distinct 
advantages for the direct synthesis of nitrogen-containing complex molecules and building blocks. 
For example, Poelarends and coworkers demonstrated that γ-aminobutyric acids (GABAs) could 
be synthesized directly and selectively using a chemoenzymatic one-pot route.53 GABAs are a 
common motif in pharmaceutically-active compounds used in pain management and are therefore 
highly attractive targets for the development of efficient and sustainable syntheses.  4-oxocrotonate 
tautomerase (4-OT) was previously shown to perform Michael addition of enolates to nitroalkenes 
with moderate enantioselectivity.53 In their efforts to improve this known transformation, 
Poelarands and coworkers undertook a protein evolution campaign, developing a 4-OT capable of 
catalyzing highly enantioselective Michael addition of acetaldehyde (1.125) to nitroalkenes 
(1.126), generating nitro-aldehyde compounds (1.127) with exquisite selectivity (Figure 1.13A).53 
The evolved "Michaelase" was then paired in a cascade process with an alcohol dehydrogenase, 





(1.128).53 Following this two-enzyme cascade, a water-compatible nitro reduction was performed 
using NiCl2 and NaBH4, yielding the target GABA compound (1.128).
53 A variety of 
pharmaceutically-active GABAs were produced using this method in moderate to good yields and 
with excellent enantioselectivities.53 This method represents a significant advancement in the 
efficient and sustainable synthesis of GABAs, laying the groundwork for chemoenzymatic 
industrial applications. 
 The enantioselective synthesis of organic building blocks is essential for improving the 
efficient construction of pharmaceuticals and natural products. Such efficiency can be improved 
by the development of novel methods to build these organic moieties in a direct and highly 
Figure 1.13. Chemoenzymatic modification of nitrogen-containing compounds.  
A. Addition of acetaldehyde to nitroalkenes catalyzed by engineered “Michaelase” paired with 
in situ oxidation catalyzed by alcohol dehydrogenase. In situ nitro reduction using nickel and 
sodium borohydride completes the synthesis of GABAs. B. KRED-catalyzed asymmetric 
reduction paired with Ru-catalyzed nitrile oxidation. C. Rh-catalyzed hydroformylation paired 





selective fashion.54 Gonzalez-Sabin and coworkers sought to construct optically-active β-
hydroxyamides (such as 1.131) through enantioselective biocatalytic reduction of α-cyanoketones, 
utilizing a KRED to generate the desired R-enantiomer of alcohol 1.130 (Figure 1.13B).54 In 
cascade with the biocatalytic reaction, they leveraged a water-stable ruthenium catalyst to perform 
a concomitant hydration and transfer hydrogenation, directly producing the desired β-
hydroxyamide 1.131 with good yields and excellent enantioselectivities.54 The use of a ruthenium 
catalyst in cascade with a biocatalyst represents a rare transformation amongst one-pot 
chemoenzymatic processes.54 Their efforts demonstrated that a phase-separated or 
compartmentalized catalyst was not necessary for these types of systems, leaving open the 
possibility for new reaction development in this area.  
 The advantages of chemoenzymatic one-pot reactions are not limited to the synthesis of 
complex molecules and pharmaceuticals. The merits of these transformations can also be applied 
to the production of bulk chemicals.55 For example, long-chain alkyl nitriles have become essential 
commodity chemicals used as solvents, and in the synthesis of quaternary amine surfactants.56 As 
a result, the development of new methods for synthesizing these compounds is critical for 
improving the sustainability and safety profiles of these transformations. Gröger and coworkers 
sought to take on this challenge and develop a chemoenzymatic route for the synthesis of long-
chain nitriles, particularly n-nonanenitrile (Figure 1.13C, 1.135).55 Their synthetic route 
commenced with rhodium-catalyzed hydroformylation of octene (1.132) under aqueous conditions 
to produce nonanal (1.133).55 Following this reaction, the product solution was diluted to 1.0 mM 
for downstream enzymatic reactions. Hydroxylamine was then added to the solution, resulting in 
condensation with aldehyde 1.133, generating the aldoxime species 1.134.55 An aldoxime 





of five homologous enzymes. The chosen biocatalyst, OxdRE, was then added in a whole-cell 
format to the reaction mixture, producing n-nonanenitrile (1.135) in high conversion and good 
yield over three steps in a single vessel.55 This new method avoids safety challenges in using 
dangerous inorganic cyanides on an industrial scale, thus offering an improved alternative to 
traditional synthesis of alkyl nitriles.55 
 
Chemoenzymatic methods using Deep Eutectic Solvents (DESs) 
 One of the most significant challenges in combining chemo- and biocatalytic processes is 
the incompatibilities between the reaction conditions required for the chemical and biocatalytic 
steps.7, 21 For example, destructive cross-reactivity between transition-metal catalysts and a 
biocatalyst can result in denaturation of the enzyme.7, 21 In the same vein, transition-metal catalysts 
often do not perform well in the aqueous environments required for biocatalysts and may require 
a phase-separated system to avoid catalyst poisoning by water.7, 21 This challenge can limit the 
overall scope of chemo- and biocatalytic transformations that can be combined in a one-pot 
process. Therefore, the development of novel systems that can overcome these limitations enables 
highly efficient one-pot chemoenzymatic transformations with improved catalytic parameters. In 
recent years, systems utilizing deep eutectic solvents (DESs) have been explored for 
chemoenzymatic reactions featuring water-sensitive transition-metal catalyzed transformations.57  
 DESs are solvent-salt mixtures that typically feature a hydrogen bond accepting quaternary 
ammonium salt, such as choline chloride (ChCl), and a hydrogen bond donor, such glycerol or 
saccharides.57 These solvent systems have been utilized for transition-metal catalyzed reactions in 
recent years, improving the solubility of organometallic catalysts under aqueous conditions, 





DESs also improve the efficiency of aqueous transition-metal catalysis by reducing water-related 
catalyst destruction, further improving the sustainability of these reactions. These reaction profile 
improvements are well-suited to chemoenzymatic processes, eliminating the need for biphasic 
reaction systems or organic cosolvents in combining chemical and biocatalytic steps in a one-pot 
system.57 
 Taking advantage of the improved characteristics of a DES-based system, Gröger and 
coworkers developed a one-pot chemoenzymatic reaction platform featuring a DES system 
containing ChCl and glycerol with a phosphate buffer (Figure 1.14A).58-59 Under DES reaction 
conditions, they performed a Suzuki-Miyaura cross-coupling reaction to generate a biphenyl 
Figure 1.14. Chemoenzymatic one-pot reactions performed in deep eutectic solvents 
(DESs). A. Suzuki-Miyaura cross coupling paired with KRED-catalyzed reduction or 
transaminase-catalyzed reductive amination. B. Ru-catalyzed alkene isomerization paired with 
KRED-catalyzed asymmetric reduction. C. Enzyme-catalyzed decarboxylation paired with Ru-





ketone (such as 1.138), coupled in a modular fashion with KREDs or transaminases to deliver 
enantioenriched benzylic amines or alcohols in moderate to good yields (see 1.139).58-59 The 
enantioselectivities achieved in these reactions were tuned by screening a library of reductive 
enzymes to give the desired enantiomer, providing a one-pot system for accessing all possible 
enantiomers of the resulting benzylic functionalized species.58-59 
 Gonzalez-Sabin and coworkers also developed a system utilizing a DES system to perform 
a ruthenium-catalyzed alkene isomerization of an allylic alcohol to generate a benzylic ketone 
(Figure 1.14B, see 1.140-1.143).60 Reduction using KREDs resulted in the formation of 
enantioenriched benzylic alcohol (such as 1.143) in moderate to good yields and excellent 
enantioselectivities.60 Notably, this reaction was performed in a cascade format and did not require 
a biphasic reaction mixture to prevent water-related destruction of the ruthenium catalyst. This 
catalyst behavior demonstrates the potential for DESs to allow previously incompatible chemical 
and biocatalytic processes in a single vessel and under mild, sustainable conditions.60 Garcia-
Alverez and coworkers built upon this work to develop a chemoenzymatic cascade reaction 
featuring an enzyme-catalyzed decarboxylation of α,β-unsaturated acids (such as 1.144) to produce 
styrenes (Figure 1.14C, 1.145).61 An immobilized phenolic acid decarboxylase from B. subtilis 
(BsPAD) was used to efficiently generate styrenes in the DES environment.61 The biocatalyst-
generated styrenes were then subjected to olefin metathesis using Grubbs 2nd generation catalyst 
to deliver substrate dimers, or a Heck cross-coupling to generate unsymmetrical aromatic olefins 
(see 1.146).61 These transformations were achieved in a one-pot process, demonstrating the 
versatility of DES environments in permitting diverse chemoenzymatic processes without the 
requirement of volatile organic cosolvents or biphasic reaction mixtures.61 Efforts to develop novel 





feasible chemical and biological transformations that can be combined in a single vessel. Such 
discoveries facilitate the removal of the barriers that prevent widespread adoption of 
chemoenzymatic processes in synthetic routes, leading to more efficient and sustainable syntheses. 
Chemoenzymatic polymer synthesis 
 As the demand for synthetic materials continues to increase, the efficient and economical 
synthesis of polymers continues to be of great importance.62-63 The search for more sustainable 
and environmentally-friendly polymerization methods has made enzymatic catalysis an attractive 
option. In particular, chemoenzymatic cascades for polymerization possess numerous desirable 
characteristics for sustainable synthesis, including: 1) robust and selective biocatalytic reactions; 
2) the ability to recycle and immobilize biocatalysts; 3) elimination of metal-based catalysts from 
the reaction process and 4) reduced chemical waste.62-63 Cascade reactions of this nature have used 
lipases as catalysts for ring-opening polymerization as well as to modify polymer building blocks 
Figure 1.15. Chemoenzymatic one-pot polymerization reactions.  
A. Lipase-catalyzed ring-opening of ε-caprolactone and in situ polymerization with styrene 
using a dual-headed radical initiator in living free radical polymerization (LFRP). B. Lipase-






before polymerization. As mentioned previously, lipases are a class of enzymes that primarily 
hydrolyze esters to yield free alcohols. Many of these biocatalysts have been well-studied, 
engineered, and commercialized as highly robust catalysts that are tolerant to both heat and organic 
solvents.47 In addition, some lipases can be immobilized, rendering a recyclable biocatalyst for use 
in industrial processes. As a result, lipases represent a highly targeted class of enzymes for 
industrial biocatalysis, including polymer synthesis. 
 Heise and coworkers took advantage of the sustainable aspects of lipase-catalyzed 
reactions by developing the first one-pot chemoenzymatic polymerization cascade (Figure 
1.15A).63 Using the commercial lipase Novozym 435, they achieved hydrolysis of 4-methyl-ε-
caprolactone (1.147) to generate free acid 1.148.63 Nitroxide 1.149 was then used as a dual-headed 
radical initiator in living free-radical polymerization (LFRP) to induce polymerization of styrene 
and form the non-ester portion of the polymer.63 Simultaneously, esterification and polymerization 
of the benzylic alcohol portion of the nitroxide initiator 1.149 resulted in the formation of a 
polymeric chain of aliphatic esters from the lipase-generated free acid 1.150. While this cascade 
was performed in one pot, precise control could be exerted over the polymerization process by 
changing the reaction temperature.63 Homolysis of nitroxide 1.149 does not occur until 
temperatures exceed 90 °C, preventing cross-reactivity challenges of rapid LFRP in the presence 
of the biocatalyst. In addition, control of polymer composition can be achieved by adjustment of 
the reaction temperature as the reaction stoichiometry changes during the operation.63 This 
optimization delivered a highly sustainable polymerization reaction combining chemo- and 






 Lipases, such as Novozym 435, have also been used to modify the monomeric subunits of 
polymers in cascade reactions. Wei and coworkers leveraged the hydrolytic abilities of Novozym 
435 to perform transesterification of trifluoroethyl ester 1.151 in the presence of various alcohols 
to generate new methacrylate monomers (Figure 1.15B, 1.153).62, 65 As new monomers were 
formed during the enzymatic reaction, radical initiator (2-bromoisobutyrate) was added to induce 
polymerization between the newly formed methacrylate monomers (1.153) and 
trifluoroethylmethacrylate (1.151). This polymer composition generated by this atom transfer 
radical polymerization process could thus be controlled by monitoring the progress of the 
enzymatic reaction and inducing polymerization when monomer composition was ideal.65 Careful 
kinetic analyses of both the enzymatic and chemical processes led to idealized conditions for the 
desired final polymer composition. A variety of alcohols were screened in this process, including 
aliphatic alcohols, benzylic alcohols, and glycols, yielding several functional polymers with 
distinct properties.65 Thus, this one-pot chemoenzymatic process provided a highly tunable and 
sustainable method for the direct synthesis of complex polymers.  
 
Chemoenzymatic synthesis of tetrahydroisoquinolines 
 Tetrahydroisoquinoline (THIQ) is a common core in a variety of biologically-active natural 
products and pharmaceuticals with antitumor and antiparasitic activities.66 The development of 
one-pot chemoenzymatic methods for building diverse THIQ cores has been explored extensively 
by numerous groups in order to rapidly generate libraries of these compounds.66 The biosynthesis 
of norcoclaurine, a plant natural product that has been used in ancient Chinese medicine, provided 
inspiration for the development of novel chemoenzymatic routes to access these compounds.67 In 





by the Pictet-Spenglerase (PSase) known as norcoclaurine synthase (NCS).67-68 In contrast, small 
molecule-based synthetic approaches require the use of chiral transition-metal catalysts to 
selectively produce the natural product scaffold.68 Macone and coworkers leveraged NCS for one-
pot synthesis of (S)-norcoclaurine from the renewable feedstock L-tyrosine (Figure 1.16A, 1.156-
1.158).68 This approach allows for in situ generation of aldehyde 1.157, which tends to polymerize 
in aqueous solutions and thus, must be generated and used quickly.68 Aldehyde 1.157 was 
produced directly by oxidative decarboxylation of L-tyrosine (1.156), using sodium hypochlorite 
as a stoichiometric oxidant.68 NCS was shown to be active in the presence of hypochlorite ion, 
allowing this reaction to be run in a cascade format and generating the natural product in high yield 
and enantioselectivity. This cascade prevented polymerization of aldehyde 1.157 and oxidation of 
dopamine that previously plagued attempts to generate (S)-norcoclaurine (1.158) biocatalytically 
on a synthetically-tractable scale.68 Mullowney and coworkers were inspired by this sodium 
hypochlorite approach in their design of a similar chemoenzymatic route to generate norcoclaurine 





decarboxylation to generate aldehydes (Figure 1.16B, see 1.159-1.160) in situ. NCS then catalyzed 
formation of various norcoclaurine derivatives (see 1.161) in a highly selective fashion with 
moderate to good yields through their cascade.69 
 Rother and coworkers developed an alternative chemoenzymatic strategy to access the 
THIQ core through a cascade reaction (Figure 1.16C).70 A carboligase from E. coli was first used 
to perform a stereoselective addition of pyruvate to benzaldehyde 1.162, generating the α-
hydroxyketone 1.163 in a highly selective manner.70 A second stereoselective reductive amination 
was performed using a transaminase from C. violaceum, producing the α-amino-benzylic alcohol 
1.164. A Pictet-Spengler reaction was then performed in situ using potassium phosphate as a base 
Figure 1.16. Chemoenzymatic one-pot synthesis of tetrahydroisoquinolines (THIQs).  
A. Hypochlorite-mediated oxidative decarboxylation of L-tyrosine paired with asymmetric 
Pictet-Spenglerase reaction catalyzed by NCS. B. Hypochlorite-mediated oxidative 
decarboxylation of L-tyrosine analogs paired with asymmetric Pictet-Spenglerase reaction 
catalyzed by NCS. C. Biocatalytic carboligation and asymmetric reductive amination paired 





and 2-bromobenzaldehyde as the corresponding aldehyde reaction partner. This yielded the THIQ 
1.165 in good yield and excellent diastereoselectivity. This approach provides the advantage of 
pre-arranged, enzyme-derived stereocontrol of the Pictet-Spengler reaction, allowing for the 
selective generation of THIQ 1.166 in an opposite configuration to that delivered by the native 
NCS reaction.70 
 Hailes and coworkers further developed the NCS reaction in a chemoenzymatic cascade to 
build tricyclic THIQs.71 Their reaction featured NCS-catalyzed Pictet-Spenger reactions using 
aldehyde reaction partners containing alkyl chains with terminal methyl esters (Figure 1.17A, 
1.166-1.169).71 The resulting THIQ products were generated stereoselectively, producing products 
with pendant alkyl esters located alpha to the amine (1.168). Following the enzymatic formation 
Figure 1.17. Chemoenzymatic one-pot synthesis of tetrahydroisoquinoline derivatives.  
A. NCS-catalyzed asymmetric Pictet-Spengler reaction paired with chemical cyclization to 
form tricyclic THIQs. B. MAO-catalyzed amine oxidation paired with Au-catalyzed alkyne 
addition. C. MAO-catalyzed amine oxidation and chemical racemization paired with berberine 





of THIQs, sodium carbonate was added to induce cyclization and form amide linkages with the 
free amine of the THIQ (see 1.168-1.169).71 This reaction resulted in the formation of tricyclic 
THIQs in moderate to good yields and with good enantioselectivity. 
 The generation of diverse THIQs through chemoenzymatic cascade is not limited to 
methods that produce the core scaffold.72 Turner and coworkers developed a method for α-
functionalization of the THIQ core with alkynes that featured site-selective MAO-catalyzed 
oxidation of the α-position to form an imine (Figure 1.17B, see 1.170-1.171).72 This was followed 
by gold-catalyzed nucleophilic addition of alkynes to the MAO-generated imine, resulting in the 
formation of α-functionalized THIQs. This one-pot process allowed for diversification of THIQs 
with a variety of alkynes under mild reaction conditions and with precise site-selectivity provided 
by the enzymatic oxidation. In addition, this method was the first to feature a free gold complex in 
a concurrent system with a biocatalyst and did not require a modular approach to the reaction.72  
 Processes that improve the stereoselectivity profiles in THIQ synthesis are critical for 
developing THIQs for pharmaceutical purposes. To this end, enzymatic processes that build 
THIQs, such as the Pictet-Spenglerase NCS, often only construct a single enantiomer of THIQ, 
providing precise stereoselectivity in the synthesis of these complex molecules.67 Kroutil and 
coworkers leveraged the enantioselectivity of berberine bridge enzyme to construct tetracyclic 
alkaloids, such as 1.176 (Figure 1.17C).73 Their chemoenzymatic cascade featured a racemization 
reaction in which one enantiomer of THIQ 1.174 was oxidized using an MAO, followed by 
racemic reduction with water-compatible morpholino-borane to generate rac-1.175.73 A single 
enantiomer of compound 1.175 was accepted by berberine bridge enzyme and cyclized to form the 
enantiopure alkaloid (S)-1.176. As this process was performed in cascade, the enantiomer (R)-





in the synthesis of (S)-alkaloid 1.176 in good yield and excellent enantioselectivities through 
dynamic kinetic resolution.73 
 
Chemoenzymatic synthesis of reactive intermediates 
 Synthetic approaches to natural products often take inspiration from biosynthetic 
pathways, attempting to mimic the elegance of Nature's ability to rapidly generate complexity from 
simple building blocks.74 Toward this goal, biosynthetic intermediates are often targeted as 
Figure 1.18. Chemoenzymatic one-pot synthesis and derivatization of o-quinols.  
SorbC-catalyzed asymmetric oxidative dearomatization of ketones and subsequent 





intermediates in the total synthesis of natural products.74 However, accessing biosynthetic 
intermediates using traditional methods can prove challenging, particularly for highly reactive 
molecules.   
 Highly reactive biosynthetic intermediates often represent a branching point for 
diversification to a variety of natural products. Thus, access to these molecules can set the stage 
for a divergent approach toward a suite of natural products. One such intermediate, 1.178, is 
involved in the biosynthesis of sorbicillinoid natural products, a structurally diverse class of 
secondary metabolites from fungi which possess numerous biological activities (Figure 1.18).29 
Cox and coworkers identified the enzyme responsible for the generation of this intermediate in the 
fungus Penicillium chrysogenum.75 This enzyme, SorbC, is a flavin-dependent monooxygenase 
that natively performs an enantioselective oxidative dearomatization on sorbicillin (1.177) or 
dihydrosorbicillin to generate reactive diene products sorbicillinol (1.178) or dihyrosorbicillinol, 
respectively.75 These biosynthetic intermediates can be further elaborated through subsequent 
transformations, including Diels-Alder cycloadditions and Michael addition reactions, to generate 
bisvertinolone (1.180), rezishanone B (1.189) and C (1.183), (+)-epoxysorbicillinol (1.181), and 
urea sorbicillinoid (1.185) among others.31 Developing a synthetic route that incorporates 
oxidative dearomatization has great potential for the divergent synthesis of this class of molecules 
and synthetic analogs.76-78 However, oxidative dearomatization is a challenging transformation to 
achieve chemically with site- and stereoselectivity, making it difficult to produce a single desired 
isomer and reducing the utility of this strategy for selective synthesis of complex molecules.30-32 
Furthermore, the intermediates generated by oxidative dearomatization are highly reactive, 
rendering their isolation and characterization difficult. To overcome these challenges, our group79 





products. In particular, SorbC-catalyzed oxidative dearomatization generates reactive diene 1.178, 
which can be further elaborated to sorbicillinoid natural products in a cascade or sequential fashion 
(Figure 1.18). We performed extensive characterization of the substrate scope of SorbC, 
demonstrating the structural requirements for productive binding and catalysis and also developed 
a one-pot chemoenzymatic route to urea sorbicillinoid (1.185) through the biocatalytic generation 
of 1.178, followed by cycloaddition with biacylated urea 1.184 and deprotection to yield 1.185.79 
Gulder and coworkers have also demonstrated the power of this chemoenzymatic approach to 
access numerous sorbicillinoid natural products.80-81 For example, bisvertinolone (1.180) was 
synthesized by [4+2] cycloaddition with the SorbC-generated dienophile 1.178, using DMF as a 
cosolvent. Diels-Alder reactions with vinyl ethers 1.182 and 1.188, as well as styrene 1.186, led to 
the synthesis of rezishanone C (1.183), rezishanone B (1.189) and sorbicatechol A (1.187), 
respectively.81 In addition, Gulder and coworkers performed the first enantioselective synthesis of 
(+)-epoxysorbicillinol (1.181) through the epoxidation of intermediate 1.178 in situ using Weitz-
Scheffer conditions.81 They note that pre-complexation of the potassium tert-butoxide species 
allows for the addition of the nucleophilic peroxide to the same face as the SorbC-installed 
hydroxyl group, thus promoting the selective epoxidation of 1.178.81 These chemoenzymatic 
approaches offer significant advantages over existing synthetic routes, including improved 
enantioselectivity, reduced step count and improved yields.80-81 Efforts such as these are critical 
for improving access to these compounds to enable biological studies and the determination of 
structure-activity relationships.25-27 
 As the field of biocatalysis continues to expand and play a greater role in synthetic 
chemistry, it is reasonable to expect that the development of innovative one-pot chemoenzymatic 





transition metal-catalyzed transformations is representative of this new frontier in biocatalysis. 
Efforts in this area will likely continue to increase in order to exploit the breadth of transition-
metal catalyzed reactions that have been established, broadening the chemical space that can be 
accessed through chemoenzymatic approaches. Furthermore, the ever-growing repository of 
annotated natural product biosynthetic pathways will similarly lead to the increasingly strategic 
use of biosynthetic enzymes to directly generate intermediates toward the synthesis of natural 
products.6, 74 A chemoenzymatic approach to the synthesis of complex molecules can provide 
selectivity, efficiency, and sustainability and, thus, stands to exert a significant influence on the 
field of complex molecule synthesis.6 The methods highlighted here demonstrate the power of 
pairing the selectivity of biocatalytic reactions with subsequent transformations to improve the 
efficiency and sustainability of a synthesis. As the volume of genome sequences available 
continues to grow, and new enzymes and transformations are discovered, it is reasonable to expect 
that the influence of biocatalysis will continue to expand. Chemoenzymatic strategies will play a 
central role in this expansion, improving the synthetic utility of these transformations and bridging 
the gap between the traditional synthetic and biocatalysis communities. 
 
1.3 Thesis Overview 
  The following chapters present the development of one-pot chemoenzymatic reaction 
sequences for the synthesis of natural products, natural product analogs, and other complex 
molecules. In particular, we used α-ketoglutarate-dependent (α-KG) non-heme iron (NHI) 
enzymes to catalyze challenging reactions with precise control over chemo- and site-selectivity. 





deliver products with increased chemical diversity, such as tropolone and chroman natural 
products.82 General contributions to the work presented in this thesis are as follows: substrate 
synthesis was performed in collaboration with Dr. Summer Baker Dockrey, Jonathan Perkins and 
Evan Romero. X-ray crystal structures presented for TropC were solved by Dr. Leena Mallik and 
Prof. Markos Koutmos (University of Michigan). Computational calculations were performed in 
collaboration with Kevin Skinner and Prof. Paul Zimmerman (University of Michigan).  
 
1.4 Non-heme iron α-ketoglutarate dependent dioxygenases 
Non-heme iron α-ketoglutarate-dependent dioxygenases 
 Non-heme iron (NHI) α-ketoglutarate-dependent (α-KG) dioxygenases are a diverse class 
of enzymes, responsible for a plethora of oxidative transformations in the context of secondary 
metabolism.83-84 These biocatalysts couple the activation of molecular oxygen to the 







decarboxylation of α-oxoacids, generating an iron(IV)-oxo species capable of performing 
hydrogen-atom abstraction.84-85 Following the formation of an iron(IV)-oxo species, a vast number 
of transformations can be achieved, including: hydroxylation, epoxidation, epimerization, 
desaturation, endoperoxidation, halogenation, demethylation, cyclization, ring contraction and 
ring expansion (Figure 1.19). This breadth of natural chemical diversity illustrates the inherent 
potential of NHI enzymes to be developed into synthetically-useful biocatalysts, which can enable 
highly chemo-, site- and stereoselective transformations. The selectivity of many NHI-catalyzed 
reactions is unmatched by traditional small molecule catalysis, making these enzymes powerful 
tools for developing novel reactions as well as direct and efficient synthetic routes to target 
molecules. However, despite their broad potential as valuable biocatalysts, NHI enzymes have 
generally been underutilized in chemoenzymatic one-pot processes, with limited examples of their 
use.86 Recent efforts to utilize NHI enzymes in synthetic routes have demonstrated that highly 
scalable platforms can be developed for these enzymes.17, 82, 86 In addition, Kourist and coworkers 
recently demonstrated that α-KG can be generated in situ through enzymatic oxidation of 
inexpensive and renewable L-glutamate by L-glutamate oxidase.87 This reaction was coupled with 
the action of an α-KG-dependent NHI enzyme on a near-process scale, producing product on the 
multi-gram scale and illustrating the scalability and sustainability offered for the use of α-KG-
dependent enzymes.87 Our work further demonstrates the scalability and synthetic utility of NHI 
enzymes in building complex molecules and natural products through the development of novel 








Mechanism of oxygen activation in α-KG-dependent NHI enzymes 
 Non-heme iron-dependent enzymes that activate molecular oxygen for oxidative chemistry 
often do so through diverse reaction mechanisms. For NHI enzymes which do not require a co-
substrate, such as catechol dioxygenases, cysteine dioxygenases or isopenicillin N synthase, 
oxygen is activated through direct binding of the substrate to the non-heme iron center, leading to 
the formation of an iron-oxygen complex which catalyzes the respective reaction.85 In comparison, 
α-KG-dependent NHI enzymes leverage the oxidative decarboxylation of co-substrate α-oxoacids 
to generate an iron(IV)-oxo active species.83, 85, 88 This reaction commences with 2-point 
coordination of α-KG, followed by substrate binding, weakening coordination of the axial water 
ligand, and allowing molecular oxygen to coordinate in the open axial site.83, 85, 88 One-electron 
reduction of oxygen from the enzyme–iron(II) complex (1.199) is proposed to generate a reactive, 
6-coordinate iron(III)-superoxo species (1.200).83, 88-90 The terminal oxygen radical of species 
1.200 is then proposed to react with the α-oxo double bond of α-KG to generate an iron(IV)-
peroxyhemiketal species (1.201) capable of undergoing two-electron oxidative decarboxylation to 
form the active iron(IV)-oxo species (1.202).83, 85, 88-90 The resulting iron(IV)-oxo species is highly 
oxidizing and capable of H atom abstraction with the substrate (shown as R–H), directly producing 
a substrate radical and iron(III)-hydroxyl species 1.203.91-94 In a canonical hydroxylation reaction, 
the resulting substrate radical and the iron(III)-hydroxyl species react in a one-electron process 
known as rebound hydroxylation (1.203-1.198).92 The formation of a substrate radical also 





desaturation, epoxidation, endoperoxidation, and halogenation. Many of these non-hydroxylation 
reactions have been studied in detail and mechanisms have been proposed for radical termination 
by the iron(III)-hydroxyl species to restart the catalytic cycle.92 
 Many years of intensive spectroscopic and structural studies have led to the establishment 
of the canonical mechanism of oxygen activation in α-KG-dependent NHI enzymes (Figure 1.20). 
Early advances in this area involved detailed mechanistic studies of taurine dioxygenase (TauD) 
from E. coli that natively catalyzes the oxidative cleavage of taurine to form aminoacetaldehyde 
and inorganic sulfite.91 Several steps of the TauD reaction have been characterized through 
extensive spectroscopic analysis which has been used to identify key intermediates in the catalytic 
cycle including (1) the high-spin TauD–Fe(II)–α-KG complex, (2) the high-spin TauD–Fe–α-KG–







substrate complex, (1.199), and (3) the Fe(IV)-oxo active species (1.202).91-98 Similar intermediate 
complexes have also been observed in other α-KG-dependent NHI enzymes, including prolyl-4-
hydroxylase and deacetoxy-cephalosporin C synthase (DAOCS).99-100  
 Detailed analyses have revealed that substrate binding and oxygen activation by 
decarboxylation of α-KG (1.199-1.202) occur in a concerted process in these model systems.88, 100 
These observations establish substrate binding as a "gatekeeper" interaction in preventing 
unwanted access to the highly-reactive Fe(IV)-oxo species. In this model, coupling substrate 
binding to the activation of oxygen prevents enzymatic self-immolation by the undesired 
generation of reactive oxidant capable of oxidizing enzymatic residues directly or through the 
release of harmful reactive oxygen species such as hydrogen peroxide into the cellular 
environment.100 Only molecules that can achieve productive binding geometries can, therefore, be 
oxidized, avoiding oxidation of non-substrate molecules and allowing precise spatiotemporal 
control over the chemo- and site-selectivity of the reaction.88, 100 
 
Structural features of α-KG-dependent NHI enzymes 
 Decades of structural studies of the α-KG-dependent subclass of NHI enzymes have 
revealed highly conserved structural motifs.101-102 The major defining fold for this enzyme class is 
a double-stranded β-helix (DSBH) structure, defined as the "jelly-roll fold" (also the cupin fold) 
for its pastry-like resemblance.101, 103-104 The jelly roll motif consists of a β-sandwich structure with  





site (Figure 1.21).105 The jelly roll fold is 
"distorted" in that one end of the β-sandwich is 
held together tightly, and the other end is more 
open, creating space for substrate entry.102, 104  
 Additional architectural features that 
assist in substrate recognition are also quite 
common in α-KG-dependent NHI enzymes, 
including α-helices or loops, which generate 
key substrate contacts in the active site.103, 106 
Substrate recognition elements can assist in the 
preorganization of the enzyme, generating the 
active enzyme-substrate-cosubstrate complex that can engage in oxygen activation and productive 
catalysis.103, 106 C-terminal regions of NHI enzymes have been shown to be quite mobile and 
capable of participating in conformational changes.101, 103 There is also evidence that α-KG binding 
is a key component of this process, leading to active site preorganization and engaging primary 
substrate recognition elements for subsequent substrate binding.101 In structures of NHI enzymes, 
α-KG (or the non-cleavable mimic N-oxalylglycine) typically coordinates the NHI center in a 
bidentate fashion with the C1-carboxylate bound equatorially to the metal complex.101, 105 The non-
coordinating carboxylate group of α-KG interacts with a polar, cationic residue (typically arginine) 
that assists in maintaining a proper geometry for oxidative decarboxylation of the cofactor and the 
subsequent release of carbon dioxide during catalysis.101, 103-104 The size of the co-substrate also 
often dictates the order of events in catalysis, as α-KG cannot typically enter the active site to bind 
while the substrate is bound.100-101 These characteristics of active site preorganization lend to a 
Figure 1.21. Ribbon representation of 
model NHI enzyme TauD. 
Crystal structure of TauD (PDB: 1GY9) 
illustrating the canonical β-sandwich 







generalized model of ordered binding in NHI enzymes in which α-KG must bind first, leading to 
active site preorganization, followed by substrate binding and catalysis as described in the previous 
section.100 
 Although substrate recognition elements vary widely amongst α-KG-dependent NHI 
enzymes, the NHI metal complex itself is typically conserved.101-102 With certain exceptions (such 
as NHI halogenases), these biocatalysts 
bind iron through a facial triad made up 
of two histidine residues and one 
carboxylate residue that can be either 
aspartic acid or glutamic acid.101-102 The 
2-His-1-carboxylate scaffold is easily 
identified within the DSBH fold through 
sequence alignment, possessing a highly 
conserved HXD/E---H motif in which X 
can be any residue.102 The resulting facial 
triad is often located near the "open" end of the β-sandwich motif, allowing co-substrate and 
substrate access to the catalytic center (for example, see Figure 1.22).101, 105 In the case of NHI 
halogenases, the carboxylate residue in the HXD/E---H motif is often replaced with alanine or 
glycine, opening up a separate site for halide (Cl- or Br-) coordination and subsequent C–H 
halogenation activity.101, 104, 107 
 
Figure 1.22. NHI active site in TauD. 
Crystal structure of TauD (PDB: 1GY9) illustrating 
the NHI center. The iron ion (brown) is coordinated 
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Chapter 2: Chemoenzymatic Ortho-quinone Methide Formation and Elaboration 
 
Adapted with permission from Doyon, T. J. et al. Chemoenzymatic ortho-quinone methide 




 Nature has developed strategies for generation of highly reactive intermediates in the 
synthesis of complex secondary metabolites.1-2 For example, cyclases control the reactivity of 
cationic or anionic intermediates in the selective biosynthesis of complex natural products.1, 3 This 
observed reactivity is controlled by the active site of the biocatalysts, directing the reaction 
outcome through controlled generation and orientation of the reactive intermediate.1, 3 Synthetic 
approaches that mimic biosynthetic pathways often encounter challenges in reproducing the 
elegance of these evolved methods, at times requiring blocking groups to achieve selectivity, or 
are inherently incompatible with a breadth of functional groups.4-7 Ortho-quinone methides (o-
QMs, 2.4) have been implicated in the biosynthesis of several families of natural products, as these 
versatile intermediates can readily participate in inverse electron-demand Diels-Alder (IEDDA) or 
1,4-addition reactions.4-6 For example, the penilactone (see 2.1),8 peniphenone (see 2.5),8 and 
communol (2.2)9 families of natural products are proposed to arise from benzylic oxidation of 





fungal metabolites (Figure 2.1A).10 Other complex natural products, such as (±)-liphagal (2.3)11-12 
and (±)-carpanone (2.4)13-14 are proposed to be generated through modification of o-QMs, 
demonstrating the structurally-diverse array of natural products which can be constructed from this 
common intermediate (Figure 2.1A). In addition, o-QMs have been leveraged for the efficient 
synthesis of complex natural products and bioactive compounds, such as (–)-peniphenone A 
(2.5),15 (+)-cytosporolide A (2.6),16 rubioncolin B (2.7),17 and (±)-schefflone (2.8),18 among 
numerous others.4-7 These examples demonstrate the synthetic utility of o-QMs, which enable 
Figure 2.1. Ortho-quinone methide-derived natural products 
A. Representative natural products proposed to arise from biosynthetic o-QM generation and 
elaboration. B. Representative natural products synthesized through elaboration of an o-QM. C. 





direct access to complex, bioactive products through IEDDA or 1,4-addition reactions. Therefore, 
the development of novel, efficient, and sustainable methods for accessing o-QM intermediates 
provides powerful opportunities for streamlined construction of natural products and their 
derivatives.19 
  
Figure 2.2. Ortho-quinone methide generation and benzylic functionalization 
A. Oxidative methods for generation of ortho-quinone methides (o-QMs). B. Biocatalytic 
oxidative benzylic functionalization. C. This work: One-pot biocatalyst-initiated o-QM 





Oxidative access to ortho-quinone methides 
 Synthetic strategies have been developed to access o-QMs through the oxidative 
functionalization of phenolic substrates to generate o-QM precursors (Figure 2.2A, 2.11-2.12).4-7 
These methods typically involve the installation and activation of a benzylic leaving group, 
followed by prolonged heating to generate the corresponding o-QM.15, 20-21 Direct oxidation 
methods using transition metals or organic oxidants have enabled access to o-QMs in a one-pot 
system without the need for pre-functionalization of the substrate (Figure 2.2A, 2.15-2.16).4-7, 22-28 
However, this approach is generally restricted to electron-rich compounds and often exhibits a lack 
of control over the chemo- or site-selectivity of oxidation.4-7, 22-28 For example, in Lei’s one-pot 
synthesis of (±)-schefflone (2.8), the natural product is produced through Ag2O-mediated oxidation 
of an electron-rich o-QM precursor (espinatol, 2.9) and subsequent trimerization of the resulting 
o-QM intermediate 2.10.18 In order to achieve the desired transformation, numerous small 
molecule oxidants and reaction conditions were screened.18 Most conditions led to undesired 
oxidation of the aromatic ring of espinatol (2.9), forming p-quinol product 2.11 as the major 
product.18 Only one set of oxidative reaction conditions selectively produced the desired product 
(2.8), highlighting chemo-selectivity challenges which can prevent oxidative o-QM synthesis.18 
Extensive screening of small molecule oxidants is often a requirement in the development of direct, 
oxidative routes to o-QMs, presenting a major roadblock to the efficient syntheses of these 
intermediates.4, 18  Furthermore, one-pot generation and functionalization of o-QMs requires a 
delicate balance between reactivity of the oxidant and compatibility with reagents for o-QM 
diversification.4, 27 Often, oxidizing reagents which are required for o-QM generation can interfere 
with downstream functionalization of o-QMs or prove incompatible with sensitive moieties 





redox-sensitive nucleophiles, such as thiols and amines, in 1,4-addition reactions with the o-QM, 
thus preventing downstream o-QM functionalization. We envisioned that a biocatalytic platform 
for o-QM formation and interception could address these challenges of chemo- and site-selectivity 
and enable one-pot generation and derivatization of an o-QM. 
 Inspired by the efficiency of Nature’s approach, we sought to exploit an enzymatic strategy 
for o-QM creation.8 Biosynthetically, o-QMs are proposed to arise from ortho-cresol precursors 
(see 2.17, 2.19, Figure 2.2B) through hydroxylation at the benzylic position, followed by loss of 
water to afford an o-QM under mild intracellular conditions.8 These intermediates can be 
intercepted by bioavailable dienophiles or nucleophiles to build the core scaffold of various natural 
products, including peniphenone D (2.21).8 We envisioned a biocatalytic approach to oxidative o-
QM generation would afford a selective and sustainable method for increasing the structural 
complexity of simple arene precursors (Figure 2.2C). This approach would combine the selectivity 
advantages of biocatalytic pre-functionalization with the ability to generate and diversify o-QMs 
in a single vessel under mild conditions. We also anticipated that the reactive nature of o-
hydroxybenzylic alcohols would reduce required reaction times and temperatures, leading to 
efficient functionalization of the resulting o-QM.  
 
Biocatalytic benzylic C–H oxidation 
 Nature has evolved numerous tools for the oxidation of benzylic C–H bonds. Several 
reports have highlighted the utility of biotransformations in accomplishing this challenging 
reaction.29-34 These methods rely on native monooxygenases present in microbes to accomplish 
benzylic oxidation on a range of substrates.29-34 Several cytochromes P450 have also been 





biocatalytic methods do not offer complete control over the final oxidation state of the product, 
they successfully reduce the overall environmental impact of the transformation by using earth-
abundant iron as the catalytic metal, molecular oxygen as the stoichiometric oxidant, and water as 
the bulk solvent.35-43  
 Motivated by the advantages of an enzymatic approach to benzylic hydroxylation, we 
sought to demonstrate the chemo- and site-selectivity of biocatalytic C–H functionalization and 
opportunities for cascade reactions under biocatalytic reaction conditions. We anticipated that an 
α-ketoglutarate-dependent (α-KG) non-heme iron oxygenase could be employed for the selective 
oxidation of primary benzylic C–H bonds. This well-studied enzyme family has demonstrated 
scalability44 and tunability through protein engineering to alter substrate scope.45 By coupling the 
activation of molecular oxygen to the decarboxylation of inexpensive α-oxoacid co-substrates, 
these enzymes generate an iron(IV)-oxo species capable of hydrogen-atom abstraction.46-47 α-KG-
dependent non- heme iron oxygenases catalyze a wide variety of selective transformations 
following this conserved mechanism, including hydroxylation, halogenation, epoxidation, 
desaturation, epimerization, endo-peroxidation, ring-contraction, and ring-expansion.46-48 Unlike 
many P450s, α-KG-dependent non-heme iron oxygenases do not require an exogenous reductase 
to complete their catalytic cycle.46-47 We anticipated that the simple reaction requirements of this 
enzyme class would provide distinct advantages in developing a widely applicable platform. 
 Our search for biocatalysts capable of selective benzylic C‒H hydroxylation led us to two 
homologous fungal NHI oxygenases (sharing 54% sequence identity): CitB, from Monascus 
ruber, and ClaD, native to Penicillium crustosum.49 Cox and coworkers demonstrated through in 
vivo experiments that CitB performs a benzylic hydroxylation in the biosynthesis of the mycotoxin 





transformation in the biosynthesis of peniphenones and penilactones (Figure 2.2B, 2.19-2.21).8 
We envisioned employing CitB and ClaD as general catalysts for benzylic hydroxylation of ortho-
cresol substrates. We anticipated that, following benzylic C–H bond oxidation, an o-QM 
intermediate (see 2.22-2.24 Figure 2.2C) could be accessed and intercepted with a variety of 
nucleophiles or dienophiles to form benzylic C–O, C–N, C–S, and C–C bonds in a biomimetic 
fashion.8 Here, we demonstrate this approach with two biocatalysts, but we anticipate this 
chemoenzymatic platform could be executed with a plethora of wild-type enzymes to access more 
diverse substrates and complementary selectivity. 
 
2.2 Analytical-scale biocatalytic benzylic C–H hydroxylation 
Proof-of-principle transformation and comparative study with chemical oxidations 
 Toward developing a chemoenzymatic method for benzylic C–H functionalization, we 
tested the feasibility of biocatalytic C–H hydroxylation, coupled with o-QM formation and 
derivatization with a model substrate (see 2.26, Figure 2.3) that captures the conserved methyl 
resorcinol core of CitB and ClaD’s native substrates. This model compound maintained the redox-
sensitive aldehyde moiety and hydroxyl groups present in the citrinin biosynthetic intermediate 
(2.27). Model compound 2.26 was completely consumed in 3 h upon exposure to 0.4 mol % CitB 
in the presence of α-KG, an iron(II) source and sodium ascorbate in 50 mM TES buffer at pH 7.5 
(Figure 2.3). From this reaction, a single benzylic alcohol product (2.27) was isolated in 82% yield 
without any evidence of oxidation of either the aldehyde or the resorcinol core. This result 
demonstrated that CitB could function on a non-native substrate with the robustness needed for 





we subjected substrate 2.26 to several chemical oxidation conditions and did not observe 
conversion to the desired benzylic alcohol 2.27 (see Table 2.S1). For example, attempts to oxidize 
2.26 with DDQ50 resulted in over-oxidation to the bis-aldehyde and no reaction was observed upon 
exposure of 2.26 to MnO2
51 or Ag2O.
52 Efforts to perform benzylic hydroxylation with K2S2O8
53 
or cerium ammonium nitrate54 led to decomposition of the substrate. Radical bromination 
conditions with AIBN/NBS resulted in aromatic bromination and did not generate the desired 
benzylic halide for subsequent hydrolysis to the benzyl alcohol.55 These results capture the 
challenge in accomplishing this seemingly simple benzylic hydroxylation in the presence of redox-
sensitive aldehyde and phenolic groups. Next, the reactivity of benzylic alcohol 2.27 was 
investigated under aqueous conditions. Gratifyingly, upon gentle heating in the presence of 
thiophenol, alcohol 2.27 was quantitatively transformed into thioether 2.300 through an anticipated 
o-QM intermediate (2.28-2.29). These experiments provided evidence for o-QM formation under 
remarkably mild conditions compared to previous reports for the generation of o-QMs from ortho-
hydroxy benzylic alcohols.5, 56-57 
 
Analytical-scale substrate screen and analysis 
 Evidence that CitB is sufficiently robust to perform preparative-scale reactions and provide 
access to o-QMs under mild conditions spurred further investigation of this chemoenzymatic 
Figure 2.3. Initial experiments to assess feasibility of NHI biocatalyst-initiated o-QM 





strategy, including studies with the homologous NHI enzyme, ClaD.  To investigate the substrate 
scope of CitB and ClaD, a panel of substrates was synthesized possessing a conserved ortho-cresol 
core (Figure 2.4).58 This panel was designed to define the electronic and steric parameters of 
substrates that undergo a productive reaction with the NHI biocatalysts. Compounds 2.19, 2.26, 
and 2.31-2.50 were subjected to analytical-scale reactions with CitB and ClaD, using standard 
conditions for α-KG-dependent non-heme iron oxygenases.48 These analytical-scale reactions 
were performed in vitro with purified enzyme (Figure 2.S5), as well as in whole cell or crude cell 
lysate format (Figure 2.4). For CitB, a whole cell reaction platform led to efficient benzylic C–H 
hydroxylation. Whereas, filtered crude cell lysate produced the best results for ClaD. Both of these 
reaction platforms provide an operationally-simple method (see Section 2.6, Part III) for preparing 
and using NHI biocatalysts in a manner that is amenable to preparative-scale reactions, avoiding 
arduous protein purification steps.59-61  
 Analytical-scale reactions revealed that CitB and ClaD each selectively hydroxylate 
compounds with a variety of steric and electronic properties (Figure 2.4). Introducing bulky, 
electron-withdrawing or electron-donating groups at either the C5 or C6 position was tolerated in 
reactions with CitB. However, ClaD demonstrated limitations in its ability to accept larger groups, 
such as phenyl substituents at C5 and C6 (see 2.44 and 2.40). The complementarity in substrate 
scope between CitB and ClaD is also observed in the substitution at C4. For CitB, the formyl group 
at C4 can be substituted with alternative electron-withdrawing substituents such as a nitro group 
(2.33) or imine (2.32). However, substrates with greater steric bulk at C4, such as ketone 
substrates, were generally not hydroxylated by CitB. ClaD demonstrated complimentary activity 
in its ability to react with ester (2.36) and a variety of ketones (see 2.34, 2.35, 2.37).  The 





dimethylresorcinol (2.31). Based on preliminary analysis of models of these biocatalysts, we 
anticipate that a hydrogen bond acceptor is critical at the C4 position to achieve a catalytically 
active conformation of the substrate-enzyme complex. Current efforts are focused on obtaining 
homologues or enzyme variants that do not require substrates bearing a hydrogen bond acceptor, 
such as an aldehyde, for a productive reaction to occur.  
 To probe the substrate scope of our 
biocatalysts beyond resorcinol substrates, 
phenolic compounds 2.50 and 2.S6 (see 
Figure 2.S5) were subjected to NHI 
hydroxylation conditions. Phenol 2.50 was 
converted to the corresponding benzylic 
alcohol; however, the position of the 
hydroxyl group proved to be important for 
catalysis as phenol 2.S6 was not oxidized 
by either CitB or ClaD.  These results 
motivated us to synthesize an additional 
panel of phenolic substrates to further 
assess the scope of NHI biocatalytic 
hydroxylation (2.47-2.49). In the case of 
CitB, increasing the steric bulk at the C5 
position increased the conversion of 
substrates to hydroxylated products except 
for 2-naphthyl substrate 2.47, which 
Figure 2.4. Substrate scope for CitB and ClaD-
catalyzed benzylic C‒H hydroxylation. 
Reaction conditions: 2.5 mM substrate, 45 
mg/mL CitB wet cell pellet or 10% v/v ClaD 
crude cell lysate, 50 mM TES pH 7.5, 5 mM α-
ketoglutaric acid (α-KG), 8 mM sodium ascorbate 
(NaAsc), 0.1 mM ferrous sulfate (FeSO4), 30 °C, 
100 rpm shaking, 3 h. [*] with 15% acetonitrile as 
cosolvent. [**] with 15% tetrahydrofuran as 
cosolvent.  Conversion to product was quantified 





demonstrated decreased conversion, possibly reflecting the steric limitations of the CitB active 
site. ClaD showed minimal ability to hydroxylate phenolic substrates 2.47-2.50. 
 Detailed analysis of reactions of CitB and ClaD with a diverse library of substrates 
demonstrated that these related enzymes exhibited complementary reactivity toward o-cresol 
substrates. Furthermore, these two enzymes represent a minute fraction of the annotated NHI 
sequences.35-36 We anticipate that the substrate scope of this NHI platform for o-QM generation 
can be further expanded by screening NHI enzyme libraries for activity against target substrates. 
Enzymes demonstrating even low levels of activity with test compounds would serve as excellent 
starting points for routine protein engineering to achieve improved product yields.  
 
2.3 Preparative-scale biocatalytic benzylic C–H hydroxylation and computational analysis 
 As a next step in the evaluation of the synthetic utility of biocatalytic benzylic 
hydroxylation, we performed reactions on preparative-scale using whole cell (CitB) and crude cell 
lysate (ClaD) conditions (Figure 2.5). This method enabled routine performance of reactions on 
>500 mg scale without the requirement for protein purification. Isolation and characterization of 
C5-substituted benzylic alcohol products 2.27 and 2.54-56 was achieved with yields that 
corresponded to starting material consumption. For example, benzylic alcohol 2.27 was isolated 
in 82% yield. However, poor isolated yields were obtained for substrates with C6-substituents, 
despite nearly complete consumption of starting material (see 2.57-2.61). Further analysis of the 
crude product mixture from these reactions revealed a second product, in which a molecule of 
ascorbic acid had been incorporated, presumably through interception of an intermediate o-QM 





 The observed reactivity of C6-substituted alcohols was explored computationally in 
collaboration with Kevin Skinner and Prof. Paul Zimmerman. This reactivity can be explained by 
Figure 2.5. Preparative-scale biocatalytic benzylic C–H hydroxylation and computational 
analysis.  
A. General scheme for CitB and ClaD-catalyzed benzylic hydroxylation and in situ 
functionalization with thiophenol. B. Preparative scale reaction isolated yields for CitB-
catalyzed hydroxylation and functionalization. Reaction conditions: 2.5 mM substrate, [a]45 
mg/mL CitB wet cell pellet or [b]10% v/v ClaD clarified cell lysate, 50 mM TES pH 7.5, 5 mM 
α-ketoglutaric acid (α-KG), 8 mM sodium ascorbate (NaAsc), 0.1 mM ferrous sulfate (FeSO4), 
30 °C, 100 rpm shaking, 3 h. [c] PhSH was added directly to reaction mixture after conversion 
to benzylic alcohol and incubated at 40 °C, 3 h, 100 rpm shaking. C. Thermodynamic analysis 
of C6-methyl (green) and C6-nitro (blue) substrates. Structures represent the starting material, 
benzylic alcohol product, o-QM, and thiophenol adducts (left to right). The energies are mass 
balanced with a truncated 2-His-1-Asp non-heme iron system (see  Figure 2.S86). Geometry 
optimizations and frequency calculations were performed at B3LYP 6-311++G** and 6-31G** 





thermodynamics of the reaction sequence of 2.51 to 2.53 (Figure 2.5A), which includes 
hypothetical substrates to explore the electronic effects at both the C5 and C6 positions (see 
Section 2.6 Part XIV for detailed analysis). We identified a relationship between inductive effects 
and Gibbs free energy. The thermodynamic trends indicated that benzylic alcohols with electron-
withdrawing substituents at the C6-position were less thermodynamically stable, making these 
substrates more reactive and prone to generation of an o-QM. This computational data supported 
our experimental observations. Therefore, we hypothesized that higher yields could be achieved if 
the reactive benzylic alcohol products were first trapped in situ as more stable benzylic thioethers. 
The corresponding thermodynamic analysis of thiophenol adducts 2.74 and 2.76 revealed that, 
regardless of substitution, the benzylic thioethers are lower in energy than their respective benzylic 
alcohol precursors (Figure 2.5C, Figures 2.S88 and 2.S89). To test this hypothesis, we developed 
an in situ functionalization protocol, demonstrating that increasing the reaction temperature to 40 
°C and adding two equivalents of thiophenol led to the isolation of the desired benzylic thioethers 
2.57-2.61 and 2.70 as the sole product in each reaction.  
 
2.4 One-pot chemoenzymatic o-QM formation and elaboration 
 Motivated by this initial success in generating and diversifying o-QMs under mild 
conditions, we assessed the range of products accessible through this cascade. First, a panel of 
nucleophiles was evaluated in 1,4-addition reactions (Figure 2.6, 2.80-2.84). Both linear and 
branched alcohols were competent nucleophiles, affording the desired products (2.80-2.82) in 
good yields. A secondary amine nucleophile was also productive (2.84); however, reactions with 





nucleophiles reacted smoothly to provide the desired conjugate addition products (2.30 and 2.83) 
in excellent yields. The comparatively high yield of thioether adducts relative to alkyl ether adducts 
is likely due to the increased nucleophilicity of sulfur compared to the alcohol precursor as well as 
the increased stability of the sulfur adducts.  
 The feasibility of benzylic C–C bond formation was probed through inverse electron-
demand Diels-Alder (IEDDA) reactions. The reactivity of biocatalyst-generated benzylic alcohol 
2.27 with various dienophiles was evaluated through a one-pot reaction sequence. Following 
generation of 2.27 by CitB, the reaction mixture was heated to 45 °C in the presence of ethyl vinyl 
ether. Gratifyingly, chroman products 2.85 and 2.86 were produced in 64% and 27% yield, 
respectively. Reactions with electron-rich dienophiles (2.87-2.90) proceeded smoothly to deliver  
mixtures of two isomeric products derived from the two possible o-QM intermediates (2.28 and 
2.29). Reactions employing electron-rich dienophiles typically afforded 4:1 mixtures of isomeric 
products, favoring the product derived from reaction with the C1 o-QM (2.28). Reactions with 
styrenes 2.91-2.94 were also carried out. Due to the electron-deficient character of these 
dienophiles, these reactions required a higher temperature, 65 °C, to undergo a productive 
reaction.4 The major products of these IEDDA reactions resulted from reaction with o-QM 2.29. 
This operationally-simple, one-pot protocol accomplishes the direct conversion of benzylic C–H 
bonds to C–O, C–N, C–S and C–C bonds, allowing for direct access to diverse chemical scaffolds 
and demonstrating the synthetic utility of these biocatalysts.   
 Upon the observation that o-QM generation occurs at reduced temperatures, we 
hypothesized that these reactions likely proceed through low barrier processes. This was assessed 
and confirmed computationally using benzylic alcohol 2.27. We generated models for both C1 and 





generation was found to proceed through a concerted, low barrier transition state, while reactions 
with ethyl vinyl ether and styrene were found to proceed through concerted, asynchronous 
transition states that are typically proposed for IEDDA mechanisms (Figures 2.S83 and 2.S84).  
 To highlight the advantages of this biocatalytic route to o-QMs, we sought applications 
that require chemoselectivity and mild reaction conditions. Specifically, we tested this chemistry 
in the selective modification of biomolecules, an application that demands both of these 
attributes.62-64 We envisioned the selective modification of cysteine residues in peptides and 
proteins could be possible under physiological conditions. Two complementary peptides were 
synthesized: one peptide that contained a cysteine residue (2.97) and another in which the cysteine 
was replaced with a lysine residue (2.S15). Substrate 2.26 was subjected to in vitro CitB-catalyzed 
hydroxylation conditions in the presence of either peptide 2.97 or 2.S15. After an 18 h incubation 
the cysteine-containing peptide was converted only to singly-modified peptide 2.98 (61% 
conversion). Under the same conditions, the peptide containing a lysine in place of cysteine (2.S15) 
was not modified. These cascade reactions demonstrate the utility of this biocatalytic method for 
in situ functionalization of peptides. We anticipate this method could be applied to the selective 
labelling of peptides with reactive molecules generated in situ. Further, the compatibility of this 
method with aldehyde and alkyne substrates provides an additional handle for introducing 
chromophores or fluorophores using biorthogonal chemistry.65-67 
 Finally, to highlight the advantages of our mild one-pot protocol we targeted the chroman 
natural product, (–)-xyloketal D (2.25), a fungal metabolite from Xylaria sp. first isolated from the 
South China Sea.68 Synthetic strategies have been developed for the synthesis of (–)-xyloketal D 
including a Diels-Alder cycloaddition by Wilson,20 a sequential Michael-addition ketalization 





Figure 2.6. One-pot NHI biocatalyst-initiated o-QM generation and diversification. 
A. Synthetic scheme for one-pot NHI biocatalyst-initiated o-QM generation and diversification. 
B. Yields of one-pot Michael addition reactions. C. Yields of one-pot IEDDA reactions. D. 
One-pot functionalization of cysteine-containing peptide. E. One-pot chemoenzymatic 





and Panda in 2013.70 Wilson and co-workers employed an o-QM as a key intermediate, with 
thermal conditions for o-QM generation leading to a 37% combined  yield of 4 products, including 
(–)-xyloketal D (2.25) and the associated ketal diastereomer (2.101), as well as two diastereomeric 
spiroketals, in a 2:1 ratio of ketal to spiroketal isomers. In this case, the formation of spiroketal 
products is a result of undesired isomerization of the dienophile under the thermal reaction 
conditions.20 Our chemoenzymatic strategy avoids this issue by providing a more reactive o-QM 
precursor (see Figure 2.S93) circumventing any dienophile isomerization challenges. After 
synthesis of chiral dienophile 2.100, according to Wilson’s established procedure, we subjected 
methyl ketone 2.99 to our conditions for biocatalytic benzylic C–H hydroxylation with ClaD crude 
lysate, obtaining complete conversion to benzylic alcohol 2.68. Following the enzymatic C–H 
benzylic hydroxylation step, benzene was added directly to the biocatalytic reaction mixture, along 
with dienophile 2.100. The reaction tube was sealed and heated to 80 °C for 16 h. This process 
generated (–)-xyloketal D (2.25, 64% yield) in a 2:1 ratio with its diastereomer (2.101, 28% yield) 
and no detectable formation of unwanted spiroketal products. Thus, our approach enabled a one-
pot chemoenzymatic synthesis of (–)-xyloketal D (2.25), with improved yields and under mild 
conditions.20 We anticipate this one-pot chemoenzymatic strategy will facilitate the streamlined 
synthesis of a variety of natural products. 
 
2.5 Conclusions 
 We have demonstrated the utility of a biocatalytic platform for chemo- and site-selective 
C–H functionalization of ortho-cresol substrates. Leveraging this biocatalytic hydroxylation, o-





The chemoselective, mild nature of this sequence allows for interception of o-QMs with small-
molecule and peptide nucleophiles as well as electron-rich dienophiles, exemplified in the total 
synthesis of (–)-xyloketal D. This platform offers a strategy for accessing o-QMs that is 
complementary to existing methods, offering new options to practicing organic chemists. We 
anticipate that biocatalyst-initiated o-QM generation can be broadly applied to other biocatalysts 
capable of benzylic C–H hydroxylation and will enable transformations complementary to small 
molecule catalysts and reagents. 
 
2.6 Experimental 
I. Substrate and peptide synthesis 
General Information: All reagents were used as received unless otherwise noted. Reactions were 
carried out under a nitrogen atmosphere using standard Schlenk techniques unless otherwise noted. 
Solvents were degassed and dried over alumina columns on an MBraun solvent system (Innovative 
Technology, Inc., Model PS-00-3). Reactions were monitored by thin layer chromatography using 
Millipore 60 F254 pre-coated silica TLC plates (0.25 mm) which were visualized using UV, p-
anisaldehyde, CAM, DNP, or bromocresol green stains. Flash column chromatography was 
performed using Machery-Nagel 60 μm (230-400 mesh) silica gel. All compounds purified by 
column chromatography were sufficiently pure for use in further experiments unless otherwise 
indicated. 1H and 13C NMR spectra were obtained in CDCl3 at rt (25 °C), unless otherwise noted, 
on Varian 400 MHz or Varian 600 MHz spectrometers. Chemical shifts of 1H and 13C NMR spectra 
were recorded in parts per million (ppm) on the δ scale. High resolution electrospray mass spectra 
were obtained on an Agilent 1290 Series Infinity II HPLC with a 6230 Series Time-of-Flight mass 





Flight mass spectrometer. UPLC-PDA spectrometric traces were obtained on a Waters Aquity H-
class instrument. IR spectra were recorded on a Perkin-Elmer Spectrum BX FT-IR spectrometer. 
 
Compounds 2.8, 2.26, 2.23, 2.26-2.28, 2.30-2.36, and 2.39 were prepared and characterized by our 
lab previously.58 Details of this characterization can be found in the Supplementary Information 
of the provided reference. Compound 2.29 (methyl atratate) was purchased from Sigma Aldrich 




A flame-dried vial equipped with a stir bar was charged with 2,4-dihydroxy-3,6-
dimethylbenzaldehyde (100 mg, 0.604 mmol, 1.00 equiv), methylamine hydrochloride (80 mg, 1.2 
mmol, 2.0 equiv), and MeOH (1.2 mL, 0.50 M). The reaction was heated at 65 °C with stirring for 
18 h during which time a pink solid precipitated out of the reaction. After cooling to room 
temperature, EtOAc (5 mL) was added to the reaction mixture. The reaction mixture was filtered 
to collect the pink solid. The pink solid was dissolved in water (5 mL) and added to a separatory 
funnel followed by the addition of saturated NaHCO3 (10 mL). This mixture was extracted with 
EtOAc (3 x 15 mL). The combined organic layers were washed with brine, dried over Na2SO4, 
and concentrated under reduced pressure to afford 107 mg (99% yield) of the title compound as a 
pink solid. The material was used without further purification. 1H NMR (599 MHz, CDCl3) δ 8.37 





162.5, 158.1, 137.3, 110.1, 109.3, 108.0, 42.8, 18.7, 7.4; HRMS (ESI) m/z: [M-H]- calculated for 
C10H12NO2
- 178.0874, found 178.0877; IR (thin film): 2925, 2652, 1733, 1643, 1606, 1502, 1457, 
1392, 1351, 1256, 1148, 1111, 1029, 1005 cm-1. 
 
2,5-dimethyl-4-nitrobenzene-1,3-diol (2.33) 
A flame-dried round-bottom flask equipped with a stir bar was charged with 2,5-dimethylbenzene-
1,3-diol (100 mg, 0.724 mmol, 1.00 equiv) and Cu(NO3)2•2.5H2O (101 mg, 0.434 mmol, 0.600 
equiv). The flask was cooled to 0 °C and Ac2O (1 mL, 0.7 M) was added to the reaction. The 
reaction was stirred for 3 h before water (5 mL) was added to the reaction and the mixture extracted 
with EtOAc (3 x 10 mL). The combined organic layers were washed with brine, dried over Na2SO4, 
and concentrated under reduced pressure. Purification on silica gel (gradient elution 1% to 75% 
EtOAc in hexanes) afforded 64 mg (35% yield) of the title compound as a yellow solid. All 
spectroscopic data for the compound was in accordance with literature values.71 1H NMR (599 
MHz, CD3OD) δ 6.32 (s, 1H), 2.49 (s, 3H), 2.06 (s, 3H); HRMS (ESI) m/z: [M-H]- calculated for 
C8H8NO4




A flame-dried round-bottom flask equipped with a magnetic stir bar was charged with 5-bromo-





mmol, 2.50 equiv) and 1,4-dioxane (4 mL, 0.25 M). Phenylboronic acid (188 mg, 1.54 mmol, 2.00 
equiv) and Pd(PPh3)4 (89 mg, 0.077 mmol, 0.10 equiv) were added to the flask. The reaction 
mixture was stirred and heated at 80 °C for 24 h before being cooled to rt and quenched by addition 
of 5 mL of saturated NaHCO3. The reaction mixture was extracted with EtOAc (3 x 20 mL). The 
combined organic layers were washed with brine, dried over Na2SO4, and concentrated under 
reduced pressure. The crude solid was transferred to a flame-dried round-bottom flask equipped 
with a magnetic stir bar and dichloromethane (3 mL, 0.25 M) was added. The flask was cooled to 
-78 °C before BBr3 (183 μL, 1.92 mmol, 2.50 equiv) was added to the reaction dropwise by syringe 
over 5 min. The reaction was removed from the cooling bath, allowed to warm to room 
temperature, and stirred for 18 h. Next, the reaction was cooled to 0 °C and quenched by slow 
addition of ice water (5 mL) by syringe followed by stirring for 10 min. The reaction mixture was 
extracted with EtOAc (3 x 10 mL). The combined organic layers were washed with brine, dried 
over Na2SO4, and concentrated under reduced pressure. Purification on silica gel (gradient elution 
5% to 40% EtOAc in hexanes) afforded 148 mg (84% yield) of the title compound as a white solid. 
1H NMR (599 MHz, CD3OD) δ 9.70 (s, 1H), 7.45 (d, J = 7.3 Hz, 2H), 7.41 (t, J = 7.6 Hz, 2H), 
7.35 (s, 1H), 7.33 (t, J = 7.4 Hz, 1H), 2.14 (s, 3H); 13C NMR (151 MHz, CD3OD) δ 196.7, 162.1, 
161.4, 138.9, 134.9, 130.5, 129.5, 128.2, 124.2, 116.0, 112.8, 7.9; HRMS (ESI) m/z: [M-H]- 
calculated for C14H11O3
-
 227.0714, found 227.7011; IR (thin film): 2926, 1625, 1425, 1377, 1305, 







A flame-dried round-bottom flask equipped with a magnetic stir bar was charged with 5-bromo-
2-methylphenol (2.00 g, 10.7 mmol, 1.00 equiv) and dichloromethane (107 mL, 0.1 M). The 
reaction was cooled to 0 °C and TiCl4 (1.41 mL, 12.8 mmol, 1.20 equiv) was added dropwise. The 
reaction was stirred at 0 °C for 30 min before dichloromethyl methyl ether (1.06 mL, 11.8 mmol, 
1.10 equiv) was added dropwise. The reaction mixture was allowed to warm to room temperature 
over 18 h with stirring. The reaction mixture was transferred to a separatory funnel and quenched 
by addition of saturated NaHCO3 (150 mL). The mixture was extracted with dichloromethane (3 
x 100 mL). The combined organic layers were washed with brine, dried over Na2SO4, and 
concentrated under reduced pressure. Purification on silica gel (gradient elution 5% to 40% EtOAc 
in hexanes) afforded 528 mg (23% yield) of the title compound as a white solid. 1H NMR (599 
MHz, CD3OD) δ 10.08 (s, 1H), 7.66 (s, 1H), 7.03 (s, 1H), 2.17 (s, 3H); 13C NMR (151 MHz, 
CD3OD) δ 191.9, 163.6, 132.9, 126.9, 126.8, 126.7, 119.8, 15.7; HRMS (ESI) m/z: [M-H]- 
calculated for C8H6O2Br
-
 212.9557, found 212.9576; IR (thin film): 3083, 1650, 1580, 1494, 1263, 
1139, 981, 901, 850, 641, 447 cm-1. 
 
4-hydroxy-5-methyl-2-phenylbenzaldehyde (2.48) 
A flame-dried round-bottom flask equipped with a magnetic stir bar was charged with 2-bromo-
4-hydroxy-5-methylbenzaldehyde (25 mg, 0.12 mmol, 1.0 equiv), K2CO3 (48 mg, 0.35 mmol, 3.0 
equiv), and 1,4-dioxane (1.0 mL, 0.12 M). Phenylboronic acid (28 mg, 0.23 mmol, 2.0 equiv) and 
Pd(PPh3)4 (27 mg, 0.023 mmol, 0.20 equiv) were added to the flask. The reaction mixture was 
stirred and heated at 80 °C for 24 h before being cooled to room temperature and quenched by 





mL). The combined organic layers were washed with brine, dried over Na2SO4, and concentrated 
under reduced pressure. Purification on silica gel (gradient elution 5% to 40% EtOAc in hexanes) 
afforded 15 mg (48% yield) of the title compound as a yellow solid. 1H NMR (599 MHz, CD3OD) 
δ 9.66 (s, 1H), 7.76 (s, 1H), 7.50-7.38 (m, 3H), 7.38-7.31 (m, 2H), 6.75 (s, 1H), 2.26 (s, 3H); 13C 
NMR (151 MHz, CD3OD) δ 192.5, 162.5, 148.4, 139.4, 131.4, 131.0, 129.4, 129.0, 127.0, 126.3, 
116.9, 15.8; HRMS (ESI) m/z: [M-H]- calculated for C14H11O2
-
 211.0765, found 211.0766. IR 






A flame-dried round-bottom flask equipped with a magnetic stir bar was charged with 2-bromo-
4-hydroxy-5-methylbenzaldehyde (25 mg, 0.12 mmol, 1.0 equiv), K2CO3 (48 mg, 0.35 mmol, 3.0 
equiv), and 1,4-dioxane (1.0 mL, 0.12 M). Naphthalene-2-boronic acid (42 mg, 0.23 mmol, 2.0 
equiv) and Pd(PPh3)4 (27 mg, 0.023 mmol, 0.20 equiv) were added to the flask. The reaction 
mixture was stirred and heated at 80 °C for 24 h before being cooled to room temperature and 
quenched by addition of 3 mL of saturated NaHCO3. The reaction mixture was extracted with 
EtOAc (3 x 10 mL). The combined organic layers were washed with brine, dried over Na2SO4, 
and concentrated under reduced pressure. Purification on silica gel (gradient elution 5% to 40% 





(599 MHz, CD3OD) δ 9.72 (s, 1H), 7.96-7.87 (m, 3H), 7.81 (s, 1H), 7.80 (s, 1H), 7.56-7.51 (m, 
2H), 7.49 (dd, J = 8.3, 1.5 Hz, 1H), 6.86 (s, 1H), 2.28 (s, 3H); 13C NMR (151 MHz, CD3OD) δ 
192.5, 162.5, 148.2, 136.8, 134.5, 134.2, 131.6, 130.0, 129.1, 128.9, 128.8, 128.7, 127.8, 127.6, 
127.3, 126.4, 117.2, 15.9; HRMS (ESI) m/z: [M-H]- calculated for C18H13O2
-
 261.0921, found 
261.0917; IR (thin film): 2991, 2913, 1732, 1436, 1373, 1241, 1042, 952, 696 cm-1. 
 
Peptide Synthesis 




Peptide design and synthesis: The peptides listed above were designed from a sequence reported 
to have a ligandable cysteine residue, based on screens with cysteine-reactive probes.72 The 
peptides synthesized using standard FMOC solid-phase synthesis methods on a Liberty Blue 
Microwave Synthesizer (CEM). Rink Amide ProTide resin (CEM) was utilized for peptide 
synthesis, providing C-terminal amide protection upon cleavage of the peptide. Amino acid 
coupling reactions were performed by mixing diisopropylcarbodiimide (7 equiv relative to resin, 
ChemImpex), Oxyma Pure (5 equiv, CEM), and amino acid (5 equiv) in N,N-dimethylformamide, 
followed by irradiation to maintain a temperature of 90 °C for 4 min. FMOC protecting groups 
were removed by suspending the resin in 20% piperidine in N,N-dimethylformamide with 0.2 M 
Oxyma Pure and irradiating to maintain a temperature of 90 °C for 1 min. The resin was rinsed (4 
times each cycle) with N,N-dimethylformamide between deprotection and coupling steps. The 





triethylamine for N-terminal acetylation. The resulting peptide was cleaved from the resin with 
95% trifluoroacetic acid (Sigma Aldrich), 2.5% ddH2O, and 2.5% triisopropylsilane (Sigma 
Aldrich). The resin was incubated in the resulting solution for 4 h at RT under continuous mixing 
conditions before filtration to remove resin. The resin was rinsed with three volumes 
dichloromethane and the resulting solution was concentrated to 1 mL total volume under a stream 
of nitrogen gas in a 15 mL Falcon tube. The peptide was precipitated by the addition of 10 mL of 
cold diethyl ether, followed by overnight incubation at -20 °C. The precipitate was collected by 
centrifugation and dried under a stream of nitrogen gas. After drying, the crude peptide mixture 
was dissolved in 1:1 MeCN/ddH2O containing 1% formic acid (2 mL total volume). 
Peptide purification: The peptide was purified by reverse-phase HPLC using an Agilent 1260 
Series LC-DAD with a 150 x 30 mm Luna Omega 5 μm PS C18 column (Phenomenex) under the 
following conditions: mobile phase (solvent A: ddH2O + 0.1% trifluoroacetic acid; solvent B: 
acetonitrile) gradient elution over 40 min (10% to 50% solvent B). The purity of the peptides was 
assessed by analytical LC/MS on an Agilent 1290 Series Infinity II HPLC with a 6230 Series 
Time-of-Flight (TOF) mass spectrometer. Samples were analyzed on a Phenomenex Aeris 3.6 μm 
WIDEPORE C4 column (2.1 x 50 mm) under the following conditions: mobile phase (solvent A: 
ddH2O + 0.1% trifluoroacetic acid; solvent B: acetonitrile + 0.1% trifluoroacetic acid) gradient 
elution over 6 min (5% to 100% solvent B). The purified peptide fractions were combined and 
concentrated to dryness under a stream of nitrogen gas. The peptide was then resuspended in 
minimal DMSO (20 μL) and the concentration quantified by UV-vis spectrometry on a Nanodrop 
spectrophotometer based on the absorbance of the N-terminal tyrosine at 280 nm (ε280 = 1280 M-






III. Plasmid and protein information 
Plasmids: The gene encoding citB (KT781075.1) was codon-optimized for overexpression in E. 
coli and synthesized by GeneArt (ThermoFisher). The synthesized sequence was cloned by 
GeneArt into a pET-151 vector containing the T7 expression system, ampicillin resistance, and N-
terminal 6 x His-tag encoded upstream from the insert gene. No further modifications to this 
plasmid construct were necessary.  
 The gene encoding claD (QBK15042.1) was codon-optimized for overexpression in E. coli 
and synthesized by Twist Bioscience. The synthesized sequence was cloned by Twist Bioscience 
into a pET-28a vector containing the T7 expression system, kanamycin resistance, and N-terminal 
6 x His tag encoded upstream from the insert gene. No further modifications to this plasmid 
construct were necessary. 































































Protein overexpression and purification: The plasmid containing citB or claD was transformed 
using a standard heat-shock protocol for chemically competent E. coli into BL21(DE3) cells. 





L flasks. 500 mL portions of autoclaved media were inoculated with 5 mL of overnight culture 
prepared from a single colony in Luria Broth (LB) and 100 μg/mL ampicillin or 50 μg/mL 
kanamycin (Gold Biotechnology). Cultures were grown at 37 °C and 200 rpm until the optical 
density (at 600 nm) reached 0.8. The cultures were then cooled to 20 °C for 1 h and protein 
expression was induced with 0.2 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG, Gold 
Biotechnology). Expression was continued at 20 °C overnight (approx. 18 h) at 200 rpm. The 
typical yield for one 500 mL culture cell pellet (wet cell pellet) was ~25 g. 
 
General purification procedure: 50-60 g of cell pellet containing CitB or ClaD was resuspended 
in 250 mL of lysis buffer containing 50 mM Tris HCl (pH 7.4), 300 mM NaCl, 10 mM imidazole 
and 10% glycerol. The mixture was homogenized using a handheld dounce homogenizer. 
Approximately 1 mg/mL lysozyme (Gold Biotechnology) was added prior to 1 h incubation on a 
rocker held at 4 °C. Cells were lysed by sonication of the total cell lysate in 100 mL batches on 
ice. Each cycle of sonication was 10 s sonication, followed by a 20 s rest period, for a total of 6 
min at 60% power. The total cell lysate was centrifuged at 45,000 x g for 30 min and the 
supernatant was removed. The cell lysate was incubated with 3 mL of Ni-NTA resin (Thermo) for 
1 h at 4 °C with gentle rocking. The supernatant was filtered through a fritted 50 mL plastic column 
(Gold Biotechnologies) to isolate the Ni-NTA resin. The resin was washed with 100 mL of wash 
buffer containing 50 mM Tris HCl (pH 7.4), 300 mM NaCl, 25 mM imidazole and 10% glycerol. 
The protein was then eluted using 15 mL of an elution buffer containing 50 mM Tris HCl (pH 7.4), 
300 mM NaCl, 250 mM imidazole and 10% glycerol. The eluted protein was concentrated to a 
volume of 2.5 mL using a 30 KDa molecular weight cutoff ultrafiltration device (Amicon). The 





a storage buffer containing 50 mM Tris HCl (pH 7.4), 300 mM NaCl, and 10% glycerol. The 
protein was eluted from the column with 3.5 mL of storage buffer, before flash freezing in liquid 
nitrogen and storage at -80 °C. Protein concentration was determined by the A280 absorbance 
method using a Nanodrop spectrophotometer. The concentration was corrected using the estimated 
extinction coefficient from the ProtParam tool on the Expasy server (CitB: ε = 1.128; ClaD ε = 
0.890). Average yield: 60 mg/L of CitB; 41 mg/L of ClaD. 
 
Preparation of clarified crude cell lysate (ClaD only): 50-60 g of cell pellet containing ClaD 
was resuspended to a volume of 45 mg/mL in lysis buffer containing 50 mM Tris HCl (pH 7.4), 
150 mM NaCl, and 10% glycerol. The mixture was homogenized using a handheld dounce 
homogenizer. Approximately 1 mg/mL lysozyme (Gold Biotechnology) was added prior to 1 h 
incubation on a rocker held at 4 °C. Cells were lysed by sonication of the total cell lysate in 100 
mL batches on ice. Each cycle of sonication was 10 s sonication, followed by a 20 s rest period, 
for a total of 6 min at 60% power. The total cell lysate was centrifuged at 45,000 x g for 30 min 
and the supernatant was removed. The resulting supernatant was clarified by filtration through a 
0.4 μm sterile filtration device. Aliquots of lysate were flash frozen in liquid nitrogen and stored 






Figure 2.S1. SDS-PAGE gel of purified CitB (40.61 kDa with 6x His tag) 
                 






























III. Biocatalytic reactions and products 
Stock solutions: Stock solutions of each substrate (50 mM) were prepared by dissolving the 
substrate in DMSO (analytical grade). Stock solutions of α-ketoglutaric acid (125 mM), ferrous 
sulfate (10 mM) and sodium ascorbate (50 mM) were freshly prepared before each use, stored on 
ice, and used within 3 h. Aliquots of CitB (124 μM) and ClaD (80 μM) were stored at -80 °C until 
needed. 
In vitro analytical-scale reactions (CitB and ClaD): Each reaction contained 50 mM TES buffer 
pH 7.5 (2.5 μL of a 1 M solution), 2.5 mM substrate (2.5 μL, 50 mM), 10 μM CitB (4 μL, 124 μM) 
or ClaD (6.25 μL, 80 μM), 5 mM α-ketoglutaric acid (2 μL, 125 mM), 0.1 mM ferrous sulfate 
heptahydrate (0.5 μL, 10 mM), 8 mM sodium ascorbate (8 μL, 50 mM) and Milli-Q water to a 
final volume of 50 μL. Reactions were carried out at 30 °C for 3 h and quenched by the addition 
of 3 volumes of acetonitrile containing 3.5 mM pentamethyl benzene as an internal standard. 
Precipitated biomolecules were pelleted by centrifugation (17,000 x g, 20 min). The supernatant 
was analyzed by UPLC-DAD and conversion obtained by comparison to calibration curves of each 
substrate. 
Whole cell analytical-scale reactions (CitB): Except where otherwise noted, each reaction 
contained 50 mM TES buffer pH 7.5 (25 μL of a 1M solution), 2.5 mM substrate (25 μL, 50 mM), 
22.5 mg CitB wet cell pellet (45 mg/mL), 5 mM α-ketoglutaric acid (20 μL, 125 mM), 0.1 mM 
ferrous sulfate (5 μL, 10 mM), 8 mM sodium ascorbate (80 μL, 50 mM) and Milli-Q water to a 
final volume of 500 μL. Reactions were carried out at 30 °C for 3 h and quenched by the addition 
of 3 volumes of acetonitrile containing 3.5 mM pentamethylbenzene as an internal standard. The 
supernatant was analyzed by UPLC-DAD and conversion obtained by comparison of remaining 





Crude cell lysate analytical-scale reactions (ClaD): Each reaction contained 50 mM TES buffer 
pH 7.5 (2.5 μL of a 1 M solution), 2.5 mM substrate (2.5 μL, 50 mM), 10% v/v ClaD (5 μL) or 5 
mM α-ketoglutaric acid (2 μL, 125 mM), 0.1 mM ferrous sulfate heptahydrate (0.5 μL, 10 mM), 8 
mM sodium ascorbate (8 μL, 50 mM) and Milli-Q water to a final volume of 50 μL. Reactions 
were carried out at 30 °C for 1 h and quenched by the addition of 3 volumes of acetonitrile 
containing 3.5 mM pentamethyl benzene as an internal standard. Precipitated biomolecules were 
pelleted by centrifugation (17,000 x g, 20 min). The supernatant was analyzed by UPLC-DAD and 
conversion obtained by comparison to calibration curves of each substrate. 
Determination of percent conversion: Percent conversion was determined by analysis of each 
reaction after 3 h. PDA spectrometric analysis was performed on a Waters Aquity H-Class 
instrument, using a Phenomenex Kinetex (1.7 μm C18, 2.1 x 150 mm) column under the following 
conditions: mobile phase (Solvent A: deionized water + 0.1% formic acid; Solvent B: acetonitrile 
+ 0.1% formic acid) 5% to 100% solvent B over 2 min, 100% solvent B for 1 min; flow rate: 0.5 
mL/min. Based on the calibration curves of the starting materials, the percent conversion of the 
substrate to hydroxylated product was calculated with AUCsubstrate (300 nm)/AUCinternal standard (270 
nm). In vitro reactions were performed and analyzed in triplicate, while whole cell reactions were 
performed and analyzed in duplicate with reported conversions as an average of those trials. 
 
General procedure for whole cell milligram-scale reactions: Except where otherwise noted, 
preparative-scale enzymatic reactions were conducted on 20-40 mg of each substrate under the 
following conditions: 2.5 mM substrate, 50 mM TES buffer pH 7.5, 5 mM α-ketoglutaric acid, 0.1 
mM ferrous sulfate, 8 mM sodium ascorbate, 45 mg/mL CitB wet cell pellet. Reactions were 





times reaction volume) and shaken at 100 rpm at 30 °C. Reaction progress was monitored at hourly 
intervals by analysis of a 50 μL aliquot by UPLC-DAD. The aliquot was processed in the manner 
described for in vitro analytical scale determination of reaction conversion. Upon satisfactory 
conversion of the substrate, the product(s) were isolated in the following manner. Isolation 
procedure: The reaction mixture was transferred to a 50 mL falcon tube and 2 volumes of acetone 
were added. The mixture was centrifuged at 4,500 x g for 10 min to separate the biomolecule 
components from the aqueous reaction mixture. The supernatant was removed and acetone 
removed under reduced pressure. The supernatant was acidified to pH 2.0 with 0.1 M HCl. The 
organic materials were extracted from the aqueous layer with ethyl acetate (3 x 50 mL). The 
organic fractions were pooled and concentrated under reduced pressure to yield a crude mixture. 
To ensure maximal product recovery, the pelleted wet cell components were extracted with 
hexanes and ethyl acetate. These fractions were concentrated under reduced pressure to yield a 
separate crude mixture. These mixtures were purified by either preparative HPLC or flash silica 
gel chromatography (Biotage). 
 
General procedure for crude cell lysate milligram-scale reactions: Except where otherwise 
noted, preparative-scale enzymatic reactions were conducted on 20-100 mg of each substrate under 
the following conditions: 2.5 mM substrate, 50 mM TES buffer pH 7.5, 5 mM α-ketoglutaric acid, 
0.1 mM ferrous sulfate, 8 mM sodium ascorbate, 10% v/v ClaD clarified crude lysate (prepared 
from 45 mg/mL wet whole cell suspension). Reactions were performed in Erlenmeyer flasks of 
appropriate volume to achieve proper oxygenation (at least 3 times reaction volume) and incubated 
at 30 °C. Reaction progress was monitored at hourly intervals by analysis of a 50 μL aliquot by 





determination of reaction conversion. Upon satisfactory conversion of the substrate, the product(s) 
were isolated in the following manner. Isolation procedure: The reaction mixture was acidified 
to pH 2.0 with 0.1 M HCl. The organic materials were extracted from the aqueous layer with ethyl 
acetate (3 x 50 mL). The organic fractions were pooled and concentrated under reduced pressure 
to yield a crude mixture. These fractions were concentrated under reduced pressure to yield a 
separate crude mixture. These mixtures were purified by either preparative HPLC or flash silica 
gel chromatography (Biotage). 
 
Modified procedure for whole-cell milligram-scale reactions with in situ functionalization: 
Preparative-scale reactions with in situ functionalization using thiophenol were set up using a 
protocol identical to the general procedure for whole cell milligram-scale reactions, except that 
after 1 h, 2 equiv of thiophenol was added and the temperature increased to 40°C. 
 
Procedure for one-pot whole-cell chemoenzymatic cascade reactions (nucleophile addition): 
Analytical scale whole-cell cascade reactions were performed in 15 mL Falcon tubes (in duplicate 
trials) in a manner analogous to analytical-scale CitB reactions, except that after 3 h, cell pellet 
was spun down at 4,000 x g for 5 min. 2 equiv of nucleophile were added directly to the 
supernatant. Each Falcon tubes was shaken at 400 rpm and 37 °C for 16 h. 50 μL of the reaction 
was removed and diluted 10x with acetonitrile containing 3.5 mM pentamethyl benzene as internal 





standard. For reactions run neat in nucleophilic solvent, 50 μL of sample was concentrated to 
dryness under reduced pressure. The dried film was then diluted 10 x with acetonitrile and internal 
standard, plus 50 μL of ddH2O to dissolve associated reaction salts. Samples were analyzed by 
UPLC using the method for determination of conversion percentage described previously, except 
for morpholine adduct 77, which was analyzed using a hydrophilic interaction column (HILIC) 
under the following conditions: mobile phase (Solvent A: deionized water + 0.1% formic acid; 
Solvent B: acetonitrile + 0.1% formic acid) 85% to 40% solvent B over 7 min, 85% solvent B for 
6 min; flow rate: 0.45 mL/min. HILIC column = Waters Acquity 1.7 μm UPLC BEH Amide HILIC 
2.1 x 100 mm. Samples were quenched by the addition of 3 equiv solution containing 1:1 deionized 
water and acetonitrile, with 3.5 mM L-tryptophan as internal standard. 
 
Procedure for one-pot whole-cell chemoenzymatic cascade reactions (Diels-Alder reactions): 
Analytical scale whole-cell cascade reactions were performed in 1 dram reaction vials (duplicate) 
in a manner analogous to analytical scale CitB reactions, except that the reactions were stirred at 
100 rpm using a Teflon stir bar for 3 h at 30 °C. After 3 h, 10 equiv of dienophile was added to the 
vial which was sealed with an air-tight cap and heated to 60 °C (65 °C for styrene and 2,3-
dihydrofuran) for 16 h. For reactions using styrenes as a dienophile, 50 μL of the reaction was 
removed and diluted 10x with acetonitrile containing 3.5 mM pentamethyl benzene as an internal 





standard. For reactions with all other dienophiles, 50 μL of sample was reduced to dryness under 
reduced pressure. The dried film was then diluted 10 x with acetonitrile and internal standard, plus 
50 μL of ddH2O to dissolve associated reaction salts. Samples were analyzed by UPLC using the 
method for determination of conversion percentage described above. Reactions were performed in 
triplicate, with reported conversions as an average of those trials. 
 
Purification by preparative HPLC: For purification of milligram-scale reactions, the resulting 
crude mixture was taken up in a 60:40 mixture of milli-Q water:acetonitrile (2 mL). The product(s) 
were purified from this mixture by preparative HPLC using a Phenomenex Kinetex 5 μm C18, 150 
x 21.2 mm column under the following conditions: mobile phase (Solvent A: deionized water + 
0.1% formic acid; Solvent B: acetonitrile + 0.1% formic acid) 5% to 100% solvent B over 13 min, 






Figure 2.S5. In vitro conversion of phenolic substrates in CitB- and ClaD-catalyzed 
benzylic hydroxylation. 
Reaction conditions: 2.5 mM substrate, 10 μM CitB or ClaD, 50 mM TES pH 7.5, 5 mM α-
ketoglutaric acid (α-KG), 8 mM sodium ascorbate (Na Asc), 0.1 mM ferrous sulfate (FeSO4), 
30 °C, 3 h. Np = 2-naphthyl. Conversion to product was quantified by UPLC-DAD analysis 






Products of biocatalytic benzylic C–H hydroxylation 
 
2,4-dihydroxy-3-(hydroxymethyl)-6-methylbenzaldehyde (2.27) 
The title compound was synthesized according to the general procedure for milligram-scale whole 
cell enzymatic hydroxylation with CitB. The reaction was performed with 500 mg of starting 
material. Purification by flash chromatography afforded 460 mg (84% yield) of the title compound 
as a white solid. 1H NMR (400 MHz, MeOD) δ 10.07 (s, 1H), 6.26 (s, 1H), 4.68 (s, 2H), 2.50 (s, 
3H); 13C NMR (150 MHz, MeOD) δ 194.5, 165.5, 165.4, 145.5, 113.7, 112.8, 111.2, 53.7, 18.2; 
HR-ESI-MS: m/z calcd for C9H11O4
+ [M+H-H2O]
+: 165.0546, found: 165.0544; IR (thin film): 




The title compound was synthesized according to the general procedure for milligram-scale whole 
cell enzymatic hydroxylation with CitB. The reaction was performed with 20 mg of starting 
material. Purification by preparative HPLC afforded 10.6 mg (50% yield) of the title compound as 
a white solid. 1H NMR (400 MHz, CD3OD) δ 9.68 (s, 1H), 7.46 (d, J = 8.8, 1H), 6.50 (d, J = 8.8, 
1H), 4.73 (s, 2H); 13C NMR (150 MHz, CD3OD) δ 196.2, 165.7, 163.5, 136.4, 115.8, 114.6, 109.4, 
53.7; HR-ESI-MS: m/z calcd for C8H11O4
+ [M+H-H2O]
+: 151.0390, found: 151.0393; IR (thin 







The title compound was synthesized according to the general procedure for milligram-scale whole 
cell enzymatic hydroxylation with CitB. The reaction was performed with 20 mg of starting 
material. Purification by preparative HPLC afforded 7.4 mg (35% yield) of the title compound as 
a tan film. 1H NMR (400 MHz, CD3OD) δ 10.07 (s, 1H), 6.73 (s, 1H), 4.68 (s, 2H); 13C NMR 
(150 MHz, CD3OD) δ 195.3, 165.0, 164.7, 128.6, 113.0, 111.2, 110.8, 61.3; HR-ESI-MS: m/z 
calcd for C8H9O4Br
+ [M+H-H2O]
+: 228.9495, found: 228.9493; IR (thin film): 3129, 2831, 1617, 
1460, 1425, 1248, 1109, 1019 cm-1. 
 
3,5-dihydroxy-4-(hydroxymethyl)-[1,1'-biphenyl]-2-carbaldehyde (2.56) 
The title compound was synthesized according to the general procedure for milligram-scale whole 
cell enzymatic hydroxylation with CitB. The reaction was performed with 20 mg of starting 
material, using 30 mg/mL CitB wet cell pellet. Purification by preparative HPLC afforded 6.8 mg 
(30% yield) of the title compound as a white film. 1H NMR (400 MHz, CD3OD) δ 9.53 (s, 1H), 
7.43 (m, 3 H), 7.38 (m, 2H), 6.38 (s, 1H), 2.58 (s, 2H); 13C NMR (150 MHz, CD3OD) δ 195.9, 
165.1, 150.4, 139.0, 130.8, 130.7, 130.1, 129.4, 129.3, 129.0, 114.0, 113.0, 111.0, 53.7; HR-ESI-
MS: m/z calcd for C14H13O4
+ [M+H-H2O]
+: 227.0703, found: 227.0705; IR (thin film): 3296, 








The title compound was synthesized according to the modified procedure for milligram-scale 
whole cell enzymatic hydroxylation with CitB and in situ functionalization with thiophenol. The 
reaction was performed with 20 mg of starting material. Purification by flash chromatography 
afforded 9.2 mg (31% yield) of the title compound as a white solid. 1H NMR (400 MHz, CD3OD) 
δ 9.67 (s, 1H), 7.78 (s, 1H), 7.37 (m, 10H), 4.28 (s, 2H); 13C NMR (150 MHz, CD3OD) δ 196.2, 
162.3, 138.4, 138.1, 136.4, 131.8, 129.7, 128.5, 127.4, 124.6, 115.7, 113.4, 27.9; HR-ESI-MS: 
m/z calcd for C20H17O3S
+ [M+H]+: 337.0893, found: 337.0903; IR (thin film): 3057, 2926, 2854, 
1606, 1549, 1456, 1438, 1306, 1087 cm-1. 
 
2,4-hydroxy-3-(hydroxymethyl)-5,6-dimethylbenzaldehyde (2.58) 
The title compound was synthesized according to the general procedure for milligram-scale whole 
cell enzymatic hydroxylation with CitB. The reaction was performed with 20 mg of starting 
material, using 30 mg/mL CitB wet cell pellet. Purification by preparative HPLC afforded 12.8 
mg (40% yield) of the title compound as a white solid. 1H NMR (400 MHz, CD3OD) δ 10.15 (s, 
1H), 7.37 (d, J = 8.0, 2H), 7.23 (t, J = 8.0, 2H), 7.15 (t,  J = 8.0, 1H) 4.23 (s, 2H), 2.46 (s, 3H), 2.11 
(s, 3H); 13C NMR (150 MHz, CD3OD) δ 195.3, 163.0, 163.0, 142.1, 138.4, 131.2, 129.6, 127.1, 
117.3, 113.9, 109.9, 27.5, 14.0, 11.66; HR-ESI-MS: m/z calcd for C16H17O3S









The title compound was synthesized according to the general procedure for milligram-scale whole 
cell enzymatic hydroxylation with CitB and in situ functionalization with thiophenol. The reaction 
was performed with 40 mg of starting material. Purification by flash chromatography afforded 
14.8 mg (23% yield) of the title compound as a white solid. 1H NMR (400 MHz, CD3OD) δ 9.63 
(s, 1H), 7.31 (s, 1H), 4.87 (s, 2H), 2.16 (s, 3H); 13C NMR (150 MHz, CD3OD) δ 196.3, 164.5, 
160.5, 135.7, 119.1, 115.1, 112.5, 56.8, 15.3; HR-ESI-MS: m/z calcd for C15H15O3S
+ [M+H]+: 




The title compound was synthesized according to the modified procedure for milligram-scale 
whole cell enzymatic hydroxylation with CitB and in situ functionalization with thiophenol. The 
reaction was performed with 20 mg of starting material. Purification by flash chromatography 
afforded 6.8 mg (24% yield) of the title compound as a white film. 1H NMR (400 MHz, CD3OD) 
δ 9.64 (s, 1H), 7.75 (s, 1H), 7.39 (m, 2H), 7.23 (m, 3H), 4.23 (s, 2H); 13C NMR (150 MHz, 





ESI-MS: m/z calcd for C14H12O3SBr
+ [M+H]+: 338.9685, found: 338.9710; IR (thin film): 3299, 
3058, 2927, 2854, 1603, 1549, 1455, 1438, 1304, 1173, 1084 cm-1. 
 
2,4-dihydroxy-5-nitro-3-((phenylthiol)methyl)benzaldehyde (2.61) 
The title compound was synthesized according to the modified procedure for milligram-scale 
whole cell enzymatic hydroxylation with CitB and in situ functionalization with thiophenol. The 
reaction was performed with 20 mg of starting material. Purification by flash chromatography 
afforded 8.0 mg (26% yield) of the title compound as a yellow film. 1H NMR (599 MHz, 
(CD3)2CO) δ 10.04 (s, 1H), 8.75 (s, 1H), 7.49-7.26 (m, 5H), 4.29 (s, 2H); 13C NMR (150 MHz, 
(CD3)2CO) δ 196.0, 173.6, 132.6, 130.5, 129.6, 128.8, 128.4, 126.5, 125.5, 114.5, 107.8, 25.9; 
HR-ESI-MS: m/z calcd for C14H12NO5S
+ [M+H]+: 306.0431, found: 306.0426; IR (thin film): 
2924, 2854, 1709, 1625, 1540, 1456, 1267, 1158, 1092 cm-1. 
 
2-bromo-4-hydroxy-5-(hydroxymethyl)benzaldehyde (2.71) 
The title compound was synthesized according to the general procedure for milligram-scale whole 
cell enzymatic hydroxylation with CitB. The reaction was performed with 40 mg of starting 
material. Purification by preparative HPLC afforded 2.7 mg (7% yield) of the title compound as a 
tan film. 1H NMR (400 MHz, CD3OD) δ 10.14 (s, 1H), 7.94 (s, 1 H), 7.07 (s, 1H), 4.60 (s, 2H); 





MS m/z calcd for C8H8BrO3
+ [M+H]+: 230.9651, found: 230.9657; IR (thin film): 3258, 2925, 
2855, 1621, 1433, 1381, 1256, 1106 cm-1. 
 
4-hydroxy-5-(hydroxymethyl)-2-phenylbenzaldehyde (2.72) 
The title compound was synthesized according to the modified procedure for milligram-scale 
whole cell enzymatic hydroxylation with CitB and in situ functionalization with thiophenol. The 
reaction was performed with 40 mg of starting material. Purification by preparative HPLC afforded 
6.0 mg (14% yield) of the title compound as a white film. 1H NMR (400 MHz, CD3OD) δ 9.71 (s, 
1H), 8.04 (s, 1H), 7.46-7.38 (m, 5H), 6.79 (s, 1H), 4.70 (s, 2H); 13C NMR (150 MHz, (CD3)2CO) 
δ 189.4, 138.0, 129.8, 128.3, 128.2, 128.0, 127.8, 127.1, 116.5, 59.8; HR-ESI-MS: m/z calcd for 
C14H13O3
+ [M+H]+: 229.0859, found: 229.0855; IR (thin film): 3266, 2925, 1659, 1602, 1484, 
1282, 1015 cm-1. 
 
5-methyl-4-nitro-2-((phenylthio)methyl)benzene-1,3-diol (2.70) 
The title compound was synthesized according to the modified procedure for milligram-scale 
whole cell enzymatic hydroxylation with CitB and in situ functionalization with thiophenol. The 
reaction was performed with 20 mg of starting material. Purification by preparative HPLC afforded 
8.1 mg (28% yield) of the title compound as a yellow solid. 1H NMR (600 MHz, (CD3)2CO) δ 
11.40 (s, 1H), 10.02 (s, 1H), 7.44 (d, J = 7.4, 2H), 7.29 (t, J = 7.4,  2H), 7.20 (t, J = 7.4, 1H), 6.50 





129.5, 129.1, 128.7, 125.9, 111.5, 110.9, 26.6, 22.0; HR-ESI-MS: m/z calcd for C14H13O3
+ 
[M+H]+: 292.0268, found: 292.0261; IR (thin film): 3356, 2931, 1603, 1549, 1455, 1415, 1306, 
1173, 1006 cm-1. 
 
1-(2,4-dihydroxy-3-(hydroxymethyl)-5-methylphenyl)butan-1-one (2.63) 
The title compound was synthesized according to the procedure for milligram-scale crude cell 
reactions with ClaD. The reaction was performed with 20 mg of starting material. Purification by 
flash chromatography afforded 8.5 mg (39% yield) of the title compound as a white solid. 1H 
NMR (600 MHz, CD3CN) δ 13.15 (s, 1H), 7.60 (s, 1H), 4.92 (s, 2H), 2.91 (t, J = 7.4, 2H), 2.14 (s, 
3H), 1.70 (sxt, J = 7.4, 2H), 0.99 (t, J = 7.4, 3H); 13C NMR (150 MHz, CD3CN) δ 205.8, 162.2, 
159.7, 131.1, 111.9, 110.9, 57.4, 39.5, 39.4, 18.0, 14.4, 13.1; HR-ESI-MS: m/z calcd for 
C12H15O3
+ [M+H-H2O]
+: 207.1016, found: 207.1024; IR (thin film): 3333, 2957, 2358, 1622, 
1168, 997, 661 cm-1. 
 
1-(2,4-dihydroxy-3-(hydroxymethyl)-5-methylphenyl)pentan-1-one (2.64) 
The title compound was synthesized according to the procedure for milligram-scale crude cell 
reactions with ClaD. The reaction was performed with 20 mg of starting material. Purification by 
flash chromatography afforded 6.5 mg (30% yield) of the title compound as a white solid. 1H 
NMR (600 MHz, CD3CN) δ 13.15 (s, 1H), 7.60 (s, 1H), 4.92 (s, 2H), 2.94 (t, J = 7.4, 2H), 2.14 (s, 





CD3CN) δ 206.0, 162.2, 159.7, 131.1, 116.7, 111.8, 110.5, 57.5, 37.3, 26.7, 22.1, 14.4, 13.2; HR-
ESI-MS: m/z calcd for C13H17O3
+ [M+H-H2O]
+: 221.1172, found: 221.1178; IR (thin film): 3394, 
2955, 2352, 2025, 1225, 961, 740 cm-1. 
 
1-(2,4-dihydroxy-3-(hydroxymethyl)phenyl)pentan-1-one (2.67) 
The title compound was synthesized according to the procedure for milligram-scale crude cell 
reactions with ClaD. The reaction was performed with 20 mg of starting material. Purification by 
flash chromatography afforded 6.1 mg (28% yield) of the title compound as a white solid. 1H 
NMR (600 MHz, CD3CN) δ 7.71 (d, J = 8.9, 1H), 6.40 (d, J = 8.9, 1H), 4.72 (s, 2H), 2.91 (t, J = 
7.5, 2H), 1.67 (m, 2H), 1.40 (m, 2H), 0.95 (t, J = 3H); 13C NMR (150 MHz, CD3CN) δ 205.5, 
163.2, 131.4, 113.4, 112.2, 106.9, 52.7, 48.1,. 37.0, 26.9, 22.0, 12.8; HR-ESI-MS: m/z calcd for 
C12H15O3
+ [M+H-H2O]




The title compound was synthesized according to the procedure for milligram-scale crude cell 
reactions with ClaD. The reaction was performed with 20 mg of starting material. Purification by 
flash chromatography afforded 4 mg (7% yield) of the title compound as a white solid. 1H NMR 
(600 MHz, CD3OD) δ 6.25 (s, 1H), 4.71 (s, 2H), 3.91 (s, 3H), 2.46 (s, 3H); 13C NMR (150 MHz, 







+: 195.0652, found: 195.0667; IR (thin film): 3388, 2954, 2364, 1719, 




The title compound was synthesized according to the procedure for milligram-scale crude cell 
reactions with ClaD. The reaction was performed with 20 mg of starting material. Purification by 
flash chromatography afforded 13.2 mg (61% yield) of the title compound as a white solid. 1H 
NMR (600 MHz, CD3CN) δ 13.90 (s, 1H), 6.26 (s, 1H), 4.80 (s, 2H), 2.61 (s, 3H), 2.53 (s, 3H); 
13C NMR (150 MHz, CD3CN) δ 205.0, 163.4, 161.4, 141.8, 114.3, 111.7, 109.9, 56.6, 32.4, 23.9; 
HR-ESI-MS: m/z calcd for C10H11O3
+ [M+H-H2O]
+: 179.0703, found: 179.0703; IR (thin film): 
3283, 2357, 1963, 1607, 1428, 1268, 1001 cm-1. 
 
1-(2,4-dihydroxy-3-(hydroxymethyl)-5-methylphenyl)ethan-1-one (2.62) 
The title compound was synthesized according to the procedure for milligram-scale crude cell 
reactions with ClaD. The reaction was performed with 20 mg of starting material. Purification by 
flash chromatography afforded 14.1 mg (65% yield) of the title compound as a white solid. 1H 
NMR (600 MHz, CD3CN) δ 13.01 (s, 1H), 7.57 (s, 1H), 4.92 (s, 2H), 2.52 (s, 3H), 2.14 (s, 3H); 





HR-ESI-MS: m/z calcd for C10H11O3
+ [M+H-H2O]
+: 179.0703, found: 179.0707; IR (thin film): 





The title compound was synthesized according to the procedure for milligram-scale crude cell 
reactions with ClaD. The reaction was performed with 20 mg of starting material. Purification by 
flash chromatography afforded 76 mg (69% yield) of the title compound as a white solid. 1H NMR 
(600 MHz, CD3CN) δ 13.17 (s, 1H), 7.68 (d, J = 8.8, 1H), 6.41 (d, J = 8.8, 1H), 4.82 (s, 1H), 2.53 
(s, 1H); 13C NMR (150 MHz, CD3CN) δ 203.7, 163.4, 161.8, 132.2, 112.9, 112.1, 107.9, 55.9, 
25.6; HR-ESI-MS: m/z calcd for C9H9O3
+ [M+H-H2O]
+: 165.0546, found: 165.0557; IR (thin 
film): 3320, 2956, 2360, 2341, 1981, 1615, 987 cm-1. 
 
2,4-dihydroxy-3-(hydroxymethyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one (2.69) 
The title compound was synthesized according to the procedure for milligram-scale crude cell 
reactions with ClaD. The reaction was performed with 10 mg of starting material. Purification by 
flash chromatography afforded 4.1 mg (37% yield) of the title compound as a white solid. 1H 
NMR (600 MHz, CD3CN) δ 13.70 (s, 1H), 6.27 (s, 1H), 4.80 (s, 2H), 2.93-2.85 (m, 2H), 2.83-





113.2, 109.8, 56.2, 40.9, 32.9, 27.1, 24.2, 20.4; HR-ESI-MS: m/z calcd for C12H13O3
+ [M+H-
H2O]




IV. Chemical oxidation reactions of substrate 2.26 
Table 2.S1. Chemical oxidation reactions of substrate 2.26.  
Reaction50-55 Result 
CitB  benzylic alcohol 
MnO2 starting material 
DDQ quinone 
K2S2O8 decomposition 
CAN, AcOH decomposition 
AIBN, NBS aromatic bromination 






















CitB enzymatic reaction 







Figure 2.S6. Chemical oxidation reactions of substrate 2.26. 






































0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00 4.20 4.40
Ag2O, MeOH 16 (m/z: 167.0703) 
1,3,5-trimethoxybenzene IS  
400 MHz, (CD3)2CO 
Figure 2.S7. Ag2O oxidation reaction of substrate 2.26. 
PDA trace of reaction analyzed at 300 nm.  
 
Figure 2.S8. Crude NMR of Ag2O oxidation reaction of substrate 2.26.  
Spectrum recorded on 400 MHz NMR in DMSO with 50 mM 1,3,5-trimethoxybenzene as 






















































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
DDQ 




1,3,5-trimethoxybenzene IS  
400 MHz, (CD3)2CO 
Figure 2.S9. DDQ oxidation reaction of substrate 2.26.  
PDA trace of reaction analyzed at 300 nm. 
Figure 2.S10. Crude NMR of DDQ oxidation reaction of substrate 2.26.  


















































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
K2S2O8 
16 (m/z: 167.0703) 
1,3,5-trimethoxybenzene IS  
400 MHz, (CD3)2CO 
Figure 2.S11. K2S2O8 oxidation reaction of substrate 2.26.6  
PDA trace of reaction analyzed at 300 nm.  
 
Figure 2.S12. Crude NMR of K2S2O8 oxidation reaction of substrate 2.26.6  


























0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00 2.20 2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00 4.20 4.40
CAN, AcOH 
1,3,5-trimethoxybenzene IS  
400 MHz, (CD3)2CO 
Figure 2.S13. Ceric ammonium nitrate (CAN) oxidation reaction of substrate 2.26.7  
PDA trace of reaction analyzed at 300 nm.  
 
Figure 2.S14. Crude NMR of CAN oxidation reaction of substrate 2.26.  
Spectrum recorded on 400 MHz NMR in DMSO with 50 mM 1,3,5-trimethoxybenzene as 
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1,3,5-trimethoxybenzene IS  
400 MHz, (CD3)2CO 
Figure 2.S15. AIBN, NBS oxidation reaction of substrate 2.26.8  
PDA trace of reaction analyzed at 300 nm.  
 
Figure 2.S16. Crude NMR of AIBN, NBS oxidation reaction of substrate 2.26.  
Spectrum recorded on 400 MHz NMR in DMSO with 50 mM 1,3,5-trimethoxybenzene as 











































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
MnO2 16 (m/z: 167.0703) 
1,3,5-trimethoxybenzene IS  
400 MHz, (CD3)2CO 
Figure 2.S17. MnO2 oxidation reaction of substrate 2.26.9  
PDA trace of reaction analyzed at 300 nm.  
 
Figure 2.S18. Crude NMR of MnO2 oxidation reaction of substrate 2.26.  







Part V. Benzylic functionalization of NHI enzyme-generated benzylic alcohols 
 
General procedure for ortho-quinone methide conjugate addition reactions: Benzylic alcohol 
2.27 (20 mg, 0.11 mmol, 1.0 equiv) was added to an oven-dried 1 dram vial equipped with a stir 
bar and dissolved in 1 mL of 1:1 H2O:MeCN. Nucleophile (2.0 equiv) was then added to the vial 
and the reaction heated at 37 °C for 18 h. The solvent and excess nucleophile were removed under 
reduced pressure. Purification on silica gel afforded the desired 1,4-addition product.  
 
2,4-dihydroxy-6-methyl-3-((phenylthio)methyl)benzaldehyde (2.30) 
The title compound was synthesized according to the general procedure for ortho-quinone methide 
conjugate addition reactions using thiophenol (22 μL, 0.22 mmol) as the nucleophile. Purification 
on silica gel (gradient elution 1% to 75% EtOAc in hexanes) afforded 30 mg (98% yield) of 2.20 
as an off-white solid.  1H NMR (400 MHz, CD3OD) δ 10.02 (s,1H), 7.39 (d, J = 7.3 Hz, 2H), 7.23 
(t, J = 7.6 Hz, 2H), 7.15 (t, J = 7.3 Hz, 1H), 6.23 (s,1H), 4.13 (s, 2H), 2.47 (s, 3H); 13C NMR (101 
MHz, CD3OD) δ 194.5, 165.1, 164.9, 144.9, 138.9, 131.2, 129.6, 127.0, 113.7, 110.9, 110.5, 27.2, 
18.2; HRMS (ESI) m/z: [M+H]+ calculated for C15H13O3S
+ 275.0736, found 275.0737; IR (thin 
film): 3076, 2242, 1584, 1480, 1430, 1330, 1256, 1025, 988, 844, 736, 687, 634, 560, 504 cm-1. 
 







The title compound was synthesized according to the general procedure for ortho-quinone methide 
conjugate addition reactions using methanol (1 mL) as both the solvent and nucleophile. 
Purification on silica gel (gradient elution 1% to 75% EtOAc in hexanes) afforded 16 mg (73% 
yield) of 2.73 as a colorless oil. 1H NMR (400 MHz, CD3OD) δ 10.07 (s, 1H), 6.27 (s, 1H), 4.53 
(s, 2H), 3.35 (s, 3H), 2.51 (s, 3H); 13C NMR (151 MHz, CD3OD) δ 194.6, 166.2, 166.1, 146.3, 
113.7, 111.2, 110.1, 63.1, 58.1, 18.3; HRMS (ESI) m/z: [M+H]+ calculated for C10H11O4
+ 
197.0808, found 197.0802; IR (thin film): 2924, 1622, 1428, 1245, 1123 cm-1. 
 
2,4-dihydroxy-3-(isopropoxymethyl)-6-methylbenzaldehyde (2.81) 
The title compound was synthesized according to the general procedure for ortho-quinone methide 
conjugate addition reactions using isopropanol (1 mL) as both the solvent and nucleophile. 
Purification on silica gel (gradient elution 1% to 75% EtOAc in hexanes) afforded 15 mg (61% 
yield) of 2.74 as a colorless oil. 1H NMR (599 MHz, CD3OD) δ 10.05 (s, 1H), 6.25 (s, 1H), 4.58 
(s, 2H), 3.74 (hept, J = 6.1 Hz, 1H), 2.49 (s, 3H), 1.18 (d, J = 6.1 Hz, 6H); 13C NMR (151 MHz, 
CD3OD) δ 194.6, 166.1, 166.0, 146.0, 113.7, 111.3, 110.6, 72.6, 59.4, 22.4, 18.3; HRMS (ESI) 
m/z: [M+H]+ calculated for C12H15O4
+ 225.1121, found 225.1106; IR (thin film): 3219, 2925, 









The title compound was synthesized according to the general procedure for ortho-quinone methide 
conjugate addition reactions using isopropanol (1 mL) as both the solvent and nucleophile. 
Purification on silica gel (gradient elution 1% to 75% EtOAc in hexanes) afforded 12 mg (47% 
yield) of 2.75 as a colorless solid. 1H NMR (599 MHz, CD3OD) δ 10.06 (s, 1H), 6.26 (s, 1H), 4.56 
(s, 2H), 3.50 (t, J = 6.6 Hz, 2H), 2.49 (s, 3H), 1.55 (dt, J = 14.5, 6.7 Hz, 2H), 1.36 (h, J = 7.4 Hz, 
2H), 0.90 (t, J = 7.4 Hz, 3H); 13C NMR (151 MHz, CD3OD) δ 194.7, 166.1, 166.0, 146.1, 113.7, 
111.2, 110.4, 71.1, 61.5, 32.7, 20.3, 18.3, 14.2; HRMS (ESI) m/z: [M+H]+ calculated for C13-
H17O4
+ 239.1278, found 239.1222; IR (thin film): 2913, 1618, 1435, 1302, 1016, 951, 697 cm-1. 
 
3-((benzylthio)methyl)-2,4-dihydroxy-6-methylbenzaldehyde (2.83) 
The title compound was synthesized according to the general procedure for ortho-quinone methide 
conjugate addition reactions using benzylmercaptan (26 μL, 0.22 mmol) as the nucleophile. 
Purification on silica gel (gradient elution 1% to 75% EtOAc in hexanes) afforded 31 mg (97% 
yield) of 2.76 as an off-white solid. 1H NMR (599 MHz, CD3OD) δ 10.03 (s, 1H), 7.32 (d, J = 7.1 
Hz, 2H), 7.24 (t, J = 7.6 Hz, 2H), 7.17 (t, J = 7.3 Hz, 1H), 6.24 (s, 1H), 3.78 (s, 2H), 3.69 (s, 2H), 





127.6, 113.7, 112.3, 111.2, 37.7, 24.0, 18.1; HRMS (ESI) m/z: [M+H]+ calculated for C16H15O3S
+ 
289.0893, found 289.0887; IR (thin film): 3083, 1606, 1429, 1288, 1255, 1102, 699 cm-1. 
 
2,4-dihydroxy-6-methyl-3-(morpholinomethyl)benzaldehyde (2.84) 
The title compound was synthesized according to the general procedure for ortho-quinone methide 
conjugate addition reactions using morpholine (19 μL, 0.22 mmol) as the nucleophile. Purification 
on silica gel (gradient elution 1% to 75% EtOAc in hexanes) afforded 18 mg (65% yield) of 77 as 
a white solid. 1H NMR (599 MHz, CD3OD) δ 10.00 (s, 1H), 6.18 (s, 1H), 3.84 (s, 2H), 3.75 (m, 
4H), 2.70 (m, 4H), 2.47 (s, 3H); 13C NMR (151 MHz, CD3OD) δ 193.9, 169.4, 165.5, 145.5, 113.0, 
112.8, 105.8, 67.3, 53.8, 53.2, 18.3; HRMS (ESI) m/z: [M+H]+ calculated for C13H16NO4
+ 
252.1230, found 252.1279; IR (thin film): 2850, 1620, 1483, 1363, 1293, 1269, 1243, 1114, 997, 
861, 626 cm-1.  
 
Figure 2.S20. Inverse electron-demand Diels-Alder reactions with benzylic alcohol, 2.27. 
General procedure for Diels-Alder reactions: Benzylic alcohol 2.27 (20 mg, 0.110 mmol, 1.0 
equiv) was added to an oven-dried 1 dram vial equipped with a stir bar and dissolved in 1 mL of 
1:1 H2O:MeCN. Dienophile (5 equiv) was then added to the vial and the reaction heated at 45-65 
°C for 18 h. The solvent and excess dienophile were removed under reduced pressure. Purification 





           
2-ethoxy-5-hydroxy-7-methylchromane-6-carbaldehyde (2.85) and 2-ethoxy-5-hydroxy-7-
methylchro-mane-8-carbaldehyde (2.86) 
The title compounds were synthesized according to the general procedure for ortho-quinone 
methide Diels-Alder reactions using ethyl vinyl ether (53 μL, 0.549 mmol) as the dienophile and 
heating at 45 °C. The reaction gave a 2:1 ratio of 2.85 and 2.86, respectively (as judged by the 1H 
NMR spectrum of the unpurified reaction mixture). Purification on silica gel (gradient elution 1% 
to 75% EtOAc in hexanes) afforded 16 mg (61% yield) of 2.85 and 8 mg (30% yield) of 2.86 as 
colorless oils. 
Data for 2.85: 1H NMR (599 MHz, CDCl3) δ 12.68 (s, 1H), 10.07 (s, 1H), 6.21 (s, 1H), 5.26 (s, 
1H), 3.87 (dq, J = 14.3, 7.1 Hz, 1H), 3.65 (dq, J = 14.3, 7.1 Hz, 1H), 2.73 – 2.62 (m, 2H), 2.49 (s, 
3H), 2.06 (dq, J = 13.3, 4.7 Hz, 1H), 1.94 – 1.84 (m, 1H), 1.20 (t, J = 7.1 Hz, 3H); 13C NMR (151 
MHz, CDCl3) δ 193.1, 163.2, 159.5, 141.0, 112.9, 111.4, 108.5, 97.8, 64.2, 25.7, 18.0, 15.1, 13.9; 
HRMS (ESI) m/z: [M+H]+ calculated for C13H15O4
+ 237.1121, found 237.1084; IR (thin film): 
2928, 1622, 1579, 1483, 1325, 1281, 1242, 1217, 1132, 1099, 1046, 967, 934, 850 cm-1. 
 
Data for 2.86: 1H NMR (599 MHz, CD3OD) δ 10.38 (s, 1H), 6.27 (s, 1H), 5.38 (s, 1H), 3.88 (dt, 
J = 14.3, 7.2 Hz, 1H), 3.76 – 3.64 (m, 1H), 2.65 (dd, J = 10.1, 6.0 Hz, 2H), 2.47 (s, 3H), 2.08 – 
2.02 (m, 1H), 1.99 – 1.93 (m, 1H), 1.21 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CD3OD) δ 191.9, 





[M+H]+ calculated for C13H15O4
+ 237.1121, found 237.1073; IR (thin film): 2924, 1626, 1493, 
1327, 1282, 1243, 1100, 1049, 935, 851 cm-1. 
 
2-(ethylthio)-5-hydroxy-7-meth-ylchromane-8-carbaldehyde (2.87) 
The title compounds were synthesized according to the general procedure for ortho-quinone 
methide Diels-Alder reactions using ethyl vinyl sulfide (56 μL, 0.549 mmol) as the dienophile and 
heating at 45 °C. The reaction gave a 4:1 ratio of 2.87 and 2.88, respectively (as judged by the 1H 
NMR spectrum of the unpurified reaction mixture). Purification on silica gel (gradient elution 1% 
to 75% EtOAc in hexanes) afforded 19 mg (70% yield) of 2.87. 1H NMR (599 MHz, CD3OD) δ 
10.10 (s, 1H), 6.23 (s, 1H), 5.64 (t, J = 4.0 Hz, 1H), 2.80 (dq, J = 13.0, 7.4 Hz, 1H), 2.75 – 2.66 
(m, 2H), 2.63 (ddd, J = 16.8, 10.2, 6.2 Hz, 1H), 2.21 (dddd, J = 14.0, 10.2, 6.3, 3.8 Hz, 1H), 2.11 
(ddt, J = 14.3, 6.2, 4.4 Hz, 1H); 13C NMR (151 MHz, CD3OD) δ 195.1, 164.3, 161.1, 142.8, 114.2, 
112.8, 109.1, 82.5, 27.4, 25.7, 18.0, 16.8, 15.6; HRMS (ESI) m/z: [M+H]+ calculated for 
C13H15O3S
+ 253.0893, found 253.0844; IR (thin film): 2926, 1624, 1578, 1481, 1419, 1372, 1321, 









The title compounds were synthesized according to the general procedure for ortho-quinone 
methide Diels-Alder reactions using 2,3-dihydrofuran (42 μL, 0.549 mmol) as the dienophile and 
heating at 45 °C. The reaction gave a 4:1 ratio of 2.89 and 2.90, respectively (as judged by the 1H 
NMR spectrum of the unpurified reaction mixture). Purification on silica gel (gradient elution 1% 
to 75% EtOAc in hexanes) afforded 18 mg (70% yield) of 2.89 as a white solid. 1H NMR (599 
MHz, CDCl3) δ 12.73 (s, 1H), 10.06 (s, 1H), 6.23 (s, 1H), 5.59 (d, J = 3.9 Hz, 1H), 4.18 – 4.11 (m, 
1H), 4.02 (q, J = 8.4 Hz, 1H), 2.94 (d, J = 17.3 Hz, 1H), 2.79 (dd, J = 17.3, 6.3 Hz, 1H), 2.75 – 
2.65 (m, 1H), 2.49 (s, 3H), 2.08 (td, J = 11.6, 10.5, 5.4 Hz, 1H), 1.69 (p, J = 9.7 Hz, 1H); 13C NMR 
(151 MHz, CDCl3) δ 193.0, 163.8, 160.1, 141.6, 113.0, 111.2, 104.6, 101.0, 68.5, 36.3, 27.5, 18.4, 
18.0; HRMS (ESI) m/z: [M+H]+ calculated for C13H13O4
+ 235.0965, found 235.0976; IR (thin 
film): 2897, 1620, 1483, 1423, 1374, 1319, 1280, 1240, 1140, 1106, 1051, 931, 833, 547 cm-1.  
 
5-hydroxy-7-methyl-2-phenylchromane-6-carbaldehyde (2.91) 
The title compound was synthesized according to the general procedure for ortho-quinone methide 
Diels-Alder reactions using styrene (63 μL, 0.549 mmol) as the dienophile and heating at 65 °C. 
The reaction gave a 1:3 ratio of 2.91 and 2.92, respectively (as judged by the 1H NMR spectrum 
of the unpurified reaction mixture). Purification on silica gel (gradient elution 1% to 75% EtOAc 
in hexanes) afforded 6 mg (33% yield) of 2.91 as a colorless oil. 1H NMR (599 MHz, CDCl3) δ 
12.78 (s, 1H), 10.08 (s, 1H), 7.45 – 7.29 (m, 5H), 6.30 (s, 1H), 5.09 (dd, J = 10.2, 2.1 Hz, 1H), 
2.82 (dt, J = 16.8, 4.3 Hz, 1H), 2.69 (ddd, J = 17.0, 11.0, 6.1 Hz, 1H), 2.51 (s, 3H), 2.27 (ddt, J = 





193.0, 163.7, 162.3, 141.1, 140.6, 128.6, 128.1, 125.9, 112.7, 111.4, 107.9, 78.5, 28.8, 18.2, 18.0. 
HRMS (ESI) m/z: [M+H]+ calculated for C17H15O3
+
 269.1172, found 269.1186; IR (thin film): 
3433, 2923, 1624, 1514, 1373, 1280, 1238, 1132, 1025, 819 cm-1. 
 
5-hydroxy-2-(2-methoxyphenyl)-7-methylchromane-6-carbaldehyde (2.93) and 5-hydroxy-
2-(2-meth-oxyphenyl)-7-methylchromane-8-carbaldehyde (2.94) 
The title compounds were synthesized according to the general procedure for ortho-quinone 
methide Diels-Alder reactions using 2-methoxystyrene (74 μL, 0.549 mmol) as the dienophile and 
heating at 65 °C. The reaction gave a 1:3 ratio of 2.93 and 2.94, respectively (as judged by the 1H 
NMR spectrum of the unpurified reaction mixture). Purification on silica gel (gradient elution 1% 
to 75% EtOAc in hexanes) afforded 16 mg (39% yield) of 2.93 and 6 mg (13% yield) of 2.94 as 
white solids.  
Data for 2.93: 1H NMR (599 MHz, CDCl3) δ 12.78 (s, 1H), 10.08 (s, 1H), 7.40 (d, J = 7.4 Hz, 
1H), 7.30 (t, J = 7.7 Hz, 1H), 7.00 (t, J = 7.4 Hz, 1H), 6.92 (d, J = 8.2 Hz, 1H), 6.30 (s, 1H), 5.47 
(d, J = 9.5 Hz, 1H), 3.86 (s, 3H), 2.77 (d, J = 16.8 Hz, 1H), 2.70 (ddd, J = 16.8, 10.8, 6.0 Hz, 1H), 
2.51 (s, 3H), 2.33 – 2.21 (m, 1H), 1.89 (dh, J = 15.5, 5.6 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ 
192.9, 163.7, 162.8, 155.8, 140.9, 129.1, 128.8, 126.2, 120.7, 112.6, 111.4, 110.4, 108.2, 73.3, 
55.4, 27.4, 18.3, 18.0; HRMS (ESI) m/z: [M+H]+ calculated for C18H17O4
+ 299.1278, found 






Data for 2.94: 1H NMR (599 MHz, CD3OD) δ 10.37 (s, 1H), 7.42 (d, J = 7.5 Hz, 1H), 7.30 (t, J = 
7.7 Hz, 1H), 7.02 (d, J = 8.2 Hz, 1H), 6.99 (t, J = 7.5 Hz, 1H), 6.25 (s, 1H), 5.41 (d, J = 9.8 Hz, 
1H), 3.87 (s, 3H), 2.81 – 2.61 (m, 2H), 2.47 (s, 3H), 2.33 – 2.23 (m, 1H), 1.87 (dh, J = 16.5, 6.0 
Hz, 1H); 13C NMR (151 MHz, CD3OD) δ 192.0, 163.1, 162.9, 157.4, 142.8, 130.7, 129.9, 126.9, 
121.7, 116.6, 111.6, 111.4, 108.7, 74.6, 55.9, 28.7, 22.3, 20.3; HRMS (ESI) m/z: [M+H]+ 
calculated for C18H17O4
+ 299.1278, found 299.1276; IR (thin film): 2927, 1625, 1494, 1373, 1281, 
1238, 1136 cm-1. 
 
5-hydroxy-2-(4-methoxyphenyl)-7-methylchromane-6-carbaldehyde (2.95) and 5-hydroxy-
2-(4-meth-oxyphenyl)-7-methylchromane-8-carbaldehyde (2.96) 
The title compounds were synthesized according to the general procedure for ortho-quinone 
methide Diels-Alder reactions using 4-methoxystyrene (73 μL, 0.549 mmol) as the dienophile and 
heating at 65 °C. The reaction gave a 1:4 ratio of 2.95 and 2.96, respectively (as judged by the 1H 
NMR spectrum of the unpurified reaction mixture). Purification on silica gel (gradient elution 1% 
to 75% EtOAc in hexanes) afforded 18 mg (44% yield) of 2.95 and 5 mg (12% yield) of 2.96 as 
white solids.  
Data for 2.95: 1H NMR (599 MHz, CDCl3) δ 12.77 (s, 1H), 10.07 (s, 1H), 7.32 (d, J = 8.5 Hz, 
2H), 6.93 (d, J = 8.6 Hz, 2H), 6.27 (s, 1H), 5.03 (dd, J = 10.5, 2.4 Hz, 1H), 3.82 (s, 3H), 2.84 (ddd, 





5.9, 2.9 Hz, 1H), 2.09 – 1.94 (m, 1H); 13C NMR (151 MHz, CDCl3) δ 192.9, 163.7, 162.4, 159.5, 
141.0, 132.7, 127.4, 114.0, 112.7, 111.4, 107.9, 78.3, 55.3, 28.6, 18.4, 18.0; HRMS (ESI) m/z: 
[M+H]+ calculated for C18H17O4
+ 299.1278, found 299.1268; IR (thin film): 2924, 1578, 1496, 
1422, 1291, 1239, 1086, 757, 695 cm-1. 
Data for 2.96: 1H NMR (599 MHz, ((CD3)2SO) δ 10.46 (s, 1H), 10.30 (s, 1H), 7.36 (d, J = 8.4 Hz, 
2H), 6.94 (d, J = 8.5 Hz, 2H), 6.26 (s, 1H), 5.09 (d, J = 10.0 Hz, 1H), 3.74 (s, 3H), 2.68 – 2.54 (m, 
2H), 2.38 (s, 3H), 2.17 (d, J = 13.4 Hz, 1H), 1.98 – 1.86 (m, 1H); 13C NMR (151 MHz, ((CD3)2SO) 
δ 189.0, 160.6, 160.6, 158.9, 140.1, 133.0, 127.3, 114.9, 113.9, 110.2, 107.1, 76.9, 55.1, 27.8, 21.6, 
18.9; HRMS (ESI) m/z: [M+H]+ calculated for C18H17O4
+ 299.1278, found 299.1268; IR (thin 
film): 2925, 1619, 1570, 1427, 1293, 1247, 1120, 729 cm-1.  
 
(-)-xyloketal D (2.25)  
Enantiomerically pure xyloketal D was prepared through the inverse electron-demand Diels-Alder 
reaction of enzymatically prepared benzylic alcohol 2.68 and dienophile 2.100. Benzylic alcohol 
2.68 (35 mg, 0.192 mmol, 1.0 equiv) was added to an oven-dried 1 dram vial equipped with a stir 
bar and dissolved in MeCN (2 mL). Dienophile 2.100 (49 μL, 0.384 mmol, 2.0 equiv) was then 
added to the vial and the reaction heated at 75 °C for 18 hours until starting material was 
completely consumed as determined by UPLC-DAD analysis. The reaction was concentrated to 
remove solvent and excess dienophile. The reaction gave a 2:1 mixture of diastereomers (as judged 
by 1H NMR and UPLC-DAD analysis of the unpurified reaction). Purification on silica gel 





Reaction analysis by UPLC-DAD with product standard curve showed full conversion of starting 
material after 18 hours and 66% yield of (-)-xyloketal D when the reaction was performed in 
benzene and heated at 80 °C. All spectroscopic data for the compound matched previously reported 
literature values. 
Data for 2.25: 1H NMR (599 MHz, CDCl3) δ13.11 (s, 1H), 7.52 (d, J = 8.9 Hz, 1H), 6.36 (d, J = 
8.9 Hz, 1H), 4.20 (t, J = 8.4 Hz, 1H), 3.56 (t, J = 8.6 Hz, 1H), 2.96 (d, J = 17.8 Hz, 1H), 2.72 (dd, 
J = 17.9, 6.5 Hz, 1H), 2.54 (s, 3H), 2.14 – 2.03 (m, 1H), 1.98 (dd, J = 11.3, 6.5 Hz, 1H), 1.53 (s, 
3H), 1.08 (d, J = 6.5 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 202.7, 162.9, 159.5, 130.0, 113.1, 
108.8, 108.3, 106.1, 77.2, 77.0, 76.8, 74.3, 46.9, 35.1, 26.1, 22.7, 18.0, 15.8; HRMS (ESI) m/z: 
[M+H]+ calculated for C18H17O4




































Y = 12.16*X + 0.2281
R2 = 0.9993




















Y = 4.929*X - 0.07186
R2 = 1





















Y = 11.49*X + 0.1774
R2 = 0.9992





















Y = 2.803*X - 0.05593
R2 = 0.9997






















Y = 8.381*X - 0.07332
R2 = 0.9999


















































Y = 4.752*X + 0.03469
R2 = 0.9996




















Y = 5.635*X - 0.09917
R2 = 0.9997





















Y = 7.5*X - 0.1211
R2 = 0.9999






















Y = 3.701*X - 0.001124
R2 = 0.9999





















Y = 5.764*X - 0.04571
R2 = 0.9999



















































 =  0 .9 9 9 2
Y = 11.94*X + 0.2534
 





















Y = 10.08*X + 0.007153
R
2
 =  0 .9 9 9 3






















2 5 Y = 8.765*X + 0.08920
R
2
 =  0 .9 9 9 7
 






















Y = 8.47*X - 0.148
R2 = 0.9994





















Y = 5.69*X - 0.3112
R2 = 0.9983















































Y = 4.206*X - 0.02675
R
2
 =  0 .9 9 9 6























Y = 8.771*X - 0.02064
R
2
 =  0 .9 9 7 8
 






















Y = 14.04*X - 0.1092
R
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 =  0 .9 9 8 2























Y = 15.98*X + 0.4071
R
2
 =  0 .9 9 7 1
 























Y = 16.23*X - 0.01113
R
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 =  0 .9 9 9 1























Y = 17.59*X - 0.09300
R
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Y = 12.07*X - 0.04807
R
2
 =  0 .9 9 9 4






















Y = 13.26*X + 0.3275
R
2
 =  0 .9 9 9 1
 





















Y = 19.77*X + 0.4357
R
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 =  0 .9 9 9 0
 





















Y = 5.078*X - 0.1354
R
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Y = 0.6299*X - 0.007494
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5 0 Y = 18.21*X - 0.01947
R
2
 =  0 .9 9 8 6























Y = 16.35*X + 0.01400
R
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 =  0 .9 9 9 1
 






















Y = 13.16*X - 0.2842
R
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 =  0 .9 9 8 5























Y = 16.62*X - 0.004673
R
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 =  0 .9 9 9 9
 
 






















Y = 13.92*X - 0.2718
R
2
 =  0 .9 9 9 4





















Y = 1.113*X - 0.008665
R
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Y = 9.318*X - 0.04202
R
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 =  0 .9 9 9 2






















Y = 2.931*X - 0.07058
R
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 =  0 .9 9 9 0
 























Y = 1.543*X + 0.1634
R
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 =  0 .9 9 6 9























Y = 0.7750*X + 0.04149
R
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 =  0 .9 9 7 6
 





















4 Y = 1.288*X - 0.08219
R
2
 =  0 .9 9 3 7























Y = 0.7977*X + 0.01947
R
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Y = 3.595*X - 0.02681
R
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 =  0 .9 9 8 3






















Y = 2.784*X + 0.03532
R
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Y = 24.36*X - 0.4574
R
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 =  0 .9 9 9 7























Y = 17.76*X - 0.2852
R
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=  0 .9 9 9 5
 
 





















Y = 9.647*X + 0.1195
R
2
=  0 .9 9 9 6





















Y = 20.70*X - 0.5513
R
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Part VII. UPLC traces of CitB-catalyzed biocatalytic reactions 
Figure 2.S21. Benzylic hydroxylation of 2.26 by CitB.  































































































Area % Area Height 
1 1.808 60277 7.28 76765 
2 1.857 617301 74.60 767275 




Area % Area Height 






Figure 2.S22. Benzylic hydroxylation of 2.38 by CitB.  





















































































Area % Area Height 
1 1.766 106501 41.09 96087 




Area % Area Height 





Figure 2.S23. Benzylic hydroxylation of 2.39 by CitB.  

































































































Area % Area Height 
1 1.808 128097 14.58 103791 
2 1.894 171465 19.52 197059 




Area % Area 





Figure 2.S24. Benzylic hydroxylation of 2.40 by CitB.  













































































































Area % Area Height 
1 2.031 81644 30.74 66110 
2 2.183 69007 25.98 59416 




Area % Area Height 





Figure 2.S25. Benzylic hydroxylation of 2.S5 by CitB.  


















































































































Area % Area Height 
1 1.933 162421 10.45 145194 
2 2.077 117134 7.53 142594 




Area % Area Height 





Figure 2.S26. Benzylic hydroxylation of 2.46 by CitB.  




























































































Area % Area Height 
1 2.156 88057 16.11 122058 
2 2.279 104200 19.07 171834 




Area % Area 





Figure 2.S27. Benzylic hydroxylation of 2.45 by CitB.  

































































































Area % Area Height 
1 1.898 206718 49.42 200189 
2 2.009 92301 22.07 84095 




Area % Area 






Figure 2.S28. Benzylic hydroxylation of 2.S4 by CitB.  

























































































Area % Area Height 
1 1.798 178212 91.61 205348 
2 1.881 8876 4.56 9736 




Area % Area Height 





Figure 2.S29. Benzylic hydroxylation of 2.44 by CitB.  




































































































Area % Area Height 
1 2.031 72174 20.42 55343 
2 2.184 84576 23.93 57187 




Area % Area 





Figure 2.S30. Benzylic hydroxylation of 2.50 by CitB.  





No Enzyme Control 
 















































































Area % Area Height 
1 1.786 48006 4.14 37151 




Area % Area Height 





Figure 2.S31. Benzylic hydroxylation of 2.49 by CitB.  


































































































Area % Area Height 
1 1.906 70147 24.27 92506 




Area % Area Height 





Figure 2.S32. Benzylic hydroxylation of 2.48 by CitB.  
























































































Area % Area Height 
1 2.141 155984 73.88 139978 




Area % Area Height 





Figure 2.S33. Benzylic hydroxylation of 2.47 by CitB.  

























































































Area % Area Height 
1 2.230 11489 4.33 18425 




Area % Area Height 





Figure 2.S34. Benzylic hydroxylation of 2.S8 by CitB.  





No Enzyme Control 
 


























































































Area % Area Height 
1 1.907 41893 2.89 54401 




Area % Area Height 
1 2.092 956958 100.00 1153000 





Figure 2.S35. Benzylic hydroxylation of 2.42 by CitB.  
















































































Area % Area Height 
1 2.179 74913 26.66 68811 




Area % Area Height 





Figure 2.S36. Benzylic hydroxylation of 2.33 by CitB.  



















































































Area % Area Height 
1 1.919 325393 61.26 83942 




Area % Area Height 





Figure 2.S37. Benzylic hydroxylation of 2.32 by CitB.  
LC/MS traces of enzymatic reaction and control reaction. 
 
  
Reaction with CitB 





Part VIII. UPLC traces of ClaD-catalyzed biocatalytic reactions 
Figure 2.S38. Benzylic hydroxylation of 2.26 by ClaD.  





























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.257 372059 27.82 183479 
2 2.601 965233 72.18 1038145 
 Retention 
Time 
Area % Area Height 





Figure 2.S39. Benzylic hydroxylation of 2.35 by ClaD.  





No Enzyme Control 
 













































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.827 10070 2.26 12630 
2 2.946 435438 97.74 531349 
 Retention 
Time 
Area % Area Height 





Figure 2.S40. Benzylic hydroxylation of 2.S7 by ClaD.  


























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.701 22569 2.65 26526 
2 2.926 828224 97.35 1022478 
 Retention 
Time 
Area % Area Height 





Figure 2.S41. Benzylic hydroxylation of 2.40 by ClaD.  























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.628 49270 27.38 54215 
2 2.881 130673 72.62 158993 
 Retention 
Time 
Area % Area Height 






Figure 2.S42. Benzylic hydroxylation of 2.39 by ClaD.  


































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.321 2148 9.27 1533 
2 2.454 16733 72.18 15666 
3 2.783 4302 18.56 5206 
 Retention 
Time 
Area % Area Height 





Figure 2.S43. Benzylic hydroxylation of 2.36 by ClaD.  























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.476 84170 18.80 72961 
2 2.743 363593 81.20 440078 
 Retention 
Time 
Area % Area Height 





Figure 2.S44. Benzylic hydroxylation of 2.19 by ClaD.  














































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.349 9326 6.25 7385 
2 2.522 64221 43.04 66319 
3 2.674 75678 50.71 92174 
 Retention 
Time 
Area % Area Height 





Figure 2.S45. Benzylic hydroxylation of 2.44 by ClaD.  





























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.752 3621 3.26 4362 
2 2.897 107598 96.74 133020 
 Retention 
Time 
Area % Area Height 





Figure 2.S46. Benzylic hydroxylation of 2.45 by ClaD.  



































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.336 11217 16.48 8670 
2 2.497 19302 28.36 15961 
3 2.752 37533 55.15 35440 
 Retention 
Time 
Area % Area Height 





Figure 2.S47. Benzylic hydroxylation of 2.33 by ClaD.  






















































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.287 27135 8.36 20949 
2 2.388 200637 61.84 185589 
3 2.699 96692 29.80 122972 
 Retention 
Time 
Area % Area Height 





Figure 2.S48. Benzylic hydroxylation of 2.37 by ClaD.  





























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.571 52992 6.57 57801 
2 2.765 754098 93.43 941895 
 Retention 
Time 
Area % Area Height 






Figure 2.S49. Benzylic hydroxylation of 2.S12 by ClaD.  




















































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.495 234136 35.21 297866 
2 2.749 430771 64.79 538897 
 Retention 
Time 
Area % Area Height 





Figure 2.S50. Benzylic hydroxylation of 2.38 by ClaD.  

















































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.100 311160 89.76 83400 
2 2.528 35513 10.24 39781 
 Retention 
Time 
Area % Area Height 





Figure 2.S51. Benzylic hydroxylation of 2.49 by ClaD.  





No Enzyme Control 
 





















































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.337 7645 2.40 5967 
2 2.658 310583 97.60 366569 
 Retention 
Time 
Area % Area Height 






Figure 2.S52. Benzylic hydroxylation of 2.48 by ClaD.  








































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.517 15034 2.97 16459 
2 2.763 491458 97.03 601297 
 Retention 
Time 
Area % Area Height 





Figure 2.S53. Benzylic hydroxylation of 2.47 by ClaD.  



















































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.781 87888 5.00 117285 
2 3.018 1668633 95.00 1956582 
 Retention 
Time 
Area % Area Height 





Figure 2.S54. Benzylic hydroxylation of 2.S10 by ClaD.  



































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.573 9363 4.62 9119 
2 2.808 97837 48.29 113182 
3 2.927 95393 47.09 115398 
 Retention 
Time 
Area % Area Height 





Figure 2.S55. Benzylic hydroxylation of 2.S11 by ClaD.  


















































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.927 39775 12.60 48177 
2 3.035 275823 87.40 338915 
 Retention 
Time 
Area % Area Height 





Figure 2.S56. Benzylic hydroxylation of 2.43 by ClaD.  


























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 3.049 4714 2.15 6257 
2 3.130 215026 97.85 251237 
 Retention 
Time 
Area % Area Height 





Figure 2.S57. Benzylic hydroxylation of 2.S13 by ClaD.  




















































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.680 17449 9.10 23001 
2 2.924 174322 90.90 223470 
 Retention 
Time 
Area % Area Height 





Figure 2.S58. Benzylic hydroxylation of 2.S8 by ClaD.  




















































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.329 171376 61.01 115246 
2 2.617 109536 38.99 123736 
 Retention 
Time 
Area % Area Height 





Figure 2.S59. Benzylic hydroxylation of 2.99 by ClaD.  














































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.237 531242 73.92 307152 
2 2.570 187452 26.08 217040 
 Retention 
Time 
Area % Area Height 





Figure 2.S60. Benzylic hydroxylation of 2.41 by ClaD.  








































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.395 156338 95.35 132623 
2 2.710 7617 4.65 10921 
 Retention 
Time 
Area % Area Height 





Figure 2.S61. Benzylic hydroxylation of 2.46 by ClaD.  


























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.290 69105 10.09 31515 
2 2.455 170675 24.92 110968 
3 2.632 445078 64.99 336764 
 Retention 
Time 
Area % Area Height 





Figure 2.S62. Benzylic hydroxylation of 2.42 by ClaD.  




   

















































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.449 28624 2.10 20551 
2 2.689 1331934 97.90 1061826 
 Retention 
Time 
Area % Area Height 





Figure 2.S63. Characterization of ascorbate adduct from reaction of 2.45 with ClaD.  
PDA traces of enzymatic reaction and isolated ascorbate product. 
 


































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.325 77133 27.84 34356 
2 2.485 164615 59.42 95691 
3 2.735 35309 12.74 14164 
 Retention 
Time 
Area % Area Height 





Part IX. UPLC traces for CitB or ClaD benzylic functionalization cascade reactions 
Figure 2.S64. Generation of 2.30 by in situ functionalization of benzylic alcohol 2.27.  




































































































Area % Area Height 
1 1.906 309186 47.62 279592 
2 1.978 39410 6.07 59128 
3 2.249 136155 20.97 167599 




Area % Area Height 





Figure 2.S65. Generation of 2.81 by in situ functionalization of benzylic alcohol 2.27.  






























































































Area % Area 
1 0.540 358000 70.88 
2 1.904 53153 10.52 
3 1.954 50460 9.99 




Area % Area 





Figure 2.S66. Generation of 2.80 by in situ functionalization of benzylic alcohol 2.27.  







































































































Area % Area Height 
1 0.538 1178917 71.01 671933 
2 1.904 97978 5.90 57828 
3 1.945 82146 4.95 62552 




Area % Area Height 





Figure 2.S67. Generation of 2.82 by in situ functionalization of benzylic alcohol 2.27.  








































































































Area % Area Height 
1 0.540 217704 51.57 134654 
2 1.906 30105 7.13 17480 
3 1.950 41174 9.75 25714 




Area % Area Height 





Figure 2.S68. Generation of 2.84 by in situ functionalization of benzylic alcohol 2.27.  






















































































































Area % Area 
1 0.605 37602 10.48 
2 0.646 27255 7.60 
3 0.694 22399 6.24 
4 1.941 163933 45.70 




Area % Area 
1 0.623 24886 100.00 





Figure 2.S69. Generation of 2.85 and 2.86 by in situ functionalization of benzylic alcohol 2.27. 


























































































Area % Area Height 
1 1.909 337063 73.92 284770 
2 2.153 33190 7.28 36905 




Area % Area Height 



















































Area % Area Height 





Figure 2.S70. Generation of 2.87 and 2.88 by in situ functionalization of benzylic alcohol 2.27. 










































































































Area % Area Height 
1 2.061 15479 15.72 8080 
2 2.163 15048 15.28 10019 
3 2.240 47127 47.86 39579 




























































Area % Area Height 
1 2.162 237852 84.14 160927 






Figure 2.S71. Generation of 2.89 and 2.90 by in situ functionalization of benzylic alcohol 2.27. 








































































































Area % Area Height 
1 0.456 727787 84.98 148137 
2 1.936 45573 5.32 15630 
3 2.207 68820 8.04 53066 




Area % Area Height 





Figure 2.S72. Synthesis of (-)-xyloketal D (2.25) and the diastereomer of (-)-xyloketal D 2.101 
by in situ functionalization of benzylic alcohol 2.68.  




























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.594 15629 11.31 12596 
2 2.982 81309 58.82 57927 
3 3.091 41299 29.88 25902 
 Retention 
Time 
Area % Area Height 






















































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 





Part X. LC/MS traces for CitB benzylic functionalization cascade reactions 
Figure 2.S73. Generation of 2.93 and 2.94 by in situ functionalization of benzylic alcohol 2.27.  
0 1 2 3 4
0
5 .01 0 3
1 .01 0 4
1 .51 0 4
5 .01 0 5
1 .01 0 6

































5 0 0 0
1 0 0 0 0
1 5 0 0 0
1 2 4 .0 8 6 6
2 1 7 .0 7 7 2
2 3 0 .0 6 9 2
2 7 4 .2 7 3 6






Rxn w/ 2-vinyl anisole 
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Figure 2.S74. Generation of 2.91 and 2.92 by in situ functionalization of benzylic alcohol 2.27. 
0 1 2 3 4
0
5 .01 0 3
1 .01 0 4
1 .01 0 6
2 .01 0 6


















0 1 0 0 2 0 0 3 0 0 4 0 0
0
2 0 0 0 0 0
4 0 0 0 0 0
6 0 0 0 0 0
1 6 5 .0 5 5 2
2 6 9 .1 1 8 6
2 7 0 .1 2 1 5






Rxn w/ styrene 
Product B Standard 
Product A Standard 











Figure 2.S75. Generation of 2.95 and 2.96 by in situ functionalization of benzylic alcohol 
2.27. 
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Part XI. LC/MS traces for peptide functionalization reactions 
Sequence of peptides used in this study: 
Peptide A. Ac-Tyr-βAla-Phe-Ala-Glu-Arg-Arg-Phe-Cys-Pro-Phe-Ala-Glu-Arg-NH2 
Peptide B. Ac-Tyr-βAla-Phe-Ala-Glu-Arg-Arg-Phe-Lys-Pro-Phe-Ala-Glu-Arg-NH2 
 
Figure 2.S76. Functionalization of peptides with CitB-generated benzylic alcohol 2.27. 
 
Analytical-scale peptide reactions: Each reaction contained 50 mM TES buffer pH 7.5 (2.5 μL 
of a 1 M solution), 50 μM peptide (1 μL of a 2.5 mM stock in DMSO), 200 μM (4 equiv) 
benzylic alcohol (2.27, 1 μL of a 10 mM stock in DMSO) and Milli-Q water to a final volume of 
50 μL. Reactions were performed (in duplicate) at 37 °C for 18 h before diluting the reaction 
with Milli-Q water (with 1% v/v formic acid) to a final concentration of 10 μM peptide. 
Reactions were analyzed by LC/MS using the method described below for peptide analysis. 
Peptide reactions were quantified by analyzing the extracted ion chromatogram for the area 
under the curve (AUC) for product/total AUC (product AUC + starting material AUC). All 









Figure 2.S77. One-pot CitB-catalyzed hydroxylation and peptide functionalization. 
 
Procedure for one-pot CitB-catalyzed hydroxylation and peptide functionalization reactions: 
CitB-catalyzed benzylic functionalization and in situ peptide functionalization was performed 
under the following conditions: 50 μL total reaction volume, 1 μM CitB, 50 mM TES (pH 7.5), 
0.2 mM substrate, 0.4 mM α-ketoglutaric acid, 8 mM sodium ascorbate, 0.1 mM ferrous sulfate, 
50 μM peptide, and Milli-Q water to obtain a total volume of 50 μL. The reaction was incubated 
for 5 h at 37°C before the addition of 200 μL 1% (v/v) formic acid in water to quench the reaction. 
The reactions were then analyzed by LC/MS (Q-TOF) using the method described below for 
peptide analysis. Peptide reactions were quantified by analyzing the extracted ion chromatogram 
for the area under the curve (AUC) for product/total AUC (product AUC + starting material AUC). 
All reactions were performed in duplicate and conversion determined as an average of those trials. 
 
LC-MS analysis of peptide reactions: Peptide reactions were quenched with 1% (v/v) formic 
acid in ddH2O before analysis by LC/MS on an Agilent 1290 Series Infinity HPLC with a 6545 
Series Quadrupole-Time-of-Flight mass spectrometer. Samples were analyzed on a Phenomenex 
Aeris 3.6 μm WIDEPORE C4 column (2.1 x 50 mm) under the following conditions: mobile phase 
(solvent A: ddH2O + 0.1% trifluoroacetic acid; solvent B: acetonitrile + 0.1% trifluoroacetic acid) 






Peptides and potential product masses 












Peptide B: Peptide without ligandable cysteine residue (2.S14) 
Ac-Tyr-βAla-Phe-Ala-Glu-Arg-Arg-Phe-Lys-Pro-Phe-Ala-Glu-Arg-NH2 
 
Liganded Peptide B (imine condensation): Peptide B liganded (2.S15) with benzylic alcohol 
2.27. 
 









Table 2.S2. Calculated and observed peptide masses for peptide MS 
 






Peptide A 1804.8820 902.4410 1804.870 
Peptide A-liganded 1968.9294 984.4647 1968.919 




1977.0119 988.5059 Not observed 
Peptide B-liganded  
(o-QM addition) 








LC-MS traces for peptide functionalization reactions 
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EIC: 901.8-902.0 
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Figure 2.S78. Functionalization of Peptide A (2.97) with benzylic alcohol 2.27.  
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Figure 2.S79. Functionalization of Peptide B (2.S14) with benzylic alcohol 2.27.  
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Figure 2.S80. In situ functionalization of Peptide A (2.97) with CitB-generated benzylic 
alcohol 2.27.  
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Figure 2.S81. In situ functionalization of Peptide B (2.S14) with CitB-generated benzylic 
alcohol 2.27.  
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600 MHz, (CD3)2CO 
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Part XIII. Computational analysis of benzylic functionalization reactions 
General computational information: All geometries and frequency computations were obtained 
using the unrestricted B3LYP density functional73-74 and 6-311++G** basis set.75-76 Reaction 
pathways were calculated using the single-ended growing string method.77 All ground state 
geometries were confirmed to have no imaginary frequencies, and transition states were confirmed 
to have one imaginary frequency. Solvent corrections were performed using the SMD implicit 
solvent model (water)78-79 and the cc-pVTZ basis set.80-85 Reported energies are Gibbs free 
energies in solvent with gas-phase entropy and enthalpy corrections (at 298.15 K). Most 
simulations were performed using the Q-Chem 4.0 package,86 except for the solvent computations, 
which were performed using ORCA 4.0.87 Computations performed by Kevin Skinner. 
 
Thermodynamics of ortho-quinone methide generation and inverse-electron demand Diels-
Alder (IEDDA) reactions: Figure 2.S68 depicts the potential energy diagram for the formation 
of the two possible ortho-quinone methides that can be accessed for benzylic alcohol 2.27, and 
their subsequent reactions with ethyl vinyl ether or styrene. The model predicts moderate barriers 
for ortho-quinone methide generation and IEDDA reactions. Concerted, late transition states are 
seen for ortho-quinone methide generation (Figure 2.S69). For the C1 ortho-quinone methide, 
bonds between atoms H1a and O1a (C1-hydroxyl), H2a and O2a (water), and O3a and C7 (benzylic 
alcohol) are broken. Bonds between H1a and O2a (water) and H2a and O3a (new water) are formed. 
For C3 ortho-quinone methide, bonds between atoms H1b and O1b (C1-hydroxyl), H2b and O2b 
(water), and O3b and C7 (benzylic alcohol) are broken. Bonds between H1a and O2a (water) and 
H2a and O3a (new water) are formed. For the IEDDA reactions, the model shows concerted, 





vinyl ether, changes in bond length are no greater than 0.996 Å (Table 2.S3). Reactions with 
styrene afford maximal bond length changes of 1.270 Å. 
Table 2.S3. Changes in C-C and C-O bond lengths during IEDDA reactions with 2.27.  
 
Figure 2.S82. Potential energy diagram for ortho-quinone methide (black) generation, and 






Figure 2.S84. Transition states for IEDDA reactions between II (left) and III (right) ortho-
quinone methides with ethyl vinyl ether (top) and styrene (bottom).  
C-C distances are shorter than C-O distances for all transition states, which indicate 
asynchronous transition states. 
Figure 2.S83. 3D representations of transition states for both C1 and C3 ortho-quinone 
methides (II and III respectively).  
Both TSI and TSII structures undergo concerted, late stage transition states. Starting material 





Thermodynamic analysis of CitB-hydroxylated products: Experimental evidence from 
preparative-scale reactions with CitB suggested that benzylic alcohol products with C6-
substitutents (2.57-2.61 and 2.70), particularly with electron-withdrawing substituents, were 
difficult to isolate without further elaboration to products downstream of ortho-quinone methide 
formation under the conditions of the CitB reaction. C5-substituted resorcinol products (2.27 and 
2.54-2.56) did not typically exhibit this behavior under the same conditions. We conducted an 
Figure 2.S85. Substrate panel used to develop thermodynamic relationships between 






analysis of the Gibbs free energies of CitB-generated benzylic alcohols of a panel of substrates 
(2.26, 2.39-2.40, 2.44-2.46, and 2.S4, 2.S16-2.S24) to examine the impact of substitution pattern 
on benzylic alcohol stability. This analysis was carried out by comparing the Gibbs free energy for 
the benzylic alcohol products to their respective starting materials (Gt). Mass balance was 
achieved by using a truncated 2-His-1-Asp non-heme iron system (Figure 2.S85).  
 The ΔGt of C6-substituted benzylic alcohols were spread over a relatively wide range of 
5.1 kcal/mol, while the energies of the C5-substituted benzylic alcohols were nearly isoenergetic, 
with a range of 0.3 kcal/mol. This data indicated that the relative energies of these products was 
influenced by their substitution pattern. Further, we noted that benzylic alcohols containing 
inductively electron-withdrawing substituents in the C6-position generally tended to have higher 
energies, whereas the benzylic alcohol containing an inductively electron-donating substituent (R 
= methyl) had the lowest Gibbs free energy value in this substrate panel. This general trend is in 
agreement with our experimental observations, as 2.S4, which contains a nitro group at the C6 
position, was quite reactive and difficult to isolate. Even upon isolation of the thiophenol adduct 
(2.61), we were required to use a non-nucleophilic NMR solvent for characterization, as MeOD 
quickly exchanged with thiophenol on the time-scale required for obtaining a 1H NMR. In 
Figure 2.S86. Truncated 2-His-1-Asp non-heme iron system used for all thermodynamic 
calculations.  
Structure on left represents [FeIV] species and the structure on the right represents the [FeII] 
species. These structures were included to maintain atom balance between starting materials 





comparison, the analogous compound bearing a methyl group at C6 (2.76) could be transferred in 
MeOH and did not exchange with MeOD in the time required for full NMR characterization. To 
further investigate these observations, the Gibbs energies of thiophenol were analyzed in the same 
manner as the benzylic alcohol products. Through this analysis, we determined that thiophenol 
adducts of each CitB-hydroxylated product were lower in energy than their benzylic alcohol 
precursors (Figure 2.S88-2.S89). We also observed that the C6-nitro thiophenol adduct (2.61) had 
a relatively high Gibbs energy, which supported our observations that 2.76 exhibited reduced 
stability when compared to other isolated thiophenol adducts. 
 
 
Figure 2.S87. Calculated thermodynamics (ΔGt) of benzyl alcohol products, compared to 
their respective starting materials (SM).  
ΔGt = (Product + [FeII]) – (SM + [FeIV]). Blue circles represent C5-substituted substrates and 
range from -43.6 to -43.9 kcal/mol. Green circles represent C6-substituted substrates and range 









Figure 2.S88. Thermodynamic comparison of C6-substituted benzylic alcohols (left) and 
thiophenol products (right).  
All thiophenol products are lower in energy than the corresponding benzyl alcohol precursor. 










Figure 2.S89. Thermodynamic comparison of C5-substituted benzylic alcohols (left) and 
thiophenol products (right), compared to their respective starting material (SM).  
All thiophenol products are lower in energy than their benzylic alcohol precursors. ΔGt = 





Multivariable linear regression Hammett plot analysis: Intrigued by the apparent relationship 
between the free energy of C6-substituted substrates and the electronics of their substituents, we 
sought to define their Hammett relationship, which compares various electronic parameters 
(Hammett constants) based on substitution on an aryl ring. A relationship was found between the 
Hammett inductive (σI) and resonance (σR) constants and the Gibbs free energy of (ΔGc) (Figure 
2.S90). When plotting ΔGc against ΔGt, we observe a correlation with an R2 of 0.7537. This 
correlation provides further support that electronics at the C6 position have an influence on the 
stability of the benzylic alcohol. An analysis of the coefficients of the regression reveals that σI 
has the larger coefficient than σR 7.7 and -4.7, respectively, and therefore is the most influential 
Figure 2.S90. Multivariable linear regression plot of combined inductive (σI) and 
resonance (σR).  
Hammett constants against calculated thermodynamics of C6-substituted substrates  (ΔGt). ΔGt 
= (Product + [FeII]) – (SM + [FeIV]). A trend can be observed from inductively electron donating 












 Figure 2.S91. Plot of the inductive Hammett constant (σI) against calculated 
thermodynamics.  
(ΔGt) of C6-substituted benzyl alcohol products compared to their respective starting materials. 










Figure 2.S92. Plot of the resonance Hammett constant (σR) against calculated 
thermodynamics (ΔGt) of C6-substituted benzyl alcohol products compared to their 
respective starting materials. 














Figure 2.S93. Thermodynamic comparison of ortho-quinone methide precursors with a 
range of common leaving groups substituted at the o-phenolic benzylic position. 
This data shows that the benzylic alcohol (A) is higher in energy than other common leaving 
groups. This data also clearly shows why methylation of the morpholine adduct precursor used 
by Wilson and co-workers was necessary to observe ortho-quinone methide activity. Overall, 
this provides evidence as to why our enzymatically generated benzylic alcohol precursors can 





Part XIV. XYZ coordinates of ortho-quinone methide and IEDDA transition states 
TS1I 
H -4.9499456400 0.3051135600 0.4113060800  
O -4.0414247800 0.1905241200 0.7316649200  
H -3.7185704200 -0.7262253000 0.3535210500  
C -2.8443859800 0.9804196500 -0.5535490500  
H -2.8982343300 2.0398600900 -0.3262081000  
H -3.4872014400 0.6268288300 -1.3533284500  
O -2.8288415100 -1.7275963500 -0.3955920400  
C -1.6393397800 0.2946932000 -0.3241739200  
C -1.6906807200 -1.1569398800 -0.3862488800  
O -0.4306888600 2.2663872900 0.1749792500  
C -0.4274093000 0.9491992800 0.0104875200  
C -0.4491738100 -1.8726385800 -0.3458470700  
H -0.4907395000 -2.9525904900 -0.4402619200  
H 0.5310208000 2.5221409900 0.3669362800  
C 0.7392063900 -1.2273708300 -0.1049139400  
C 0.7792546300 0.2024476000 0.0963095000  
H 2.4888134500 -1.9392928100 0.9623600200  
H 1.8051811700 -3.0951191200 -0.1884324400  
C 2.0123708200 -2.0365368800 -0.0196777200  
C 1.9892074500 0.9210841300 0.3723851700  





H 2.7457984200 -1.7139288300 -0.7673807000  
H 2.9269280300 0.3453623700 0.4282085900  
TS1II  
C 0.7609422300 0.1826692100 -0.1350069500  
C -0.4964908500 0.8856089700 -0.1546474000  
C -1.7258848300 0.1103971800 -0.1903379600  
C -1.6772023100 -1.2857305800 0.0411133300  
C -0.4530291600 -1.9336355000 0.1110299500  
C 0.7594621700 -1.2197443900 0.0026149300  
C -2.9128524600 0.8306537100 -0.4052586300  
O -2.8796925500 2.1523788000 0.9999659900  
O -2.8619882500 -1.9446020500 0.1171147800  
O -0.6028285200 2.1579348100 -0.0720095800  
C 2.0424029900 -2.0078820400 0.0633685700  
C 1.9809787700 0.9937082200 -0.2035304900  
O 3.1315683400 0.5696553400 -0.1979127100  
H -3.8689494900 0.3410491300 -0.2553586700  
H -3.4167840300 2.9079700900 0.7141229600  
H -2.6927820400 -2.8869331400 0.2528852400  
H -2.8928470200 1.6279710000 -1.1413423900  
H -1.9066230500 2.3524182000 0.6613052800  
H -0.4226526100 -3.0137369500 0.2324542800  





H 2.6245371300 -1.8785628000 -0.8535223400  
H 2.6898093800 -1.6438364000 0.8650917200  
H 1.7830838200 2.0797994900 -0.2703474600  
TS2Ia 
C -1.0362475800 0.3915354700 0.1127718900  
C -2.0615369900 0.1378212700 1.0725993800  
C -0.0597492100 -0.5883230500 -0.1641720100  
C -0.1436962400 -1.8527799200 0.5091458900  
C -1.1368341600 -2.1592796100 1.3890075100  
C -2.1783460900 -1.1933113900 1.6999297900  
H 0.6267831200 -2.5891380300 0.2836518800  
H -1.1929744200 -3.1267625300 1.8779376600  
C 0.9834671200 -0.3028425800 -1.1064803500  
O 1.1034419600 0.7706324200 -1.7268151700  
H 1.7244237900 -1.1066493800 -1.2807559800  
O -1.0156784200 1.5790666500 -0.4947504200  
O -3.1598839500 -1.4608426800 2.4283619100  
C -3.0138825700 1.0977774500 1.4049750700  
C -4.8437205100 0.8224115400 0.2447003600  
H -2.8993381100 2.1125795500 1.0398365400  
H -3.5530445300 0.9572028600 2.3335939000  
C -5.0492786600 -0.5187795500 0.4351395700  





H -5.4492681200 1.5227910700 0.8086404500  
O -4.4938790600 -1.3977908900 -0.3844311100  
H -5.5876000600 -0.9092717700 1.2958225800  
H -0.2157145800 1.5704210300 -1.1031544200  
C -4.6185120300 -2.8028294300 -0.0320072100  
C -5.9827659900 -3.3543429000 -0.4152536300  
H -6.0193004800 -4.4268427800 -0.1937596800  
H -6.1754384200 -3.2159495900 -1.4839817400  
H -6.7875383900 -2.8692274800 0.1482685500  
H -4.3983097600 -2.8995740300 1.0356854600  
H -3.8207333900 -3.2869228100 -0.5986686500  
TS2Ib 
C -1.1226393400 0.4771206900 0.3527469300  
C -2.2120106100 0.4039241900 -0.5616932000  
C -0.2721416300 -0.6349971700 0.5572912100  
C -0.5632216800 -1.8842882200 -0.1275907300  
C -1.6552283100 -1.9951897400 -0.9387664200  
C -2.5544406700 -0.8830068400 -1.1847780000  
C 0.3396985900 -3.0794168800 0.0769665800  
H -1.8947797700 -2.9328825600 -1.4310999600  
C 0.8369690300 -0.4834008500 1.4561665900  
O 1.1044273600 0.5629569700 2.0851172100  





O -0.9197703700 1.6337977300 0.9874699100  
O -3.5984034500 -0.9780117400 -1.8632513500  
C -3.0365223100 1.4960453100 -0.8593276500  
C -4.7863019700 1.4571353000 0.2066467100  
H -3.5597654200 1.4417813800 -1.8070949000  
H -2.7357836400 2.4810870700 -0.5160489400  
C -5.3160086700 0.1829797300 0.0818792700  
H -5.2571192100 2.2592739200 -0.3545150600  
H -4.3441247900 1.7631078100 1.1497444700  
H -5.9832313000 -0.0217203700 -0.7505884600  
C -5.0291217300 -0.9304689700 0.9534445900  
H -0.0944095300 1.5010391800 1.5532405600  
C -4.1049026600 -0.8441494500 2.0185403000  
C -5.6864753500 -2.1629981300 0.7358036800  
C -5.4513617600 -3.2529684300 1.5606200500  
C -3.8625849800 -1.9445608200 2.8364557600  
C -4.5375094300 -3.1466547000 2.6166736400  
H -3.5778012800 0.0842896400 2.2106592500  
H -3.1469792800 -1.8624805800 3.6496698400  
H -5.9708757900 -4.1901963800 1.3821240800  
H -4.3514799500 -4.0005532800 3.2623996900  
H -6.3790517300 -2.2482040000 -0.0972220800  





H -0.0162700300 -3.9314923200 -0.5080897500  
H 0.3768056300 -3.3872254700 1.1295924300  
TS2IIa 
C 1.3663481200 0.8862776400 0.6794257500  
C 0.0739675900 0.2354337600 0.4151188100  
C 2.5765996900 0.2267469900 0.1966877000  
C 2.4802819100 -0.9561587200 -0.5451555000  
C 1.2131151800 -1.5167931600 -0.8471165000  
C 0.0446510800 -0.9313547000 -0.4041025500  
H 1.1694713700 -2.4318909900 -1.4346299900  
C 3.8507670900 0.8734376600 0.5186424700  
O 4.9682919300 0.4846176100 0.1917999100  
H 3.7360883000 1.7979606900 1.1151505700  
O 1.3780583500 1.9979432800 1.2647325000  
C -1.0779428100 0.8384189000 0.9101031300  
C -1.5987970800 2.6437180000 -0.2694298100  
H -0.9843355900 1.4793521800 1.7778721000  
H -2.0401297600 0.3659645400 0.7446094300  
C -0.6136810000 3.4930963900 0.1635385600  
H -2.5926116100 2.7234478700 0.1599288100  
H -1.5153371900 2.2134381700 -1.2596314300  
O -0.7734149800 4.2077050900 1.2686333100  





O -1.1831846400 -1.4448259400 -0.6912279800  
C 3.6987185500 -1.6796834700 -1.0634888100  
H 4.2822048600 -1.0396443400 -1.7325871100  
H 3.4101751500 -2.5902761800 -1.5982089600  
H 4.3800075700 -1.9397816200 -0.2481818200  
H -1.0699674400 -2.2492892900 -1.2225538500  
C 0.3763652800 4.9034843100 1.8129863000  
C 0.5525250800 4.5074021000 3.2669427700  
H 0.1696705700 5.9738690300 1.7043239400  
H 1.2621005100 4.6405793500 1.2286608100  
H -0.3588723600 4.7066594500 3.8403023000  
H 1.3707554400 5.0874505200 3.7089355200  
H 0.7994148600 3.4449303200 3.3295001100  
TS2IIb 
C 1.0776353600 1.8739808300 -0.3393770100  
C -0.0114023500 1.0045305600 0.1353536500  
C 2.4492733000 1.3772349000 -0.2320166900  
C 2.6918462100 0.1186801100 0.3232158500  
C 1.6193084300 -0.6691403600 0.8216167000  
C 0.3124637500 -0.2302909000 0.7637797400  
H 1.8426930700 -1.6405329100 1.2590520500  
C 3.5071395600 2.2606430600 -0.7310854500  





H 3.1265411400 3.2153802900 -1.1387416700  
O 0.7817387000 3.0092089400 -0.7772632500  
C -1.3132370300 1.4913287000 -0.0067980000  
C -1.7338153000 2.9518040500 1.4151011700  
H -2.1494701300 0.8475312200 0.2473228700  
H -1.4633571200 2.2024051300 -0.8101354200  
C -0.7023248000 3.8754775400 1.3924754300  
H -1.8237642500 2.2635336400 2.2501405100  
H -2.6773182100 3.2315585800 0.9558029900  
C 0.4977034200 3.8195029000 2.1962047100  
H -0.7780233700 4.7180259100 0.7109601700  
O -0.7302737900 -0.9531443600 1.2645062000  
C 4.0826983400 -0.4566886400 0.4345712100  
H 4.5569438300 -0.5368651100 -0.5484770500  
H 4.0563829700 -1.4464955000 0.9017815800  
H 4.7355387700 0.2006925500 1.0163531100  
H -0.3897157100 -1.7907372700 1.6179999800  
C 0.7927955400 2.7304215000 3.0440297000  
C 1.4274425000 4.8814311400 2.1255758100  
C 2.5916237400 4.8634750900 2.8807909900  
C 1.9676044100 2.7101969200 3.7913817200  
C 2.8670510700 3.7751089100 3.7174798900  





H 3.7817299400 3.7575060500 4.3034370700  
H 1.2230721700 5.7155843200 1.4594676600  
H 3.2936566800 5.6896618800 2.8133536600  
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Chapter 3: Chemoenzymatic Synthesis of γ-hydroxytropolones and Tropolone 
Meroterpenoids 
3.1 Introduction 
 Secondary metabolites produced by plants and microorganisms often possess important 
biological activities which can be leveraged in the development of novel pharmaceuticals.1-4 
Thorough evaluation of these valuable molecular properties requires facile access to a source of 
the natural product through synthesis of the target compound or fermentation of the producing 
organism to isolate useful quantities of product.1-3, 5 However, difficulties in culturing many 
metabolite-producing organisms, as well as associated challenges in the isolation of the natural 
products, present a major roadblock in generating a suitable quantity of product for further 
experimentation.3, 6 In addition, many natural product scaffolds represent challenging synthetic 
targets, requiring intensive efforts to design and execute a scalable synthetic campaign.7-8 In 
comparison, Nature has developed direct and efficient routes to access these complex molecules. 
Biosynthetic enzymes within host organisms regularly perform selective reactions to produce 
secondary metabolites in rapid fashion from bioavailable base materials.9 These enzymes offer 
numerous advantages for the construction of complex scaffolds, including exquisite selectivity 
profiles and sustainable reaction conditions.9-11 Despite the broad potential of enzymes to improve 
natural product synthesis, these catalysts remain largely underdeveloped as synthetic tools, 
particularly for complex transformations and rearrangements.4, 12 Biocatalytic transformations 





reduction and hydrolytic reactions, providing great advantages for the selective construction of 
complex molecules.12 However, to further expand the synthetic toolbox available to organic 
chemists and develop new approaches for natural product synthesis, diverse enzymatic 
transformations must be explored for their synthetic potential. Enzymes which perform 
complexity-generating reactions can possess the ability to construct synthetically-useful targets, 
with distinct advantages over existing synthetic methods.4, 12 For example, enzymes which 
selectively control the fate of a reactive intermediate, such as a radical or cation, often proceed 
with a reactivity that is fundamentally divergent from small molecule catalysts.13-14 Diverse 
enzyme classes, including cyclases,15 Diels-Alderases,14 and polyketide synthases13 leverage this 
ability to generate products with great selectivity. The enzyme active site provides three-
dimensional control over the bond formation steps, leading to a particular outcome.13 Such 
selectivity is often unmatched by small molecule methods, which can require extensive substrate 
engineering to produce the desired transformation. Therefore, the detailed characterization of 
enzymes which perform complex, synthetically-challenging reactions can lead to the development 
of novel biocatalytic reactions to construct natural products.16-17 
 Tropolones are a class of natural products which are difficult to access through synthesis 
or biological fermentation. These compounds are structurally-diverse metabolites containing a 7-
membered aromatic ring with an α-hydroxyketone moiety.18-19 Tropolones are produced within 
bacteria, fungi and plants and often possess unique biological activities including antiviral,20-22 
antifungal,23-26 antibacterial,25, 27 anticancer28-36 and anthelmintic37 properties. However, a 
thorough investigation of the biological activities of many tropolones has been limited by 
roadblocks in accessing these natural product cores, many of which have not yet been targeted for 





producing the 7-membered aromatic core with the desired substitution pattern to match the natural 
Figure 3.1. Synthesis and biosynthesis of tropolone natural products.  
A. Representative tropolone meroterpenoids possessing biological activities. B. Previous 
syntheses of 18-deoxyepolone B. C. Abbreviated biosynthesis of γ-hydroxytropolone natural 





product of interest (Figure 3.2).18-19 Early efforts to synthesize tropolones focused on direct 
oxidation of substituted cycloheptatrienes or tropones, generating the tropolone core (Figure 3.2A, 
see 3.17-3.19).38-40 However, this approach proved synthetically intractable, as direct oxidation 
often proceeded with poor selectivity, leading to complex product mixtures and reduced yields.18 
Other early tropolone natural product syntheses leveraged existing tropolone natural product cores 
to generate new tropolone metabolites (Figure 3.2B).18, 41-43 For example, a formal total synthesis 
of colchicine was achieved through elaboration of the commercially-available natural product 
purpurogallin (3.20) to desacetamidocolchicine (3.21).41-42 However, this approach requires access 
to a variety of tropolone natural product cores, which is limited due to challenges in obtaining 
tropolone metabolites from source organisms.18 Tropolones have also been constructed through 
ring-closing metathesis (RCM) or cyclization reactions, enabling late-stage tropolone formation 
and allowing greater flexibility in substrate design (Figure 3.2C).18, 44-46 Despite these advantages, 
late-stage access to tropolones still requires extensive substrate design considerations, leading to 
lengthy, linear reaction sequences with few opportunities for the development of divergent 
synthetic routes.18 In addition, some methods can suffer from poor regioselectivity in the 
cyclization step, a common challenge in the synthesis of medium-sized rings.47 The most common 
synthetic tactic to access tropolones involves rearrangements from smaller rings, such as the 
Büchner reaction (see 3.24-3.26), the de Mayo fragmentation, and [5+2] cycloadditions (Figure 
3.2D).18, 48 As with ring-closing reactions, these methods also require specific substrate design 
considerations to achieve the intended transformation.18-19 Consequently, ring expansion 
approaches to access tropolone natural products vary widely depending on the target structure, 
obfuscating efforts to achieve a generalized method for tropolone synthesis.47-48 Therefore, the 





derivatives remains a major challenge in synthetic chemistry. We aimed to address this challenge 
by leveraging Nature’s tools for the construction of tropolone natural products and their analogs 
through a scalable chemoenzymatic process. 
 We envisioned an approach which utilizes a two-enzyme cascade reaction involving a 
flavin-dependent monooxygenase and an α-KG-dependent NHI enzyme which directly produce 
tropolone natural products in native fungal tropolone biosynthesis (Figure 3.1C). This ring 
expansion reaction has been studied in multiple fungal species and has been identified as an 
intermediate step in the biosynthesis of the secondary metabolites xenovulene A and eupenifeldin 
(3.30), among others (Figure 3.3).49-51 In this biosynthetic pathway, a non-reducing polyketide 
synthase (PKS) is responsible for the synthesis of β-orcinaldehyde (3.9) which then undergoes a 
site- and stereoselective oxidative dearomatization reaction catalyzed by a flavin-dependent 
monooxygenase to produce diene 3.10 (Figure 3.1C).49-52 Following this step, an α-KG-dependent 
NHI enzyme performs an oxidative ring expansion reaction, resulting in the formation of 
Figure 3.2. Synthetic approaches to accessing the tropolone core. 
A. Direct oxidation of cycloheptatrienes to access the tropolone core. B. Formal synthesis of 
colchicine from tropolone natural product purpurogallin (3.20). C. Ring closing metathesis 
(RCM) to access the tropolone core. D. Büchner ring expansion reaction to generate tropolone 





stipitaldehyde (3.11), which serves as the common branch point in the biosynthesis of related 
natural products (Figure 3.3).49-53 While many tropolone biosynthetic pathways remain 
unexplored, a variety of bioactive tropolones possess the γ-hydroxytropolone core present in 
stipitaldehyde (3.11), suggesting that this ring expansion cascade is conserved in the biosynthesis 
of numerous tropolone natural products.50 We aimed to leverage this enzymatic sequence for the 
synthesis of a variety of substituted tropolones. We also envisioned that this cascade could allow 
facile access to a bioactive class of tropolone natural products known collectively as tropolone 
meroterpenoids.  
 As a result of the wide-ranging challenges in tropolone synthesis, only two synthetic groups 
have achieved successful construction of tropolone meroterpenoid cores. The Baldwin group 
accessed the deoxy-form of the natural product epolone B (3.7) through a 21-step synthesis of a 
phenylthioether-substituted tropolone 3.5, which served as a precursor to an o-tropolinone methide 
(o-TM) species.54 This intermediate then underwent a racemic inverse electron-demand Diels-
Alder (IEDDA) reaction with α-humulene (3.16) to generate the desired product, 18-deoxy-
epolone B (3.7).54 A thesis from the Sarlah group recently reported a strategy involving a de Mayo 





fragmentation to directly produce the o-TM precursor 3.8 in a 6-step sequence from 1,3-chlorobut-
2-ene.55 The elaboration of 3.8 was again accomplished by a racemic IEDDA reaction with α-
humulene (3.16), generating the desired product in a more direct fashion.55 We envisioned 
pursuing a chemoenzymatic route to 18-deoxyepolone B (3.7), leveraging the advantages of a 
biocatalytic platform for the direct synthesis of the tropolone core. Similar to the approach taken 
by Baldwin and Sarlah, we aimed to exploit the reactive nature of o-TM intermediate 3.6, 
performing an IEDDA reaction with α-humulene to construct the desired tropolone product (Figure 
3.1D). To generate o-TM precursor 3.6, we anticipated that stipitol (3.15), a proposed intermediate 
in eupenifeldin (3.30) biosynthesis (Figure 3.3), could be directly accessed by chemical reduction 
of stipitaldehyde (3.11).50 We further aimed to develop a one-pot, two-enzyme oxidative 
dearomatization and ring expansion reaction platform to produce stipitaldehyde (3.11) from β-
orcinaldehyde (3.9), providing a direct, chemoenzymatic approach to accessing the tropolone core. 
This reaction platform would leverage a flavin-dependent monooxygenase, TropB for the site- and 
stereoselective oxidative dearomatization of 3.9 to generate o-quinol 3.10, followed by an 
oxidative ring expansion reaction catalyzed by an α-KG-dependent NHI dioxygenase to produce 
stipitaldehyde (3.11). This proposed route takes advantage of the reactivity of stipitol (3.15) to 
serve as a precursor to an o-TM, enabling rapid access to tropolone meroterpenoid natural product 
cores. In addition, we hypothesized that a hetero-Diels-Alderase, XenE (Figure 3.3), which was 
previously characterized in vivo in the biosynthesis of xenovulene A, could be leveraged for the 
enantioselective synthesis of 18-deoxyepolone B (3.7) from 3.15, representing the first selective 
synthesis of this product.50 A related biosynthetic pathway was recently characterized by Chen et 
al. for the in vivo synthesis of neosetophomone B using the hetero-Diels-Alderase EupF to achieve 





proposed chemoenzymatic reaction platform, we aimed to construct a scalable biocatalytic method 
for the direct and selective synthesis of 18-deoxyepolone B (3.7), as well as other tropolone natural 
product derivatives.  
3.2 Identification of candidate NHI dioxygenase for ring expansion reactions 
 Toward the development of a direct chemoenzymatic route for the synthesis of tropolones, 
we first sought to identify a biocatalyst capable of efficiently accessing tropolones through a one-
pot, two-enzyme oxidative dearomatization and ring expansion process. As the enzyme TropC had 
been previously shown to perform a ring expansion reaction, we used the TropC amino acid 
sequence as a starting point for identifying homologs which could engage in the same ring 
expansion reactions.49 An initial basic local alignment tool (BLAST) search of the National Center 
for Biotechnology Information (NCBI) database yielded several NHI dioxygenases sharing 
Table 3.1. Comparison of TropC homologs in one-pot reaction with substrate 3.9  
Reaction conditions: 2 mM substrate, 10 μM TropC, 5 μM TropB or AzaH, 50 mM TES pH 
7.5, 5 mM α-ketoglutaric acid (α-KG), 4 mM sodium ascorbate, 0.1 mM ferrous sulfate 
(FeSO4), 5 mM glucose-6-phosphate (G6P), 0.1 mM nicotinamide adenine diphosphate 
(NADP+), 0.1 U/mL glucose-6-phosphate dehydrogenase (G6PDH), 30 °C. Conversion to 






sequence identity with TropC (Table 3.1). To ensure that these unannotated sequences were indeed 
functional homologs of TropC, we then confirmed the presence of a TropB homolog within the 
gene cluster of the species of interest. From this set of sequence results, we selected three homologs 
sharing various levels of sequence identity with TropC. These genes were ordered from Twist 
Biosciences in pET-28a expression vectors. The constructs were transformed into BL21(DE3) E. 
coli, expressed and purified using the standard conditions described in Section 3.8 of this chapter. 
All of the homologous enzymes were soluble and were used in subsequent reactions to assess their 
relative performance in a one-pot oxidative dearomatization/ring expansion process. Our group 
has previously demonstrated the substrate promiscuity of flavin-dependent monooxygenase TropB 
in performing site- and stereo-selective oxidative dearomatization of resorcinols. Taking 
advantage of this selective reaction, we established a modular, one-pot platform in which TropB-
catalyzed dearomatization was allowed to proceed until completion, followed by the addition of 
each NHI dioxygenase and the cofactors α-KG, sodium ascorbate and ferrous sulfate heptahydrate. 
Under the same reaction conditions, TropC homologs performed with varied efficiency. After 3 h, 
the reaction was quenched with methanol, and the product conversions were analyzed by LC-MS. 
For all homologs tested, we observed conversion of compound 3.10 to stipitaldehyde. However, 
the most effective enzyme in catalyzing this ring expansion reaction was the NHI dioxygenase 
from the fungus S. strictum known as XenC. Recently, XenC has been shown to catalyze the 
formation of stipitaldehyde natively in the context of xenovulene A biosynthesis, demonstrating 
that 3.10 is the native substrate for the enzyme.51 Encouragingly, this biocatalyst converted nearly 
all of substrate 3.10 to stipitaldehyde (3.11) in this one-pot process. As a result of this superior 





3.3 Scope of oxidative dearomatization and ring expansion platform 
 We first explored the ability of NHI dioxygenase XenC to convert ortho-quinols (such as 
3.13) to γ-hydroxytropolones in a one-pot oxidative dearomatization/ring expansion cascade. 
Tropolones possessing synthetically-tractable functional handles, such as aldehydes, halogens, 
alkynes and nitro groups, were produced with good conversion (51-96% conversion, Figure 3.5, 
3.33-3.35, 3.42). The diversity of functional groups which were incorporated in the final tropolone 
products provide the ability to achieve a divergent synthesis of complex tropolones following a 
simple chemoenzymatic synthesis of the core structure. In addition, we explored the feasibility of 
generating tropolone structures which were substituted at the C3 (3.37) and C7 (3.38) positions 
respectively. The resulting tropolones were generated with moderate to good conversion over two 
Figure 3.4. Substrate scope for XenC-catalyzed ring expansion.  
Reaction conditions: 2 mM substrate, 10 μM TropC, 5 μM TropB or AzaH, 50 mM TES pH 
7.5, 5 mM α-ketoglutaric acid (α-KG), 4 mM sodium ascorbate, 0.1 mM ferrous sulfate 
(FeSO4), 5 mM glucose-6-phosphate (G6P), 0.1 mM nicotinamide adenine diphosphate 
(NADP+), 0.1 U/mL glucose-6-phosphate dehydrogenase (G6PDH), 30 °C. Conversion to 





steps, demonstrating the ability of XenC to generate tropolones possessing non-native substitution 
patterns. The C5 aldehyde of stipitaldehyde (3.11) could also be replaced with a similar sized 
electron-withdrawing group, such as a methyl ketone (3.39) or nitro group (3.42), although with 
reduced conversion over two steps. However, larger ketones, such as n-propyl (3.40) or n-butyl 
(3.41) were not converted by XenC through this reaction sequence, suggesting a limitation in the 
size of substrates able to achieve productive binding in the XenC active site. Encouragingly, other 
large, bulky tropolones, such as phenyl tropolone 3.36 were produced, but with lower conversion 
compared to smaller tropolones, again suggesting a limitation of XenC to catalyze ring expansion 
of larger substrates. However, this limitation is overshadowed by the ability of XenC to generate 
tropolones with a broad array of functional handles which can be used to produce more complex 
tropolone structures from accessible precursors. 
3.4 Preparative-scale oxidative dearomatization and ring expansion 
 In order to test the synthetic utility of this chemoenzymatic one-pot tropolone synthesis 
platform, we performed milligram-scale synthesis of several tropolones. One-pot reactions with 
TropB and XenC were performed in a sequenced fashion. The initial TropB dearomatization 
reaction was allowed to reach full conversion (typically 1-2 h) before the addition of XenC and 
the necessary cofactors ferrous sulfate, sodium ascorbate and α-KG. This sequenced approach 
resulted in improved conversion of material through the initial dearomatization reaction, which 
was notably less efficient with the addition of XenC cofactors when attempting reactions under 
cascade conditions. Following the addition of XenC, each reaction was incubated at 30 °C for 4 h 





 Initial efforts to isolate stipitaldehyde (3.11) from the crude product mixture were met with 
challenges related to the reactivity of the tropolone with proteinaceous materials, particularly as 
proteins were denatured in the presence of organic solvents used for liquid-liquid extraction of 
biocatalytic products. Following the denaturation of enzyme, the brown tropolone material could 
be visually identified as being located within the debris of denatured enzyme and initial yields of 
stipitaldehyde were correspondingly low (12% yield) despite high conversion through the reaction 
sequence (68% conversion). Based on these observations, we anticipated that the electrophilic  
aldehyde group of the natural product core could participate in condensation reactions with 
enzymatic lysine residues or free N-terminal amines, yielding an enzyme-tropolone complex. 
Challenges associated with handling tropolones have been similarly documented in the literature.38 
Trace metal contamination has led to isolation challenges due to the affinity of tropolones for 
divalent metal ions.38, 42 In addition, tropolones are well-known inhibitors of numerous 
metalloenzymes, generating stable enzyme-tropolone complexes that have been characterized by 
X-ray crystallography.19-20, 22, 57-58 Our attempts to extract this crude enzymatic material indicated 
that tropolone materials trapped within this complex could not be liberated in the presence of 
myriad solvent combinations, under basic or acidic conditions, or under aqueous high temperature 
(60-100 °C) conditions. To circumvent this issue, we evaluated possible extraction procedures 
involving in situ protection of the tropolone and remaining enzymatic materials in the crude 
biocatalytic mixture. Attempted acylation of the crude mixture using acetic anhydride in the 
presence of pyridine yielded monoacylated tropolones as detected by LC-MS. However, attempted 
isolation of acylated material through extraction under acidic conditions yielded only unprotected 
tropolone in slightly higher yields, indicating that the installed acyl group was labile. We then 





maintained by potassium carbonate (40 equiv). Full methylation of the tropolone mixture could be 
achieved under these conditions, yielding two methyl protected tautomers38 of stipitaldehyde in 
52% yield. We further desired to determine if this methylation procedure could be leveraged for 
isolation of unprotected tropolones by capping nucleophilic amines within the crude enzymatic 
material of the biocatalytic mixture. Analytical-scale isolation experiments demonstrated that 
methylation with only 4 mol % dimethylsulfate under basic conditions yielded unprotected 
stipitaldehyde (3.11) with a minor amount of protected stipitaldehyde, whereas controls without 
the addition of dimethylsulfate yielded no detectable stipitaldehyde (see Section 3.8 Experimental 
for details). This demonstrated that in situ methylation enabled isolation of unprotected 
stipitaldehyde and circumvented apparent reactivity between XenC and aldehyde-containing 
tropolone products.  
 Following the procedure for in situ methylation of the crude enzymatic materials, 
tropolones 3.11, 3.32, 3.34, 3.37 and 3.42 were synthesized, isolated, and characterized using the 
one-pot TropB/XenC reaction (Figure 3.6). XenC native product stipitaldehyde (3.11) was 
Figure 3.5. Preparative-scale XenC-catalyzed ring expansion.  
Reaction conditions: 2.5 mM substrate, 10 μM TropC, 5 μM TropB, 50 mM TES pH 7.5, 5 
mM α-ketoglutaric acid (α-KG), 4 mM sodium ascorbate, 0.2 mM ferrous sulfate (FeSO4), 5 
mM glucose-6-phosphate (G6P), 0.1 mM nicotinamide adenine diphosphate (NADP+), 0.1 





generated in moderate yield along with 3-methylated tropolone 3.11 and 6-desmethyl tropolone 
3.32. 5-nitro- (3.42) and 6-iodo-tropolone 3.34 was also generated in moderate yields, providing 
an additional functional handle for potential tropolone modification reactions. 
3.5 Synthesis of (+/-)-18-deoxyepolone B 
 After demonstrating that rapid, preparative-scale biocatalytic synthesis of tropolones could 
be achieved using the XenC ring expansion reaction, we aimed to elaborate XenC products to more 
complex natural products, including 3.7. The ortho-phenolic aldehyde moiety in stipitaldehyde 
(3.11) set the stage to access ortho-tropolinone methide (o-TM) species 3.6. We envisioned that 
this reactive o-TM could be accessed by borohydride reduction of stipitaldehyde (3.11) to produce 
tropolonic alcohol 3.15, a proposed biosynthetic precursor to form o-TM 3.6. We also anticipated 
that heating alcohol 3.15 in the presence of α-humulene (3.16), would enable in situ formation of 
o-TM 3.6 and inverse electron demand Diels Alder (IEDDA) reaction with the C1-C2 double bond 






of the α-humulene macrocycle. This reaction would directly deliver the racemic form of 18-
deoxyepolone B (3.7, Figure 3.7) 
 Initial experiments to generate stipitol (3.15) through sodium borohydride reduction of 
stipitaldehyde (3.11) were successful, yielding the o-TM precursor in an 84% yield on milligram 
scale (Figure 3.7). The tropolone was then used in analytical-scale IEDDA reactions with α-
humulene. We subjected stipitol (3.15) to thermal IEDDA conditions (80 °C for 18 h) in a solvent 
mixture of acetonitrile and water (1:1). These conditions resulted in direct formation of a product 
matching the expected mass of 18-deoxyepolone B. However, conversion to the product was quite 
low, requiring additional optimization of reaction conditions. Table 3.2 describes the conditions 
screened in this optimization process, including the development of microwave conditions, which 
reduced reaction times significantly to around 1 h for complete substrate conversion. In addition, 
the use of DMSO and benzene (1:1) improved the solubility of α-humulene, improving the overall 
conversion under thermal conditions. These idealized conditions were applied to microwave 
reactions, generating 18-deoxyepolone B (3.7) with >99% conversion of the starting material 
observed in 1 h. Efforts are ongoing to isolate the product from preparative-scale reactions. 
3.6 XenE-catalyzed synthesis of 18-deoxyepolone B 
 In addition to our efforts to thermally generate 18-deoxyepolone B, we sought to 
characterize the activity of putative Diels-Alderase XenE51 in a [4+2] reaction between stipitol 
(3.15) and α-humulene (3.16) to produce 18-deoxyepolone B (Figure 3.8, 3.7). Early efforts to 
achieve productive catalysis were challenging, as no previous in vitro activity was reported for this 
enzyme. We first evaluated the activity of XenE in performing a hetero-Diels-Alder reaction under 





presence of 2 equiv α-humulene. MeCN (10 % v/v in water) was used in these reactions to improve 
solubility of α-humulene. However, under these initial reaction conditions, we did not observe 
substrate conversion. Screening pH conditions using a citrate-KPi buffer system, we observed a 
significant increase in conversion of starting material (95%) near pH 5.8 (Table 3.3). Under these 
conditions we observed the greatest percentage of substrate conversion to produce 18-





optimized for product formation. Furthermore, the product generated by XenE in this reaction 
eluted at the same reaction time and with the same extracted ion mass as the product generated in 
thermal IEDDA reactions, suggesting that the hetero-Diels-Alderase-catalyzed reaction is likely 
Table 3.3 Optimization of reaction conditions for  XenE-catalyzed hetero-Diels-Alderase 





producing an identical product. Efforts to generate this product on preparative-scale are ongoing. 
We anticipate that full characterization of this product will provide valuable information on the 
enantioselectivity of the hetero-Diels-Alderase reaction catalyzed by XenE. This route can 
potentially deliver the first enantioselective synthesis of 18-deoxyepolone B (3.7), illustrating the 
synthetic utility of this biocatalytic platform. 
3.7 Conclusions 
 In this work, we have demonstrated the potential for NHI dioxygenases to synthesize 
tropolone natural product analogs through a two-enzyme oxidative dearomatization and ring 
expansion reaction sequence. We have applied this biocatalytic platform to the preparative-scale 
synthesis of a variety of tropolone natural product derivatives, demonstrating the synthetic 
potential of these transformations. Furthermore, we have leveraged the chemoenzymatic synthesis 
of the natural product stipitaldehyde (3.11) to construct 18-deoxyepolone B under thermal and 
enzymatic conditions. This represents the first successful demonstration of the activity of hetero-
Diels-Alderase XenE in vitro, illustrating the potential to apply hetero-Diels-Alderases for the 
synthesis of natural products. We aim to further characterize the activity of XenE through 
preparative-scale reactions with stipitol (3.15), enabling characterization of the enantioselectivity 
of this reaction. In addition, our work provides a novel and direct route to the synthesis of 
tropolones, improving on existing synthetic methods by harnessing the potential of Nature’s 






3.8 Experimental  
I. Substrate synthesis 
General Information: All reagents were used as received unless otherwise noted. Reactions were 
carried out under a nitrogen atmosphere using standard Schlenk techniques unless otherwise noted. 
Solvents were degassed and dried over aluminum columns on an MBraun solvent system 
(Innovative Technology, inc., Model PS-00-3). Reactions were monitored by thin layer 
chromatography using Millipore 60 F254 pre-coated silica TLC plates (0.25 mm) which were 
visualized using UV, p-anisaldehyde, CAM, DNP, or bromocresol green stains. Flash column 
chromatography was performed using Machery-Nagel 60 μm (230-400 mesh) silica gel. All 
compounds purified by column chromatography were sufficiently pure for use in further 
experiments unless otherwise indicated. 1H and 13C NMR spectra were obtained in CDCl3 at rt (25 
°C), unless otherwise noted, on Varian 400 MHz or Varian 600 MHz spectrometers. Chemical 
shifts of 1H NMR spectra were recorded in parts per million (ppm) on the δ scale. High resolution 
electrospray mass spectra were obtained on an Agilent 1290 Series Infinity II HPLC with a 6230 
Series Time-of-Flight mass spectrometer or an Agilent 1290 Series Infinity HPLC with a 6545 
Series Quadrupole-Time-of-Flight mass spectrometer. UPLC-PDA spectrometric traces were 
obtained on a Waters Aquity H-class instrument.  
Part II. Plasmid and protein information 
Plasmid: The genes encoding xenC (listed as “L3” in Sarcocladium strictum, MG736817.1) and 
xenE (listed as “asR5” in Sarcocladium strictum, AOA2U8U2M1.1) were codon-optimized for 
overexpression in E. coli and synthesized by Twist Biosciences. The synthesized sequences were 





kanamycin resistance, and N-terminal 6xHis-tag encoded upstream from the insert gene. No 
further modifications to these plasmid constructs were necessary. Information regarding the tropB 
plasmid has been published by our group previously.59 














































































































































Protein Overexpression and Purification: The plasmid containing xenC was transformed using 
standard heat-shock protocols for chemically competent E. coli into BL21(DE3) cells. The plasmid 
containing XenE was transformed into LEMO(DE3) cells. Overexpression of xenC and xenE was 
achieved using 4% glycerol (v/v) Terrific Broth (TB) in 2.8 L flasks. 500 mL portions of 
autoclaved media were inoculated with 5 mL of overnight culture prepared from a single colony 
in Luria Broth (LB) and 100 μg/mL kanamycin (Gold Biotechnology). Cultures were grown at 37 
°C and 200 rpm until the optical density (at 600 nm) reached 0.8. The cultures were then cooled 
to 20 °C for 20 min for xenC expression (16 °C for xenE expression) and protein expression was 
induced with 0.2 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG, Gold Biotechnology). 
Expression was continued at 20 °C overnight for xenC and 16 °C overnight for xenE (approx. 18 
h) at 200 rpm. The typical yield for one 500 mL culture cell pellet (wet cell pellet) was ~25 g. 
General Purification Procedure: 50-60 g of cell pellet was resuspended in 250 mL of lysis buffer 
containing 50 mM Tris HCl (pH 7.4 for XenC, pH 8.0 for XenE), 300 mM NaCl, 10 mM imidazole 
and 10% glycerol. The mixture was homogenized using a handheld dounce homogenizer. 
Approximately 1 mg/mL lysozyme (Gold Biotechnology) was added prior to 1 h incubation on a 
rocker held at 4 °C. Cells were lysed by sonication of the total cell lysate in 100 mL batches on 





min at 60% power. The total cell lysate was centrifuged at 45,000 x g for 30 min and the 
supernatant was removed. The cell lysate was then batch-bound to 3 mL of Ni-NTA resin (Thermo) 
for 1 h at 4 °C with gentle rocking. The supernatant was filtered through a fritted 50 mL plastic 
column (Gold Biotechnologies) to isolate the Ni-NTA resin. The resin was washed with 100 mL 
of wash buffer containing 50 mM Tris HCl (pH 7.4 for XenC, pH 8.0 for XenE), 300 mM NaCl, 
25 mM imidazole and 10% glycerol. The protein was then eluted using 15 mL of an elution buffer 
containing 50 mM Tris HCl (pH 7.4 for XenC, pH 8.0 for XenE), 300 mM NaCl, 250 mM 
imidazole and 10% glycerol. The eluted protein was concentrated to a volume of 2.5 mL using a 
30 KDa molecular weight cutoff ultrafiltration device (Amicon). The concentrated protein was 
desalted using a PD-10 desalting column that was pre-equilibrated with a storage buffer containing 
50 mM Tris HCl (pH 7.4 for XenC, pH 8.0 for XenE), 300 mM NaCl, and 10% glycerol. The 
protein was eluted from the column with 3.5 mL of storage buffer, before flash freezing in liquid 
nitrogen and storage at -80 °C. Protein concentration was determined by the A280 absorbance 
method using a Nanodrop spectrophotometer. The concentration was corrected using the estimated 
extinction coefficient from the ProtParam tool on the Expasy server. Average yield: 80-100 mg/L 
of XenC. 20-30 mg/L of XenE. Flavin-dependent monooxygenase TropB was expressed and 
purified using the construct and conditions reported previously and is found within the 






Figure 3.S1. SDS-PAGE gel of purified TropC                
 
 









































Part III. Biocatalytic reactions and products 
Stock solutions: Stock solutions of each substrate (50 mM) were prepared by dissolving the 
substrate in DMSO (analytical grade). Stock solutions of α-ketoglutaric acid (125 mM), ferrous 
sulfate (10 mM) and sodium ascorbate (50 mM) were freshly prepared in MQ water before each 
use, stored on ice, and used within 3 h. Aliquots of glucose-6-phosphate (G6P, 500 mM), glucose-
6-phosphate dehydrogenase (G6PDH, 100 U/mL), and nicotinamide adenine dinucleotide 
(NADP+, 100 mM) were prepared and stored at -20 °C before use. Aliquots of XenC were stored 
at -80 °C. 
In vitro analytical-scale cascade ring expansion reactions: Cascade oxidative 
dearomatization/ring expansion reactions were performed as follows. Each reaction contained 50 
mM TES buffer pH 7.5 (2.5 μL, 1 M), 2.0 mM substrate (2.0 μL, 50 mM in MeOH), 5 μM TropB 
(4 μL, 124 μM), 10 μM XenC (or homolog), 5 mM G6P (0.5 μL, 500 mM), 1 mM NADP+ (0.5 
μL, 100 mM), 5 mM α-ketoglutaric acid (2 μL, 125 mM), 0.1 mM ferrous sulfate (0.5 μL, 10 mM), 
4 mM sodium ascorbate (4 μL, 50 mM) and Milli-Q water to a final volume of 50 μL. Reactions 
were carried out at 30 °C for 3 h and quenched by the addition of 3 volumes of methanol containing 
600 μM 2,6-dimethoxytoluene as an internal standard. Precipitated biomolecules were pelleted by 
centrifugation (17,000 x g, 20 min). The supernatant was analyzed by LC-TOF MS and conversion 
obtained by comparison to calibration curves of each substrate. 
In vitro analytical-scale XenE-catalyzed Diels-Alder reactions: XenE-catalyzed Diels-Alder 
reactions were performed as follows. Each reaction contained 50 mM TES buffer pH 6.8 (2.5 μL, 
1M), 2 mM stipitol (2.0 μL, 50 mM in MeOH), 4 mM α-humulene (4.0 μL, 50 mM in MeOH),   





methanol containing 600 μM 2,6-dimethoxytoluene as an internal standard. Precipitated 
biomolecules were pelleted by centrifugation (17,000 x g, 20 min). The supernatant was analyzed 
by LC-TOF MS and conversion obtained by comparison to calibration curves of each substrate. 
Determination of percent conversion: Percent conversion was determined by analysis of each 
reaction after 3 h. LC/MS spectrometric analysis was performed on an Agilent 1290 Series Infinity 
II HPLC with a 6230 Series Time-of-Flight (TOF) mass spectrometer, using a Phenomenex 
Kinetex (1.7 μm C18, 2.1 x 150 mm) column under the following conditions: mobile phase 
(Solvent A: deionized water + 0.1% formic acid; Solvent B: acetonitrile + 0.1% formic acid) 5% 
to 100% solvent B over 2 min, 100% solvent B for 2 min; flow rate: 0.4 mL/min. Based on the 
calibration curves of the starting materials, the percent conversion of the substrate to tropolone 
product was calculated with AUCsubstrate/AUCinternal standard. In vitro reactions were performed and 
analyzed in triplicate with reported conversions as an average of those trials.  
General procedure for in vitro milligram-scale reactions: Except where otherwise noted, 
preparative-scale enzymatic reactions were conducted on 20-100 mg of each substrate under the 
following conditions: 2.5 mM substrate, 50 mM TES buffer pH 7.5, 5 mM α-ketoglutaric acid, 0.1 
mM ferrous sulfate, 8 mM sodium ascorbate, and 10 μM XenC. Reactions were performed in 
Erlenmeyer flasks of appropriate volume to achieve proper oxygenation (at least 3 times reaction 
volume) at 30 °C. Reaction progress was monitored at hourly intervals by analysis of a 50 μL 






aliquot by LC-TOF MS. The aliquot was processed in the manner described for in vitro analytical 
scale determination of reaction conversion.  
In situ methylation procedure: Products of enzymatic reactions were isolated following 
methylation of the tropolone vinylogous acid moiety to improve yields and ensure compound 
stability. Following completion of the milligram-scale enzymatic ring expansion reaction, the pH 
of the crude reaction mixture was increased to >10 by the addition of K2CO3 while the mixture 
was stirred at room temperature. 20 equiv of dimethylsulfate was added via syringe and the crude 
mixture was stirred for 16 h. The pH of the reaction was routinely monitored and more K2CO3 was 
added when necessary to maintain a pH greater than 9-10. Reaction conversion was monitored by 
LC-TOF MS. An identical procedure was used isolate unmethylated tropolones (by capping 
nucleophilic residues in XenC following the reaction), except that 0.4 equiv of dimethylsulfate 
was used. The methylation was allowed to proceed for 2 h before workup and isolation (see 
isolation procedure). 
Isolation procedure: Following in situ methylation, the reaction mixture was acidified to pH 2.0 
with 0.1 M HCl. The organic materials were extracted from the aqueous layer with ethyl acetate 
(3 x 50 mL). The organic fractions were pooled and concentrated under reduced pressure to yield 
a crude mixture. Products were purified from this crude mixture by preparative HPLC. 
Purification by preparative HPLC: For purification of milligram-scale reactions, the resulting 
crude mixture was taken up in a 50:50 mixture of milli-Q water:acetonitrile (2 mL). The product(s) 
were purified from this mixture by preparative HPLC using a Phenomenex Kinetex 5 μm C18, 150 





0.1% formic acid; Solvent B: acetonitrile + 0.1% formic acid) 5% to 100% solvent B over 13 min, 






Products of biocatalytic ring expansion 
 
2,4-dihydroxy-7-methyl-5-oxocyclohepta-1,3,6-triene-1-carbaldehyde (stipitaldehyde) (3.11) 
The title compound was synthesized according to the general procedure for milligram-scale 
enzymatic ring expansion with XenC. The reaction was performed with 100 mg of starting 
material. Purification by preparative HPLC afforded 57 mg (58% yield) of the title compound as 
an orange solid. 1H NMR (400 MHz, MeOD) δ 10.12 (s, 1H), 6.83 (s, 1H), 6.81 (s, 1H), 2.65 (s, 
3H); 13C NMR (150 MHz, MeOD) δ 196.67, 177.19, 175.40, 165.67, 150.70, 125.04, 115.01, 
110.49, 24.87; HR-ESI-MS: m/z calcd for C9H8O4
+ [M+H]+: 181.0495, found: 181.0497. 
 
2,4-dihydroxy-3,7-dimethyl-5-oxocyclohepta-1,3,6-triene-1-carbaldehyde (3.37) 
The title compound was synthesized according to the general procedure for milligram-scale 
enzymatic ring expansion with XenC. The reaction was performed with 20 mg of starting material. 
Purification by preparative HPLC afforded 8 mg (43% yield) of the title compound as a tan solid. 
1H NMR (400 MHz, MeOD) 10.12 (s, 1H), 6.85 (s, 1H), 2.64 (s, 3H), 2.33 (s, 3H); 13C NMR 
(150 MHz, MeOD) δ 197.19, 161.39, 150.18, 141.63, 124.10, 109.59, 105.56, 24.66, 11.23; HR-
ESI-MS: m/z calcd for C9H8O4







The title compound was synthesized according to the general procedure for milligram-scale 
enzymatic ring expansion with XenC. The reaction was performed with 20 mg of starting material. 
Purification by preparative HPLC afforded 4 mg (20% yield) of the title compound as a yellow 
solid. 1H NMR (400 MHz, MeOD) δ 10.31 (s, 1H), 7.10 (s, 1H), 6.84 (s, 1H); HR-ESI-MS: m/z 
calcd for C9H8O4
+ [M+H]+: 292.9305, found: 292.9309. 
 
2,4-dihydroxy-5-oxocyclohepta-1,3,6-triene-1-carbaldehyde (3.32) 
The title compound was synthesized according to the general procedure for milligram-scale 
enzymatic ring expansion with XenC. The reaction was performed with 20 mg of starting material. 
Purification by preparative HPLC afforded 8.7 mg (44% yield) of the title compound as a yellow 
solid. 1H NMR (400 MHz, MeOD) δ 9.80 (s, 1H), 7.21 (d, JHH = 8.0, 1H), 6.97 (s, 1H), 6.89 (d, 
JHH = 8.0, 1H); 13C NMR (150 MHz, MeOD) δ 196.72, 142.13, 135.51, 114.40, 113.43, 110.27, 
110.25, 100.59; HR-ESI-MS: m/z calcd for C9H8O4









The title compound was synthesized according to the general procedure for milligram-scale 
enzymatic ring expansion with XenC. The reaction was performed with 20 mg of starting material. 
Purification by preparative HPLC afforded 8.5 mg (44% yield) of the title compound as a yellow 
solid. 1H NMR (400 MHz, MeOD) δ 6.90 (s, 1H), 6.89 (s, 1H), 2.30 (s, 3H); 13C NMR (150 MHz, 
MeOD); HR-ESI-MS: m/z calcd for C9H8O4
+ [M+H]+: 198.0397, found: 198.0394. 
 
2,4-dihydroxy-5-(hydroxymethyl)-6-methylcyclohepta-2,4,6-trien-1-one (stipitol) (3.15) 
The title compound was synthesized by sodium borohydride reduction of stipitaldehyde (3.11). 10 
mg (0.06 mmol) of stipitaldehyde was suspended in 1 mL total volume of MeCN and water (1:1) 
in a 20 mL scintillation vial with a stir bar. 1.1 equiv of sodium borohydride (122 μL of a 500 mM 
solution in water) was added at rt and allowed to stir for 10 min. The resulting solution was directly 
injected on preparative HPLC to afforded 8.5 mg (84% yield) of the title compound as a light 
yellow residue. 1H NMR (400 MHz, CD3CN) δ 8.10 (s, 1H), 7.03 (s, 1H), 6.89 (s, 1H), 4.63 (s, 
2H), 2.48 (s, 3H); HR-ESI-MS: m/z calcd for C9H8O4






Part IV. Substrate and product standard curves 
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Figure 3.S4. LC/MS traces for one-pot TropB/XenC cascade to generate product 3.11.  
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Figure 3.S5. LC/MS traces for one-pot TropB/XenC cascade to generate product 3.32. 
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Figure 3.S6. LC/MS traces for one-pot TropB/XenC cascade to generate product 3.37. 
 
 
Reaction with TropB and XenC 








0 1 2 3 4 5
0
2 .01 0 6
4 .01 0 6
6 .01 0 6
 
Reaction with TropB only 








0 1 2 3 4 5
0
2 .01 0 6
4 .01 0 6
6 .01 0 6






No enzyme control 








0 1 2 3 4 5
0
5 .01 0 6
1 .01 0 7
 
 









1 0 0 1 5 0 2 0 0 2 5 0 3 0 0
0
2 0 0 0 0
4 0 0 0 0
6 0 0 0 0
8 0 0 0 0
1 9 5 .0 6 5 7
1 2 4 .0 8 8 0






Figure 3.S7. LC/MS traces for one-pot TropB/XenC cascade to generate product 3.39. 
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Figure 3.S8. LC/MS traces for one-pot TropB/XenC cascade to generate product 3.34. 
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Figure 3.S9. LC/MS traces for one-pot TropB/XenC cascade to generate product 3.35. 
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Figure 3.S10. LC/MS traces for one-pot TropB/XenC cascade to generate product 3.36.  
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Figure 3.S11. LC/MS traces for one-pot TropB/XenC cascade to generate product 3.33.  
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Figure 3.S13. LC/MS traces for one-pot TropB/XenC cascade to generate product 3.42. 
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Part VI. Reactions with tropolone products 
Figure 3.S14. LC/MS traces for Diels-Alder reaction to generate product 3.7. 
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Chapter 4: Characterization of the Mechanism of Ring Expansion in NHI Enzyme-
catalyzed Tropolone Synthesis 
 
4.1 Introduction 
 Enzymes from secondary metabolic pathways catalyze challenging transformations with 
exquisite control over chemo-, site- and stereoselectivity, directing the synthesis of structurally-
complex products from bioavailable starting materials. These transformations often take advantage 
of the three-dimensional architecture of the enzyme active site to guide reactive intermediates 
toward formation of the desired product.1 Biocatalytic control over the fate of reactive 
intermediates is a common mechanistic archetype in a variety of enzymes such as cyclases, which 
leverage active site geometries to induce selective cyclization reactions, polyketide synthases that 
deliver specific products from large, structurally-complex intermediates, Diels-Alderases, which 
choreograph the relative position of two reactive components to form a stereo-enriched product, 
and non-heme iron (NHI) dioxygenases, an enzyme class known to catalyze numerous skeletal 
rearrangements through radical or polar mechanisms.1-4 In many cases, reactions of identical 
intermediates generated outside of the enzyme active site proceed in an uncontrolled fashion, 
leading to racemic products or fundamentally divergent reactivity.1-2   
 In contrast to the selectivity demonstrated by enzyme-mediated transformations, small 
molecule-enabled transformations often require careful substrate design to achieve a desired 





resulting syntheses.5-6 Radical-based rearrangements are particularly impacted by selectivity 
challenges, as competing radical pathways often complicate anticipated reaction outcomes.5-6 As 
a result, selectivity can be achieved only through optimization of substrate design and reaction 
Figure 4.1. Ring rearrangements in natural product scaffold synthesis and biosynthesis. 
A. Ring rearrangement reactions catalyzed by NHI enzymes. B. Radical tropolone synthesis 
from dearomatized ortho-phenols. C. Biosynthesis of stipitaldehyde (4.11) on path to fungal 






conditions to favor the desired reaction pathway.5-6 In comparison, biocatalysts operate with 
precise control over the reaction outcome, enabling highly selective and direct synthesis of natural 
product scaffolds.7-9 Therefore, thorough examination of the mechanistic details of enzyme-
catalyzed rearrangements is critically important to the development of novel, selective approaches 
to complex molecule synthesis. 
 Non-heme iron (NHI) enzymes perform an array of oxidative transformations and 
rearrangements in secondary metabolism.4, 10-11 Members of the α-ketoglutarate-dependent family 
of NHI dioxygenases couple the oxidative decarboxylation of α-ketoglutarate (α-KG) to the 
activation of molecular oxygen, generating an iron(IV)-oxo species (4.17, Figure 4.1D).12-13 
Through this common mechanism of oxygen activation, NHI enzymes catalyze a variety of 
selective transformations that are often initiated by hydrogen atom abstraction, followed by a 
variety of processes including hydroxylation, desaturation, halogenation, endoperoxidation, 
epimerization, ring expansion and ring contraction, among others.4, 11-13 Understanding how the 
fate of a radical intermediate is controlled by each catalyst has motivated structural, spectroscopic 
and computational studies of NHI enzymes. In-depth interrogation of NHI-catalyzed reaction 
mechanisms has revealed critical enzyme-substrate interactions that dictate the reaction outcome 
in several cases.7-9 These studies provide mechanistic detail for several NHI-catalyzed 
rearrangements, including ring contractions and ring expansions.14-17 Ring-modifying 
transformations often proceed through an initial C–H atom abstraction, followed by radical 
rearrangement and termination by single electron oxidation or hydroxylation to yield product.7-9, 
14-17 The NHI active site architecture dictates the reaction outcome by exerting fine control over 
events downstream from hydrogen atom abstraction, enabling highly selective transformations.7-9, 





divergent transformations on a common substrate to generate preaustinoid A3 (4.1) and 
berkeleydione (4.2), respectively (Figure 4.1A).7-9 Structural and computational studies have 
shown that minor differences in their active site architecture play a critical role in determining the 
outcome of the initial enzyme-catalyzed desaturation, ultimately leading to the formation of two 
distinct natural products through a divergent radical rearrangement process.7, 9 Similar mechanistic 
studies found that the NHI-catalyzed biosynthesis of cycloclavine (4.3) and deacetoxy-
cephalosporin C (4.4) proceed through a one-electron reaction pathway, suggesting a common 
mechanistic architype for ring rearrangements catalyzed by NHI enzymes (Figure 4.1A).14-16, 18  
 Natural products often possess medium-sized rings (7-11 atoms) which can be difficult to 
access using small molecule techniques. One such class of synthetically-challenging targets are 
tropolones, a structurally-diverse group of bioactive metabolites with an aromatic cycloheptatriene 
core structure containing an α-hydroxyketone moiety (see Figure 4.1C, 4.11).19-21 Tropolones have 
been synthesized through a variety of approaches, typically involving ring expansion.22 These 
transformations include classic two-electron rearrangements such as the Büchner reaction,23 the 
de Mayo fragmentation24 and [5+2] cycloadditions.22 In addition, radical-based approaches have 
been successful in synthesizing tropolones from ortho-dearomatized catechols (4.5) through a 
selective radical ring expansion mechanism (Figure 4.1B).25-26 This approach required pre-
functionalization of the arene to ensure that radical initiation occurred at the methyl halide ipso to 
the site of dearomatization, leading to the desired rearrangement (Figure 4.1B).25-26 While these 
methods have been successful in enabling ring expansion, they require arduous synthetic efforts 
to achieve the desired substitution pattern of the tropolone natural product, preventing facile access 
to the target compound.22 In contrast, Nature efficiently assembles complex tropolones using 





biosynthetic gene cluster in T. stipitatus provided a blueprint for the assembly of these aromatic 
seven-membered rings in Nature (Figure 4.1C).21 Fungal tropolone biosynthesis, in the case of 
stipitatic acid, commences with polyketide synthase production of 3-methylorcinaldehyde (4.9) 
and subsequent flavin-dependent monooxygenase-mediated oxidative dearomatization.21, 27 It has 
been established that the resulting dienone (4.10) undergoes an oxidative ring expansion catalyzed 
by an α-KG-dependent NHI enzyme, TropC, to afford stipitaldehyde (4.11). Downstream 
enzymatic modifications of stipitaldehyde (4.11) generate stipitatic acid (4.12).21 Since the 
identification and characterization of enzymes involved in stipitatic acid biosynthesis, several 
other tropolone natural products have been shown to proceed through the same oxidative 
dearomatization/ring expansion cascade to generate the tropolone core.28-29 Motivated to 
understand the chemical steps of this powerful transformation, we initiated our studies on the 
chemistry and mechanism of the TropC-catalyzed ring expansion. In particular, we sought to 
investigate two transformations which TropC has been shown to catalyze (1) ring expansion to 
generate stipitaldehyde (4.11) and (2) a fragmentation reaction which produces 3-
hydroxyorcinaldehyde (4.18), a known shunt product in fungal tropolone biosynthesis (Figure 
4.1D). 
 As the fate of a radical intermediate in NHI dioxygenase-catalyzed transformations is 
critical to the observed reactivity of the enzyme, we envisioned that TropC-catalyzed ring 
expansion could occur through several possible mechanistic pathways. Cox and coworkers initially 
proposed that TropC performs a polar ring expansion to produce stipitaldehyde (4.11, Figure 4.1D, 
Path 1).19-21 Their proposal commences with TropC-mediated C–H atom abstraction on dienone 
4.10 to generate radical species 4.14.19-21 Subsequent rebound hydroxylation would afford diol 





We anticipated that this rearrangement could be assisted by residues in the TropC active site 
through activation of the alcohol leaving group in diol intermediate 4.13.19-21 The proposed ring 
expansion mechanism is also consistent with the observed formation of a shunt product in this 
biosynthetic pathway, 4.18, which is anticipated to arise through loss of formaldehyde and 
concomitant rearomatization to produce 3-hydroxyorcinaldehyde 4.18 (Figure 4.1D, Path 3).21 
Based on the radical reaction pathways that have been proposed for other ring modifying enzymes, 
we envisioned an alternative mechanism to arrive at stipitaldehyde in which radical 4.14 directly 
undergoes ring expansion, followed by radical termination via a single electron oxidation 
involving the iron(III)-hydroxyl species (Figure 4.1D, Path 2). Under this model, the product 
generated by the enzyme is determined by the radical termination process which occurs in the 
active site. If rebound hydroxylation predominates, then 3-hydroxyorcinaldehyde (4.18) will be 
the major product formed. If radical rearrangement is preferred under the reaction conditions, then 
stipitaldehyde (4.11) formation will dominate. To decipher the ring expansion mechanism used by 
TropC, we aimed to investigate the active site architecture of the enzyme, as well as the reactivity 
of proposed ring expansion intermediate 4.13. 
4.2 Computational analysis of proposed ring expansion pathways 
 To determine the nature of the TropC-catalyzed ring expansion, a computational analysis 
of the proposed pathways was carried out by our collaborator Kevin Skinner, under the guidance 
of Prof. Paul Zimmerman (Figure 4.1D). Through these calculations, we aimed to compare the 
relative barriers of proposed ring expansion pathways to assess the feasibility of a one- or two-
electron ring expansion mechanism. Each mechanistic pathway was evaluated using a small 





reaction pathway products to model stipitaldehyde (4.11) and the 3-hydroxyorcinaldehyde shunt 
product 4.18 as protonated, neutral structures, reflecting the enzymatic reaction conditions for 
TropC-catalyzed ring expansion (pH 7.0). Water molecules were used as proton shuttles to mimic 
the protonation and deprotonation events that would be facilitated by residues in the enzyme active 
site.  
 These computational investigations were initiated using the radical intermediate 4.14 
(Figure 4.2), which is the divergence point for each of the pathways along the potential energy 
surface (PES). We first explored the radical rearrangement (Path 2), which occurs with a barrier 
of 12.7 kcal/mol (4.16). A subsequent H-atom abstraction by an iron(III)-hydroxyl species to 
Figure 4.2. QM calculations for TropC-catalyzed reaction pathways to generate 






produce the tautomer of stipitaldehyde (4.11) was calculated to be barrierless. This calculation was 
supported by literature precedent which demonstrated that tropolones could be synthesized from 
ortho-dearomatized radicals (Figure 4.1B).22, 26 We then explored the rebound hydroxylation and 
semi-pinacol rearrangement (Path 1). As expected, rebound hydroxylation to produce diol 4.13 
was found to be a barrierless process in our active site model.12, 30-31 In an enzyme active site, we 
anticipate that substrate movement and alignment would be restricted by local residues, resulting 
in thermodynamic barriers to this process.12, 30-31 The barrier for the proposed semi-pinacol 
rearrangement was observed to be excessively high at 48.8 kcal/mol (4.24), indicating that this 
transformation is not likely to occur. These barriers are in agreement with computational analysis 
by Siegbahn and coworkers examining ring expansion mechanisms of ortho-dearomatized 
phenols, indicating that a semi-pinacol type ring expansion is unlikely to occur in these systems.32 
In comparison, fragmentation to afford an aromatic product from diol 4.13 (Path 3) to produce 
formaldehyde and 3-hydroxyorcinaldehyde 4.18 was found to be a low barrier process at 18.2 
kcal/mol (4.23). These calculations suggest that diol 4.13 favorably undergoes fragmentation and 
rearomatization (Path 3), rather than the proposed semi-pinacol ring expansion (Path 1). The 
calculated low barrier for Path 3 is supported by experimental observation of 3-
hydroxyorcinaldehyde formation during the TropC-catalyzed reaction. Taken together, the QM 
simulations support our alternative mechanistic proposal in which the radical rearrangement is a 
kinetically and thermodynamically accessible route towards tropolone formation (Path 2).  
4.3 X-ray crystal structure of wild-type TropC 
Next, we sought experimental evidence to discriminate between the two reaction pathways 





proposed ring expansion mechanisms by performing a detailed mutational analysis of TropC in 
order to determine if specific active site residues are responsible for catalyzing the ring expansion 
to the tropolone. To gain structural information, we purified TropC to homogeneity and provided 
materials to our structural biology collaborators Dr. Leena Mallik and Prof. Markos Koutmos, who 
obtained TropC crystals using the sitting drop vapor diffusion method (see Section 4.7 
Experimental for details). Following data collection, we found that TropC crystallized in the P3121 
space group with two molecules of TropC in the asymmetric unit (PDB ID: 6XJJ). The crystal 
structure of unliganded TropC was solved at a resolution of 2.7 Å with the molecular replacement 
method using the structure of thymine-7-hydroxylase (T7H) of Neurospora crassa as a search 
model (Figure 4.3).33 Our analysis of the structural data indicated that TropC adopts a similar 
Figure 4.3. Overall architecture of TropC determined using X-ray crystallography (PDB 
ID: 6XJJ).  
(Left) Structure of TropC from T. stipitatus in ribbon representation. At the core of TropC, the 
Fe (III) shown with red sphere and side chain of residues, H210, D212 and H269, are shown 
in stick representation. (Right) Rotated view of crystal structure of TropC and active site 







architecture as other α-KG-dependent NHI dioxygenases 34. The three-dimensional structure of 
TropC consists of double-stranded β-helix (DSBH or jelly-roll) fold at the core of the protein 34. 
The DSBH core of TropC is comprised of ten anti-parallel β-strands, which form two β-sheets, 
called major and minor β-sheets. Major β-sheets of TropC include β1-5, β8 and β10, and the minor 
β-sheet consists of β6, β7 and β9 (Figure 4.S29). The exterior of the major β-sheets of the DSBH 
fold is surrounded by α-helices (α1-3, α5 and α7) to form a compact globular structure. 
 Structures similar to TropC in the Protein Data Bank (PDB) were explored by using the 
DALI server (Table 4.S2),35 revealing the highly similar structures of isopenicillin N synthase 
from Pseudomonas aeruginosa PAO1 (PaIPNS, PDB ID: 6JYV, Z-score: 32.2)36 and thymine-7-
hydroxylase (T7H, PDB ID: 5C3Q, Z-score: 31.8) of Neurospora crassa.36  An overall structural 
comparison of TropC with PaIPNS and T7H suggested a putative substrate binding site for TropC 
(Figure 4.S30). Overlaying TropC with T7H revealed several shared residues which define the 
substrate binding site in the T7H structure (Figure 4.S31).33 Specifically, residues F284 and F213 
align well with two conserved aromatic residues in T7H, F292 and Y217, respectively.33 F292 and 
Y217 have been demonstrated as critical for substrate binding and alignment in T7H, with F292 
providing π-π stacking interactions that align thymine in the enzyme active site for productive 
catalysis.33 The conservation of these aromatic residues in homologs of T7H and their alignment 
with F284 and F213 in TropC suggests that these residues may play an analogous role in substrate 
alignment.33 In addition, bound metal ion was observed in the structure of TropC, which was 
refined to be Fe. As has been observed with the active site of other α-KG-dependent NHI 
dioxygenases, our structure demonstrates that the conserved HxD/E…H metal binding residues 





residues H210, D212 and H269 (located at the loop between β4-5 and β9) to the active site Fe 
atom (Figure 4.3).   
4.4 Computational modelling of TropC-substrate-cosubstrate complex and alanine-scan of 
TropC active site 
  Crystallography experiments yielded vital information on structural features of TropC and 
enabled further investigation of mechanistic considerations by computational and mutagenic 
analysis. Toward this goal, we anticipated that an enzyme-substrate complex would provide 
critical information for determining which active site residues are involved in mediating the ring 
expansion. To construct a computational substrate-bound model, Kevin Skinner, Dr. Troy Wymore 
and Prof. Paul Zimmerman modeled the missing electron density from the C-terminus and used an 
overlaid structure of T7H to establish the coordinates of critical enzyme cofactors, such as α-KG, 
ferrous iron and substrate (see Section 4.7 Experimental for model construction and simulation 
details). To prepare the model for substrate binding studies, they performed a molecular mechanics 
(MM) minimization over 5000 steps. The system was then prepared for a combined quantum 
mechanics and molecular dynamics (QM/MD) simulation. The system was subjected to three 
phases of MD simulations in which the system was heated, equilibrated, and sampled for a total 
of 12 ns to generate an enzyme-substrate-cosubstrate complex with the appropriate geometry and 
alignment for C–H atom abstraction (see Section 4.7 Experimental for details). 
 Our analysis of the substrate-bound TropC model revealed that substrate 4.10 was flanked 
by numerous active site residues that could potentially be involved in substrate binding or catalysis 
(Figure 4.4C). Residues from the TropC substrate pocket were identified and selected for alanine 





anticipated that a TropC variant, without the required residue for a polar, semi-pinacol-type ring 
expansion, would be unable to generate stipitaldehyde (4.11), resulting in a change to the ratio of 
observed enzyme products toward formation of the shunt product, 4.18 (Figure 4.4A). We carried 
out mutagenesis of twelve active site residues, generating the corresponding alanine variants 
(Figure 4.4B and Figure 4.S2) as well as variants with isosteric and isoelectronic residues at the 
same position. These residues were chosen using the substrate-bound TropC model as a guide and 
were selected for their proximity to the substrate as well as their ability to participate in the 
proposed reaction pathways. Many of the resulting variants were soluble, but catalytically inactive, 
suggesting that the structural changes in some variants prevented productive catalysis. 
Catalytically active variants exhibited reduced enzymatic conversion to products, but the product 
Figure 4.4. Analysis of TropC variant reactivity and enzymatic synthesis of proposed ring 
expansion intermediate 4.13. A. Oxidative dearomatization and ring expansion cascade to 
generate stipitaldehyde (4.11) and 3-hydroxyorcinaldehyde (4.18). B. Product profiles observed 
in alanine-scanning of TropC active site residues. C. Enzymatic synthesis of proposed ring 
expansion intermediate, diol 4.13. D. Close-up view of substrate-bound model of TropC with 
select targeted alanine-scanning residues highlighted in blue, α-KG highlighted in green and 









profiles were largely unaltered, and stipitaldehyde (4.11) remained the major product under the 
reaction conditions, suggesting that most of the substrate-flanking residues were not involved in 
catalysis. However, the F284A variant uniquely demonstrated a shift in the product profile to 
produce nearly equimolar amounts of stipitaldehyde (4.11) and 3-hydroxyorcinaldehyde (4.18). 
Analysis of the substrate-bound TropC model suggests that this residue could be important for 
positioning of the substrate in the active site. This proposed role is analogous to the function of 
residue F292 in T7H, which has been shown to be critical for binding and alignment of substrate 
for productive catalysis. The binding mode of substrate 4.10 in the TropC MD simulation 
demonstrates that F284 and F213 flank the substrate in the active site, potentially guiding the 
proper alignment for C–H atom abstraction. This proposal is likewise analogous to the reported 
role of F292 and Y217 in T7H, suggesting a similar function in aligning the TropC substrate to 
achieve catalysis.33 To further investigate this hypothesis, we generated the isosteric variant TropC 
F284Y which reconstituted the ring expansion activity of the enzyme, providing further evidence 
that F284 is a critical residue for determining the product mixtures generated by TropC. We aimed 
to further analyze this reaction by generating a TropC F213A variant but were unable to produce 
soluble protein with this construct. Despite this challenge, the data generated through alanine 
scanning of the TropC active site suggested that substrate alignment plays a role in determining 
the product profile of the enzyme. Perturbations of this alignment often result in a change to the 
products generated by the enzyme, providing clues about the mechanism of the transformation.7, 9 
In particular, substrate alignment relative to the iron(III)-hydroxyl species is key in discriminating 
whether rebound hydroxylation occurs over other NHI-catalyzed reactivity, such as 
halogenation.37 In the context of our TropC model, these observations support the proposed 





(rearrangement versus rebound hydroxylation) determines which product is generated by the 
enzyme. In addition, mutagenic changes to polar residues did not produce a corresponding shift in 
the product profile to the production of 3-hydroxyorcinaldehyde 4.18, suggesting that local acid 
or base catalysis does not drive a ring expansion mechanism (Figure 4.1D, Path 1).  
4.5 Chemoenzymatic synthesis of proposed ring expansion intermediate 4.13 
 We aimed to further interrogate the proposed semi-pinacol rearrangement (Figure 4.1D, 
Path 1) by evaluating the reactivity of the proposed diol intermediate 4.13. To generate the target 
diol in the absence of TropC, a biocatalytic approach was employed using CitB and TropB.21, 27, 
38-40 We aimed to directly synthesize diol 4.13 through oxidative dearomatization of benzylic 
alcohol 4.25 using TropB. Notably, 3-hydroxyorcinaldehyde 4.18 was detected in these reactions, 
but diol intermediate 4.13 was not observed, suggesting that the fragmentation reaction described 
in Path 3 (Figure 4.1D) occurs spontaneously under the reaction conditions. To further probe 
whether diol 4.13 is a ring expansion intermediate in TropC catalysis, we again performed a 
TropB-catalyzed oxidative dearomatization of benzylic alcohol 4.25 and included TropC in this 
reaction. We envisioned that diol 4.13, when generated in situ, could enter the active site of TropC 
and undergo a ring expansion reaction as proposed in reaction Path 2 (Figure 4.1D). In this 
reaction, exclusive formation of 3-hydroxyorcinaldehyde (4.18) was observed with no 
stipitaldehyde (4.11) detected, suggesting that fragmentation and rearomatization of diol 4.13 is 
the predominant mode of reactivity observed for this putative intermediate (Figure 4D). In support 
of this finding, Riess and coworkers noted this same fragmentation and rearomatization reactivity 
in their attempts to perform ring expansion reactions on ortho-dearomatized phenols to produce 





which suggests that fragmentation and rearomatization is a low-barrier process (18.2 kcal/mol). 
Taken together, these data indicate that diol intermediate 4.13 is unlikely to be the correct ring 
expansion intermediate in the TropC-catalyzed reaction, further suggesting that a radical 
mechanism (Path 2) leads to tropolone formation in this NHI system.    
4.6 Conclusions  
 These experimental observations and QM calculations suggest that TropC-catalyzed ring 
expansion occurs through a radical-based process (Path 2), rather than the previously proposed 
rebound hydroxylation/semi-pinacol sequence (Path 1).  This mechanistic proposal is supported 
by structural characterization, modelling and mutagenic analysis of the TropC active site, 
demonstrating that modification of a residue involved in substrate positioning altered the products 
generated by the enzyme. These data suggest that substrate positioning in TropC determines which 
radical termination step predominates: rebound hydroxylation or radical rearrangement followed 
by single electron transfer. Furthermore, we have demonstrated that rebound hydroxylation 
generates an intermediate (4.13) which does not undergo ring expansion, but rather a fragmentation 
and rearomatization process to produce 3-hydroxyorcinaldehyde 4.18. The observed reactivity of 
intermediate 4.13 illustrates the thermodynamic favorability for rearomatization over ring 
expansion in ortho-dearomatized phenols, as has been documented in previous studies.32, 41 This 
revised proposal of radical-based ring expansion is also supported by literature precedent, 
demonstrating that tropolones can be synthesized from ortho-dearomatized radicals. These 
findings provide strong evidence of a radical-based mechanism for fungal tropolone biosynthesis, 
representing a major shift in the current understanding of the role of NHI enzymes in this process. 





enzymes for the selective synthesis of complex molecules. We anticipate that computational 
studies that consider active site geometries could provide additional insight into the molecular 
details of these transformations and the observed behavior of TropC variants. Furthermore, we 
envision that the molecular details of NHI-catalyzed ring expansion can be leveraged to address 
current challenges in the synthesis of tropolone natural product scaffolds. 
4.7 Experimental 
Part I. Substrate synthesis information 
General Information: All reagents were used as received unless otherwise noted. Reactions were 
carried out under a nitrogen atmosphere using standard Schlenk techniques unless otherwise noted. 
Solvents were degassed and dried over aluminum columns on an MBraun solvent system 
(Innovative Technology, inc., Model PS-00-3). Reactions were monitored by thin layer 
chromatography using Millipore 60 F254 pre-coated silica TLC plates (0.25 mm) which were 
visualized using UV, p-anisaldehyde, CAM, DNP, or bromocresol green stains. Flash column 
chromatography was performed using Machery-Nagel 60 μm (230-400 mesh) silica gel. All 
compounds purified by column chromatography were sufficiently pure for use in further 
experiments unless otherwise indicated. 1H and 13C NMR spectra were obtained in CDCl3 at rt (25 
°C), unless otherwise noted, on Varian 400 MHz or Varian 600 MHz spectrometers. Chemical 
shifts of 1H NMR spectra were recorded in parts per million (ppm) on the δ scale. High resolution 
electrospray mass spectra were obtained on an Agilent 1290 Series Infinity II HPLC with a 6230 
Series Time-of-Flight mass spectrometer or an Agilent 1290 Series Infinity HPLC with a 6545 





obtained on a Waters Aquity H-class instrument. IR spectra were recorded on a Perkin-Elmer 
Spectrum BX FT-IR spectrometer. 
Compound 4.9 was prepared and characterized by our lab previously.39 Details of this 
characterization can be found in the Supplementary Information of the provided reference.  
 
Part II. Plasmid and protein information 
Plasmid: The genes encoding tropC (DAA64706.1), citB (KT781075.1), and tropB 
(DAA64700.1) were codon-optimized for overexpression in E. coli and synthesized by GeneArt 
(ThermoFisher). The synthesized sequence was cloned by GeneArt into a pET-151 vector 
containing the T7 expression system, ampicillin resistance, and N-terminal 6xHis-tag encoded 
upstream from the insert gene. No further modifications to this plasmid construct were necessary. 






















































































Protein Overexpression and Purification: The plasmids containing tropC, tropB, and citB were 
transformed using standard heat-shock protocols for chemically competent E. coli into BL21(DE3) 
cells. Overexpression of these enzymes was achieved using 4% glycerol (v/v) Terrific Broth (TB) 
in 2.8 L flasks. 500 mL portions of autoclaved media were inoculated with 5 mL of overnight 
culture prepared from a single colony in Luria Broth (LB) and 100 μg/mL ampicillin (Gold 
Biotechnology). Cultures were grown at 37 °C and 200 rpm until the optical density (at 600 nm) 
reached 0.8. The cultures were then cooled to 20 °C for 1 h and protein expression was induced 
with 0.2 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG, Gold Biotechnology). Expression 
was continued at 20 °C overnight (approx. 18 h) at 200 rpm. The typical yield for one 500 mL 
culture cell pellet (wet cell pellet) was ~25-30 g. 
General Considerations: HisPur nickel-nitrilotriacetic acid resin (Ni-NTA resin) was purchased 
from Thermo Scientific. Fast protein liquid chromatography (FPLC) purification was conducted 
on an ÄTKA Pure FPLC system (GE Healthcare) equipped with a HiPrep 16/60 Sephacryl S-200 
HR column purchased from GE Healthcare. Proteins were concentrated at 4,500 x g at 4 °C using 
Amicon centrifuge filters purchased from EMD Millipore. 
General Purification Procedure (for biocatalytic reactions): 50-60 g of cell pellet was 
resuspended in 250 mL of lysis buffer containing 50 mM Tris HCl (pH 7.4), 300 mM NaCl, 10 
mM imidazole and 10% glycerol. The mixture was homogenized using a handheld dounce 
homogenizer. Approximately 1 mg/mL lysozyme (Gold Biotechnology) was added prior to 1 h 
incubation on a rocker held at 4 °C. Cells were lysed by sonication of the total cell lysate in 100 
mL batches on ice. Each cycle of sonication was 10 s sonication, followed by a 20 s rest period, 





and the supernatant was removed. The cell lysate was then batch-bound to 3 mL of Ni-NTA resin 
(Thermo) for 1 h at 4 °C with gentle rocking. The supernatant was filtered through a fritted 50 mL 
plastic column (Gold Biotechnologies) to isolate the Ni-NTA resin. The resin was washed with 
100 mL of wash buffer containing 50 mM Tris HCl (pH 7.4), 300 mM NaCl, 25 mM imidazole 
and 10% glycerol. The protein was then eluted using 15 mL of an elution buffer containing 50 mM 
Tris HCl (pH 7.4), 300 mM NaCl, 250 mM imidazole and 10% glycerol. The eluted protein was 
concentrated to a volume of 2.5 mL using a 30 KDa molecular weight cutoff ultrafiltration device 
(Amicon). The concentrated protein was desalted using a PD-10 desalting column that was pre-
equilibrated with a storage buffer containing 50 mM Tris HCl (pH 7.4), 300 mM NaCl, and 10% 
glycerol. The protein was eluted from the column with 3.5 mL of storage buffer, before flash 
freezing in liquid nitrogen and storage at -80 °C. Protein concentration was determined by the 
A280 absorbance method using a Nanodrop spectrophotometer. The concentration was corrected 
using the estimated extinction coefficient from the ProtParam tool on the Expasy server (ε = 
1.128). Average yield: 60-70 mg/L of TropC. 40-50 mg/L of TropB. 60-70 mg/L of CitB. 
 
Purification protocols for TropC crystallography: Initial purification steps are identical to those 
outlined above. Following purification by Ni-NTA column, the volume of the resulting protein 
solution was reduced by ultrafiltration (Amicon, 30 KDa weight cutoff) to a volume of 2 mL. The 
concentrated protein solution was loaded onto a 16/60 Sephacryl S200 HR column at 0.5 mL/min 
from a 2 mL sample loop using the ÄTKA Pure FPLC system with the size exclusion buffer 
containing 20 mM Tris HCl (pH 7.4), 1 mM tris(2-carboxyethyl)phosphine (TCEP),  and eluted at 





containing 0.1 mg/mL of TEV protease. The TEV protease digestion was allowed to incubate for 
18 h at 4 °C in TEV protease dialysis buffer (50 mM TrisHCl, 50 mM NaCl, 0.5 mM EDTA, 1 
mM DTT). After completion of the TEV digestion, the protein solution was incubated for 1 h with 
1 mL of Ni-NTA resin at 4 °C. The reaction mixture was loaded onto a 50 mL fritted column and 
the flow through was collected and concentrated to 12 mg/mL. The resulting protein solution was 






Figure 4.S1. SDS-PAGE gels of purified wild-type TropC and TropC variants (39.95 kDa with 
6x His tag) 





















TropC variants purified for biocatalytic experiments 
 





























Part III. Site-directed mutagenesis of TropC 
 
Table 4.S1. Primers used in the generation of TropC variants. 
Whole plasmid mutagenesis procedure: Variants of TropC were generated via polymerase chain 
reaction (PCR) using the primers listed above. Substitutions were generated by site-directed 
mutagenesis of the pET-151-tropC parent plasmid. 25 μL PCR reaction mixtures contained 5 x 
Phusion HF buffer (NEB), 1 ng/μL parent plasmid, 500 nM primer, 200 μM dNTPs, 1% DMSO, 
and 1 U/μL Phusion HF DNA polymerase (NEB). Mutant plasmid amplification was accomplished 
using the following procedure. 98 °C (30 s) then a repeating cycle (30 cycles) of the following 
temperatures: 98 °C (30 s), Tm – 5 °C (30 s), 72 °C (3 min), followed by a final extension at 72 °C 
for 10 min. Parent plasmid DNA was digested in a 10 μL reaction containing 8 μL PCR product 
TropC 
variant 
Vector Primer sequence 
TropC Y194A pET-151 CGCCTGCTGCATGCGGCTCCGCAAG 
TropC Y194F pET-151 CGCCTGCTGCATTTTGCTCCGCAAGAAAAT 
TropC R278A pET-151 GTATATTACAGGTGAACGTGCGTATAGCGTTGCC 
TropC R278K pET-151 GTATATTACAGGTGAACGTAAATATAGCGTTGCC 
TropC F284A pET-151 CGTCGTTATAGCGTTGCCGCGTTTCTGAATGGTAAC 
TropC F284Y pET-151 CGTCGTTATAGCGTTGCCTATTTTCTGAATGGTAAC 
TropC R190A pET-151 GAGCATTCCGATGGCGCTGCTGCATTATG 
TropC R190K pET-151 CCGAGCATTCCGATGAAACTGCTGCATTATG 
TropC C108A pET-151 CCGGATACAAAAGAAGCGTTTATTACCGGTGC 
TropC H97A pET-151 CTGATTCAGACCGCGCAGGATGGTCTG 
TropC K106A pET-151 CTGCTGCCGGATACAGCGGAATGTTTTATTAC 
TropC K106R pET-151 CTGCTGCCGGATACACGTGAATGTTTTATTACC 
TropC D104A pET-151 GATGGTCTGCTGCCGGCGACAAAAGAATG 
TropC D104N pET-151 GATGGTCTGCTGCCGAACACAAAAGAATG 
TropC I110A pET-151 CAAAAGAATGTTTTGCGACCGGTGCAGAAATC 
TropC F86A pET-151 GCCTGGGCAAAAGCGCGCGTGGTTATGAAC 
TropC F86Y pET-151 GCCTGGGCAAAAGCTATCGTGGTTATGAACCG 
TropC F213Y pET-151 GTTGGTGATCACACCGATTATGGTTGTGTTAGCATTC 
TropC Q95A pET-151 GAACCGAGCCTGATTGCGACCCATCAGGATGG 
TropC S217A pET-151 CGATTTTGGTTGTGTTGCGATTCTGCTGCAACAG 










mixture, 1 μL CutSmart buffer (NEB), and 20 U (1 μL) DpnI endonuclease (NEB). The reaction 
was incubated at 37 °C for 3 h and transformed into chemically competent DH5-α E. coli cells. 
Part IV. Biocatalytic reaction conditions and products 
Stock solutions: Stock solutions of each substrate (50 mM) were prepared by dissolving the 
substrate in DMSO (analytical grade). Stock solutions of α-ketoglutaric acid (125 mM), ferrous 
sulfate (10 mM) and sodium ascorbate (50 mM) were freshly prepared in MQ water before each 
use, stored on ice, and used within 3 h. Aliquots of glucose-6-phosphate (G6P, 500 mM), glucose-
6-phosphate dehydrogenase (G6PDH, 100 U/mL), and nicotinamide adenine dinucleotide 
(NADP+, 100 mM) were prepared and stored at -20 °C before use. Aliquots of WT TropC and 
variants were stored at -80 °C. 
In vitro analytical-scale TropB/TropC cascade reactions: Cascade oxidative 
dearomatization/ring-expansion reactions were performed as follows. Each reaction contained 50 
mM TES buffer pH 7.5 (2.5 μL, 1 M), 2.5 mM substrate (2.5 μL, 50 mM), 5 μM TropB, 10 μM 
TropC, 5 mM glucose-6-phosphate (G6P, 0.5 μL, 500 mM), 1 mM nicotinamide adenine 
dinucleotide phosphate disodium salt (NADP+, 0.5 μL, 100 mM), 1 U/mL glucose-6-phosphate 
dehydrogenase (G6PDH, 0.5 μL, 100 U/mL),  5 mM α-ketoglutaric acid (α-KG, 2 μL, 125 mM), 
0.1 mM ferrous sulfate (FeSO4, 0.5 μL, 10 mM), 8 mM sodium ascorbate (8 μL, 50 mM) and 
Milli-Q water to a final volume of 50 μL. Reactions were carried out at 30 °C for 3 h and quenched 
by the addition of 3 volumes of methanol containing 3.5 mM pentamethyl benzene as an internal 
standard. Precipitated biomolecules were pelleted by centrifugation (17,000 x g, 20 min). The 
supernatant was analyzed by UPLC-DAD and conversion obtained by comparison to calibration 





In vitro analytical-scale TropB reactions: Analytical-scale oxidative dearomatization reactions 
were performed as follows. Each reaction contained 50 mM TES buffer pH 7.5 (2.5 μL, 1 M), 2.5 
mM substrate (2.5 μL, 50 mM), 5 μM TropB, 5 mM glucose-6-phosphate (G6P, 0.5 μL, 500 mM), 
1 mM nicotinamide adenine dinucleotide phosphate disodium salt (NADP+, 0.5 μL, 100 mM), 1 
U/mL glucose-6-phosphate dehydrogenase (G6PDH, 0.5 μL, 100 U/mL) and Milli-Q water to a 
final volume of 50 μL. Reactions were carried out at 30 °C for 3 h and quenched by the addition 
of 3 volumes of methanol containing 3.5 mM pentamethyl benzene as an internal standard. 
Precipitated biomolecules were pelleted by centrifugation (17,000 x g, 20 min). The supernatant 
was analyzed by UPLC-DAD and conversion obtained by comparison to calibration curve of the 
product. 
Determination of percent yield: Percent yield of product was determined by analysis of each 
reaction after 3 h. PDA spectrometric analysis was performed on a Waters Aquity H-Class 
instrument, using a Phenomenex Kinetex (1.7 μm C18, 2.1 x 150 mm) column under the following 
conditions: mobile phase (Solvent A: deionized water + 0.1% formic acid; Solvent B: acetonitrile 
+ 0.1% formic acid) 5% to 100% solvent B over 2 min, 100% solvent B for 1 min; flow rate: 0.5 
mL/min. Based on the calibration curves of isolated products, the percent yield of stipitaldehyde 
(4.11) was calculated with AUCproduct (360 nm)/AUCinternal standard (270 nm). The percent yield of 3-
hydroxyorcinaldehyde 4.18 was calculated with AUCproduct (360 nm)/AUCinternal standard (270 nm). 
In vitro reactions were performed and analyzed in duplicate, with reported conversions as an 
average of those trials. 
Procedure for in vitro milligram-scale TropB/TropC reactions: Preparative-scale cascade 





contained 50 mM TES buffer pH 7.5, 2.5 mM substrate, 5 μM TropB, 10 μM TropC, 5 mM G6P, 
1 mM NADP+, 1 U/mL G6PDH,  5 mM α-KG, 0.1 mM FeSO4, 8 mM sodium ascorbate. TropB-
catalyzed oxidative dearomatization was carried out at 30 °C and allowed to proceed to completion 
(~1 h) before the addition of TropC, α-KG, ascorbate and FeSO4. The reaction was then further 
incubated at 30 °C for an additional 2 h before workup. Reaction progress was monitored by 
UPLC-DAD analysis of 50 μL samples, quenched by the addition of 3 volumes of methanol 
containing 3.5 mM pentamethyl benzene as an internal standard. Precipitated biomolecules were 
pelleted by centrifugation (17,000 x g, 20 min). The supernatant was analyzed by UPLC-DAD and 
conversion obtained by comparison to calibration curves of each product. Isolation procedure: 
The reaction mixture was transferred to a separatory funnel and acidified to pH 2.0 with 0.1 M 
HCl. The organic materials were extracted from the aqueous layer with ethyl acetate (3 x 50 mL). 
The organic fractions were pooled and concentrated under reduced pressure to yield a crude 
mixture. This mixture was purified using preparative HPLC according to the procedure listed 
below. 
Purification by preparative HPLC: For purification of milligram-scale reactions, the resulting 
crude mixture was taken up in a 50:50 mixture of milli-Q water:acetonitrile (4 mL). The product(s) 
were purified from this mixture by preparative HPLC using a Phenomenex Kinetex 5 μm C18, 150 
x 21.2 mm column under the following conditions: mobile phase (Solvent A: deionized water + 
0.1% formic acid; Solvent B: acetonitrile + 0.1% formic acid) 5% to 100% solvent B over 10 min, 
100% solvent B for 4 min; flow rate: 11.5 mL/min. Product elution was monitored at wavelengths 
corresponding to maximal absorbances for each product: stipitaldehyde (4.11) at 360 nm, 3-





Procedure for in vitro milligram-scale CitB reaction: Preparative-scale enzymatic reactions 
were conducted on 200 mg scale under the following conditions: 2.5 mM substrate, 50 mM TES 
buffer pH 7.5, 5 mM α-ketoglutaric acid, 0.1 mM ferrous sulfate, 8 mM sodium ascorbate, 45 
mg/mL CitB wet cell pellet. Reactions were performed in Erlenmeyer flasks of appropriate volume 
to achieve proper oxygenation (at least 3 times reaction volume) and shaken at 100 rpm at 30 °C. 
Reaction progress was monitored at hourly intervals by analysis of a 50 μL aliquot by UPLC-DAD 
as described previously.38 Upon satisfactory conversion of the substrate, the product(s) were 
isolated in the following manner. Isolation procedure: The reaction mixture was transferred to a 
50 mL falcon tube and 2 volumes of acetone were added. The mixture was centrifuged at 4,500 x 
g for 10 min to separate the biomolecule components from the aqueous reaction mixture. The 
supernatant was removed and acetone removed under reduced pressure. The supernatant was 
acidified to pH 2.0 with 0.1 M HCl. The organic materials were extracted from the aqueous layer 
with ethyl acetate (3 x 50 mL). The organic fractions were pooled and concentrated under reduced 
pressure to yield a crude mixture, which was purified by silica gel chromatography to yield the 
hydroxylated product. 







Biocatalytic reaction products 
 
2,4-dihydroxy-3-(hydroxymethyl)-6-methylbenzaldehyde (4.25) 
The title compound was synthesized and characterized previously by our group using a procedure 
for preparative-scale benzylic hydroxylation reactions with CitB.38 Purification by flash 
chromatography afforded 460 mg (84% yield) of the title compound as a white solid. 1H NMR 
(400 MHz, MeOD) δ 10.07 (s, 1H), 6.26 (s, 1H), 4.68 (s, 2H), 2.50 (s, 3H); HR-ESI-MS: m/z 
calcd for C9H11O4
+ [M+H-H2O]
+: 165.0546, found: 165.0544. 
 
 
2,3,4-trihydroxy-6-methylbenzaldehyde (3-hydroxyorcinaldehyde 4.18) 
The title compound was synthesized according to the procedure for preparative-scale 
TropB/TropC reactions. Full characterization for this compound has been reported previously.21 
Purification by preparative HPLC afforded 10.2 mg (20% yield) of the title compound as a yellow 
solid. 1H NMR (400 MHz, CDCl3) δ 10.08 (s, 1H), 6.35 (s, 1H), 2.90 (s, 3H). HR-ESI-MS: m/z 
calcd for C8H8O4









2,4-dihydroxy-7-methyl-5-oxocyclohepta-1,3,6-triene-1-carbaldehyde (stipitaldehyde, 4.11) 
The title compound was synthesized according to the procedure for preparative-scale 
TropB/TropC reactions. Full characterization for this compound has been reported previously.21 
Purification by preparative HPLC afforded 8 mg (16% yield) of the title compound as an orange 
solid. 1H NMR (600 MHz, MeOD) δ 10.13 (s, 1H), 6.83 (s, 1H), 6.82 (s, 1H), 2.65 (s, 3H). HR-
ESI-MS: m/z calcd for C9H8O4
+ [M+H]+: 181.0495, found 181.0497. 
 
Part V. Product standard curves 
 
 






















5 0 Y = 16.97*X - 0.3265
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Part VI. UPLC traces of biocatalytic reactions 
Figure 4.S3. Reaction of wild-type TropC with TropB-generated dienone 4.10. PDA traces of 





































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.656 8022 4.49 3380 
2 1.986 5527 3.09 8463 
3 2.266 165108 92.42 95011 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 
































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 2.285 110190 100.00 63128 
 Retention 
Time 
Area % Area Height 





Figure 4.S4. Reaction of TropC R190A with TropB-generated dienone 4.10. PDA traces of 



























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.675 61537 94.92 23309 
2 1.946 3294 5.08 4602 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S5. Reaction of TropC R190K with TropB-generated dienone 4.10. PDA traces of 




























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.674 63799 94.66 22880 
2 1.949 3601 5.34 4825 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S6. Reaction of TropC D104A with TropB-generated dienone 4.10. PDA traces of 


























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.681 98240 95.26 34505 
2 1.951 4891 4.74 7063 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S7. Reaction of TropC D104N with TropB-generated dienone 4.10. PDA traces of 
























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.668 97336 95.10 29302 
2 1.951 5013 4.90 6842 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S8. Reaction of TropC Y194A with TropB-generated dienone 4.10. PDA traces of 









































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.692 70681 93.73 27731 
2 1.956 2433 3.23 4819 
3 1.992 638 0.85 777 
4 2.345 1653 2.19 307 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S9. Reaction of TropC Y194F with TropB-generated dienone 4.10. PDA traces of 












































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.677 74618 79.52 23525 
2 1.952 2759 2.94 4890 
3 1.989 583 0.62 640 
4 2.292 15872 16.92 2962 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S10. Reaction of TropC K106A with TropB-generated dienone 4.10. PDA traces of 














































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.676 47508 37.52 13538 
2 1.953 1816 1.43 3056 
3 1.990 1741 1.38 2689 
4 2.270 75547 59.67 21945 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S11. Reaction of TropC K106R with TropB-generated dienone 4.10. PDA traces of 


























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.660 88528 95.85 25190 
2 1.952 3835 4.15 6351 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S12. Reaction of TropC H97A with TropB-generated dienone 4.10. PDA traces of 













































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.663 71366 78.57 19312 
2 1.952 2552 2.81 4487 
3 1.989 1065 1.17 1516 
4 2.288 15843 17.44 3331 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S13. Reaction of TropC I110A with TropB-generated dienone 4.10. PDA traces of 











































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.682 60457 66.12 19206 
2 1.956 2285 2.50 4020 
3 1.993 376 0.41 586 
4 2.287 28321 30.97 5705 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S14. Reaction of TropC F213Y with TropB-generated dienone 4.10. PDA traces of 











































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.688 64855 66.86 22883 
2 1.957 2595 2.67 4564 
3 1.993 646 0.67 1063 
4 2.285 28901 29.80 6834 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S15. Reaction of TropC F283A with TropB-generated dienone 4.10. PDA traces of 









































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.629 195814 63.48 44839 
2 1.945 5569 1.81 9326 
3 1.982 31658 10.26 37019 
4 2.264 75432 24.45 40034 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S16. Reaction of TropC F283Y with TropB-generated dienone 4.10. PDA traces of 











































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.674 58765 36.59 15106 
2 1.954 1990 1.24 3339 
3 1.991 463 0.29 700 
4 2.271 99381 61.88 27052 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S17. Reaction of TropC F86A with TropB-generated dienone 4.10. PDA traces of 

























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.675 87718 95.29 28900 
2 1.956 4337 4.71 6627 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S18. Reaction of TropC F86Y with TropB-generated dienone 4.10. PDA traces of 
























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.678 94345 96.33 31408 
2 1.955 3599 3.67 5966 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S19. Reaction of TropC S217A with TropB-generated dienone 4.10. PDA traces of 










































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.657 67041 57.09 19048 
2 1.950 2538 2.16 4320 
3 1.986 270 0.23 477 
4 2.282 47580 40.52 9389 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S20. Reaction of TropC S217T with TropB-generated dienone 4.10. PDA traces of 










































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.632 47777 31.65 10364 
2 1.948 1693 1.12 2886 
3 1.985 268 0.18 546 
4 2.268 101199 67.05 33239 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S21. Reaction of TropC C108A with TropB-generated dienone 4.10. PDA traces of 










































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.635 40674 24.93 9174 
2 1.949 1422 0.87 2302 
3 1.986 4246 2.60 5332 
4 2.268 116799 71.59 46252 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S22. Reaction of TropC Q95A with TropB-generated dienone 4.10. PDA traces of 

























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.651 103456 96.37 31979 
2 1.946 3896 3.63 6593 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S23. Reaction of TropC R278A with TropB-generated dienone 4.10. PDA traces of 



























































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.650 82678 95.66 24152 
2 1.946 3749 4.34 5727 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S24. Reaction of TropC R278K with TropB-generated dienone 4.10. PDA traces of 












































































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.627 75546 76.95 17601 
2 1.943 3035 3.09 4982 
3 1.980 207 0.21 372 
4 2.281 19389 19.75 3622 
 Retention 
Time 
Area % Area Height 
1 1.650 96047 95.01 29701 





Figure 4.S25. Reaction of wild-type TropC with dienone 4.10. PDA traces of enzymatic 































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.646 620887 83.70 291746 
2 1.836 93090 12.55 112386 





Figure 4.S26. Reaction of wild-type CitB with substrate 4.9. PDA traces of enzymatic reaction 


































































































Area % Area Height 
1 1.808 60277 7.28 76765 
2 1.857 617301 74.60 767275 




Area % Area Height 





Figure 4.S27. Reaction of TropB with benzylic alcohol 4.25. PDA traces of enzymatic reaction 




































































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.833 112936 27.55 152592 
2 2.014 296957 72.45 453413 
 Retention 
Time 
Area % Area Height 

























Figure 4.S28. Reaction of TropB and TropC with benzylic alcohol 4.25. PDA traces of 




With TropB and TropC 
 
  
3-hydroxyorcinaldehyde (4.18) product standard 
 

























































210.00 220.00 230.00 240.00 250.00 260.00 270.00 280.00 290.00 300.00 310.00 320.00 330.00 340.00 350.00 360.00 370.00 380.00 390.00
 Retention 
Time 
Area % Area Height 
1 1.834 47107 18.87 55552 
2 2.015 202502 81.13 251750 
 Retention 
Time 
Area % Area Height 
































Part VII. NMR spectra of isolated products 
 
 









600 MHz, CD3OD 





Figure 4.S29. Previously reported rearomatization reactivity of ortho-dearomatized 
phenols.41 
Part VIII. X-ray crystallography 
General considerations: Our initial structure prediction analysis of TropC using the JPRED 
server suggested that the N-terminal region could be disordered, leading to potential challenges in 
crystal generation. In an effort to develop a TropC variant amenable to crystallization, we 
generated a construct containing a 7-residue N-terminal truncation (TropC-7N).42 TropC-7N was 
purified to homogeneity and the N-terminal 6x His tag was removed by incubation with TEV 
protease (see Section II for details). 
Crystallization: Crystals of TropC were grown using the sitting drop vapor diffusion method. 
Crystallization of the purified TropC was initially performed with commercially available screens 
from Rigaku and Molecular Dimension at 20°C and 4° C. Each drop consisted 1:2 mixture of 
protein solution (10-12 mg/ml in 50 mM Tris-HCl pH 7.4, 0.2 M NaCl and 1 mM TCEP) with 
reservoir solution. TropC crystals were observed after two weeks at 4˚C. TropC was crystallized 
in the condition of 0.2 M Magnesium Acetate, 20% PEG 8000, 0.01 M Yttrium (III) Chloride 
hexahydrate. Crystals were transferred to a cryo-protectant solution containing the corresponding 
conditions described above and 20% (v/v) glycerol before harvesting. The crystals were harvested 





Data collection and processing: Diffraction data were collected on LS-CAT 21-ID-D beamline 
at Advanced Photon Source (APS), Argonne National Laboratory using Eiger-9M detector. Data 
collection and processing statistics are summarized in Table 4.S2.   
Structure solution and refinement: The structure of TropC was determined by molecular 
replacement method with MOLREP3 43 in CCP4 suite, using the structure of T7H Neurospora 
crassa as a search model44. Model was built manually using the program Coot45 and structure 
refinement was performed using refmac546-47 in CCP4 suite.48 The structure was validated using 
MolProbity.49 Open source program, PyMOL, was used for molecular visualization and generating 






Table 4.S2: Data collection and refinement parameters. 
 
 TropC 
Data collection  
Beamline APS, LSCAT 21-IDD 
Wavelength (Å) 1.0332 
Temperature (K)  100 
Resolution (Å) 48.07-2.7 (2.873-2.7) 
Space group P3121 
Cell dimensions (Å) a = 111.0, b = 111.0, c = 89.9 
Cell dimensions (°) α = β = 90, γ = 120 
Observed reflections 100802 (13636) 
Unique reflections  17040 (2288) 
Rmerge (%) 0.070 (1.073) 
Rpim (%) 0.034 (0.721) 
<I/σ> 14.4 (1.7) 
CC(1/2) 0.999 (0.766) 
Multiplicity 5.9 (6.0) 
Completeness (%) 95.4 (71.7) 
Overall B (Å2) (Wilson plot) 64.9 
Refinement  
Resolution range 48.07-2.7 
Number of reflections  
(work/test set) 
17015 (796) 
Rwork/Rfree (%) 21.3/25.0 




B-factors (Å2)  
     Protein 72.83 
Water 69.4 
Ligand 93.8 
Rmsd deviations  
Bond lengths (Å) 0.005 
     Bond angles (°) 0.890 
Ramachandran plot  
Favored/allowed/outliers 96.2/3.8/0 








Figure 4.S30. Structure of TropC from T. stipitatus.  
Overall structure of TropC (PDB ID: 6XJJ) shown in ribbon representation colored in spectrum, 
which starts with blue (N-terminal) to red (C-terminal). Jelly-roll (or DSBH) motif at the center of 
the protein, which comprised of major (β1-5, β8 and β10) and minor (β6, β7 and β9) β-sheets. 
Fe(III) shown in purple sphere, located at the center of major and minor β-sheet, and in close 
proximity to β10. Helices (α1-7) are wrapped around the β-sheet. The enzymatic metal binding 
site is located in similar position as PaIPNS (6JYV) and T7H (5C3Q), which is positioned toward 









Table 4.S3. Top 30 structures similar to TropC from protein data bank (PDB) listed by DALI 





# No   Chain    Z-score    rmsd   %id  
 
   1   6jyv-A  32.2   2.1     32   PROBABLE IRON/ASCORBATE OXIDOREDUCTASE;                     
   2   5c3q-A  31.8   2.1     29   THYMINE DIOXYGENASE;                                        
   3   3oox-A  29.9   2.3     26   PUTATIVE 2OG-FE(II) OXYGENASE FAMILY PROTEIN;               
   4   1gp6-A  29.5   2.2     25   LEUCOANTHOCYANIDIN DIOXYGENASE;                             
   5   5v2z-A  29.2   2.1     22   2-OXOGLUTARATE-DEPENDENT ETHYLENE/SUCCINATE-FORMI           
   6   5o7y-A  28.9   2.2     27   THEBAINE 6-O-DEMETHYLASE;                                   
   7   2vau-A  28.8   2.3     22   ISOPENICILLIN N SYNTHETASE;                                 
   8   4xae-A  27.9   2.4     31   FERULOYL COA ORTHO-HYDROXYLASE 1;                           
   9   6tto-A  27.4   2.1     24   HYOSCYAMINE 6 BETA-HYDROXYLASE;                             
  10   3on7-B  24.8   2.4     24   OXIDOREDUCTASE, IRON/ASCORBATE FAMILY;                      
  11   5tcv-A  24.5   2.3     25   1-AMINOCYCLOPROPANE-1-CARBOXYLATE OXIDASE 1;                
  12   1unb-A  23.3   2.6     20   DEACETOXYCEPHALOSPORIN C SYNTHETASE;                        
  13   5udb-8  19.8   2.4     13   DNA REPLICATION LICENSING FACTOR MCM2;                      
  14   6n1f-D  14.4   3.2     11   OXIDOREDUCTASE, 2OG-FE(II) OXYGENASE FAMILY;                
  15   4kbz-A  13.3   3.6     16   EGL NINE HOMOLOG 1;                                         
  16   4iw3-A  13.2   2.9     16   PUTATIVE UNCHARACTERIZED PROTEIN;                           
  17   5zm3-B  12.8   3.1     13   DIOXYGENASE ANDA;                                           
  18   4nhy-A  12.7   3.0     13   2-OXOGLUTARATE AND IRON-DEPENDENT OXYGENASE DOMAI           
  19   6ec3-C  12.4   3.2     11   METHYLTRANSFERASE DOMAIN-CONTAINING PROTEIN;                
  20   6iuq-B  12.4   3.1     15   PROLYL 4-HYDROXYLASE;                                       
  21   4xbz-C  12.3   2.8     12   EVDO1;                                                      
  22   6nie-A  12.3   3.3      8   BESD, LYSINE HALOGENASE;                                    
  23   5erl-D  12.1   3.1      7   SNON,SNON;                                                  
  24   5v1b-A  12.1   3.6     12   EGL NINE HOMOLOG 2;                                         
  25   4nao-A  12.1   3.7     13   PUTATIVE OXYGENASE;                                         
  26   3kt4-A  12.0   3.3      7   PKHD-TYPE HYDROXYLASE TPA1;                                 
  27   5nci-B  12.0   3.0     11   LEUCINE HYDROXYLASE;                                        
  28   4ie6-A  12.0   3.6     10   ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO;              
  29   5ybm-A  11.9   3.4     11   PRHA;                                                       








Figure 4.S31. Superimposition of TropC (PDB ID: 6XJJ) with isopenicillin N synthase from 
Pseudomonas aeruginosa PAO1 (PaIPNS, PDB ID: 6JYV) and thymine-7-hydroxylase (T7H) 






Figure 4.S32. Superimposition of TropC (PDB ID: 6XJJ) and thymine-7-hydroxylase (T7H) 
of Neurospora crassa (PDB ID: 5C3Q).  
Close-up image of active site. TropC is pictured in grey with native substrate 4.10 in purple. T7H 







Part VIV. Quantum mechanical (QM) analysis of TropC-catalyzed reactions 
General Computational Details: All geometries and frequency computations were obtained 
using the unrestricted B3LYP density functional51-52 and 6-311++G** basis set.53-54 Reaction 
pathways were calculated using the single-ended growing string method.55 Initial alignment of 
substrate and iron model was obtained using ZStruct.56-58 All ground state geometries were 
confirmed to have no imaginary frequencies, and transition states were confirmed to have one 
imaginary frequency. Solvent corrections were performed using the SMD implicit solvent model 
(water)59-61 and the cc-pVTZ basis set.62-67 Reported energies are Gibbs free energies in solvent 
with gas-phase entropy and enthalpy corrections (at 298.15 K). Most simulations were performed 
using the Q-Chem 5.0 package,68 except for the solvent computations, which were performed using 
ORCA 4.0.69 A small non-heme iron model (Figure 4.S32) was used mimic the active site of 
TropC. Methylimidazoles represent histidine side chains, acetates represent aspartate side chains 
and succinate, respectively. A hydroxyl group was placed in a productive orientation for catalysis, 
and as a mimic of the Fe(III)-OH group after initial H-atom abstraction. 
 
  
Figure 4.S33. Active-site model before (a) and after (b) truncation of His210, Asp212, 





Part X. XYZ Coordinates for QM calculations 




  C     -1.36405068     -1.04444925      0.16913242 
  C     -1.45915056      0.31190738     -0.26869486 
  C     -0.28554711      0.95947356     -0.85288205 
  C      1.09466613      0.30994795     -0.49075439 
  C      1.01915666     -1.23660759     -0.40613088 
  C     -0.19132751     -1.78476718      0.09622804 
  O     -0.30044119      1.98364475     -1.52269526 
  C     -2.66921645      1.09132468     -0.24942917 
  O     -3.78685400      0.76992397      0.17727125 
  O      2.09452996      0.67636495     -1.41848883 
  C      1.41357514      0.83748332      0.87600449 
  O      2.02539566     -1.87024130     -0.75775811 
  C     -2.59608233     -1.75803877      0.67311221 
  H      0.85725578      0.50641152      1.74369756 
  H      2.04446893      1.71572266      0.93543639 
  H     -2.52506060      2.10689144     -0.66221531 
  H     -3.39790032     -1.73035359     -0.06811200 
  H     -3.00415839     -1.25585346      1.55358611 
  H     -2.36068665     -2.79609046      0.92170180 
  H      2.61511614     -0.14068631     -1.51516834 











  C     -1.32321465     -1.03988654      0.21419164 
  C     -1.39007402      0.32425418     -0.17447546 
  C     -0.18009975      1.04298777     -0.60439486 
  C      1.26948593      0.17963835     -0.46201451 
  C      1.05672415     -1.31453846     -0.41919394 
  C     -0.16039692     -1.80299589      0.12094035 
  O     -0.14164956      2.08361048     -1.28715414 
  C     -2.60283559      1.09865564     -0.21585736 
  O     -3.75096181      0.74966098      0.09616481 
  O      2.27250203      0.55020730     -1.33546093 
  C      1.07409494      0.99782463      0.70972805 
  O      1.97743103     -2.01000848     -0.90395541 
  C     -2.57108589     -1.75422595      0.68295646 
  H      0.65745715      0.57791273      1.61415998 
  H      1.55603390      1.96477056      0.73476049 
  H     -2.43421348      2.13590494     -0.56102868 
  H     -3.34757052     -1.73755859     -0.08530076 
  H     -3.01348004     -1.25411600      1.54812585 
  H     -2.33859154     -2.79054105      0.94265854 
  H      2.58639562     -0.30700825     -1.68045282 













  C     -2.51544722     -1.71261253      0.73291417 
  C     -1.31723648     -0.93897085      0.20358618 
  C     -0.19146631     -1.71504774     -0.01064276 
  C      1.09187639     -1.37259732     -0.56825818 
  O      1.86803001     -2.22061600     -1.11646024 
  C      1.59730649     -0.03726647     -0.45888863 
  C      0.96967314      1.05507017      0.30802773 
  C     -0.43814432      1.43606988     -0.21626141 
  O     -0.56398938      2.58604909     -0.65545511 
  C     -1.51185653      0.46793074     -0.08365824 
  C     -2.82907289      1.04187117     -0.26258200 
  O     -3.93577462      0.48863803     -0.22679102 
  O      2.80062695      0.16222538     -1.02297890 
  H      0.86430425      0.74632632      1.35888882 
  H      1.58410863      1.95342826      0.25823812 
  H     -2.78638526      2.12780156     -0.45781491 
  H     -3.30001380     -1.79170083     -0.02155678 
  H     -2.97696943     -1.19782104      1.57964654 
  H     -2.20810635     -2.71304784      1.04700828 
  H      3.00127970     -0.73918939     -1.38088968 













  C     -2.21373926     -1.72739805      0.83750339 
  C     -1.22169769     -0.69199008      0.32730357 
  C      0.09972721     -1.12083985      0.39560405  
  C      1.32780725     -0.56850947     -0.10206171 
  O      2.40551081     -1.17106760     -0.06260436 
  C      1.33538123      0.86758082     -0.64930370 
  O      2.01827171      1.19075901     -1.59684813 
  C      0.46764691      1.83574440      0.11149114 
  C     -1.01396650      1.77850110     -0.33269154 
  O     -1.48195146      2.83216749     -0.77381117 
  C     -1.77185872      0.54880576     -0.15689623 
  C     -3.17865129      0.68808963     -0.49225195 
  O     -4.06912070     -0.16814836     -0.47660367 
  H      0.51511053      1.59164814      1.17939501 
  H      0.80738191      2.85482845     -0.06459116 
  H     -3.43231565      1.71294587     -0.81091656 
  H     -2.96065266     -1.27759343      1.49402980 
  H     -1.68738022     -2.52110903      1.37150574 
  H     -2.77855585     -2.16339358      0.01093572 
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Path 1: Radical Rearrangement















  C     -1.29438791     -1.03884351      0.19797988 
  C     -1.45664211      0.30204921     -0.24074957 
  C     -0.28614153      1.11253935     -0.54693263 
  C      1.12812135      0.52401174     -0.27055120  
  C      1.16750040     -0.95953795      0.14290246 
  C     -0.04552971     -1.62914569      0.38223867 
  O     -0.33134983      2.26635259     -0.97033814 
  C     -2.74007501      0.94336319     -0.42549600 
  O     -3.86374138      0.46624630     -0.23605586 
  C      1.69247770      1.36284179      0.91047298 
  O      3.00885254      0.98292189      1.31003137 
  O      1.89184003      0.72827388     -1.45239656 
  O      2.30165941     -1.49085238      0.29768675 
  C     -2.50146428     -1.89908807      0.48386328 
  O      4.68512743     -0.43512533     -0.80821939 
  H      1.00220068      1.29934316      1.76333682 
  H      1.73893020      2.39772717      0.56975567 
  H     -2.64888075      1.98784727     -0.77129720 
  H     -3.13791803     -1.43995314      1.24338391 
  H     -2.19082307     -2.89303871      0.81419119 






  H      2.77711864      0.35508475     -1.32492888 
  H      3.00227839      0.01382494      1.37952026 
  H      0.02123743     -2.66303475      0.70398755 
  H      3.99032565     -1.03282560     -0.47279428 
  H      4.63979630      0.30785011     -0.19237772 
Compound 4.21 
-1 1 
  C      1.66584328      1.14862049      0.72194060 
  C      1.30004206      0.14491849     -0.23662013  
  O      1.91202776      0.02791017     -1.39888957 
  C      1.06282759     -1.20094689      0.48678287 
  O      2.08057320     -1.74624542      0.96672238 
  C     -0.24340562     -1.73919809      0.60470045 
  C     -1.40296429     -1.05636302      0.28978850 
  C     -2.70139489     -1.78923268      0.53789581 
  C     -1.44637497      0.27329527     -0.24429853 
  C     -2.67461685      0.97038542     -0.57672242 
  O     -3.83632692      0.58286374     -0.42797168 
  C     -0.25281583      1.02406318     -0.54527983 
  O     -0.15790683      2.07435613     -1.13734568 
  O      3.53385955      0.53363876      1.34904372 
  O      4.29287218      0.85926760     -1.21462365 
  H      1.23776767      1.11346010      1.71723486 
  H      2.00458213      2.11284433      0.36258720 
  H     -2.49386048      1.97564377     -0.99804195 
  H     -3.33236126     -1.24856279      1.24668862 






  H     -3.29167932     -1.85644797     -0.37816810 
  H      3.31535772      0.55625621     -1.39838709 
  H      3.24256284     -0.41126905      1.30428002 
  H     -0.31373666     -2.73089249      1.04052893 
  H      4.84302630      0.19105141     -1.63226123 
  H      4.00578860      0.67669524      0.48571617 
Compound 4.22 
-1 1 
  C     -2.25401026     -1.75617440      0.76590681  
  C     -1.25372999     -0.70106981      0.32139887 
  C      0.07508605     -1.14386310      0.40799575 
  C      1.31639352     -0.60605482     -0.01985828 
  O      2.37512390     -1.27049518     -0.00694604 
  C      1.42542246      0.85503036     -0.47758075 
  O      2.29103006      1.20339461     -1.25394801 
  C      0.45891698      1.82017907      0.15002069 
  C     -0.97693855      1.72907084     -0.41104900 
  O     -1.39320889      2.72609722     -0.99955866 
  C     -1.77906944      0.53762810     -0.15282249 
  C     -3.19794603      0.73707673     -0.42589698 
  O     -4.12109347     -0.07354403     -0.33774280 
  O      4.86330784     -0.51778568     -1.05924377 
  O      4.91999847     -1.37214971      1.73885531 
  H      0.41619932      1.60820485      1.22522267 
  H      0.80375699      2.83749599     -0.02474090 
  H     -3.42095547      1.76749496     -0.74948867 






  H     -1.73823427     -2.58255824      1.25743182 
  H     -2.81469026     -2.14238546     -0.08845610 
  H      4.73744343      0.37266880     -1.40237037 
  H      3.99137031     -1.55121921      1.54049150 
  H      0.20102893     -2.15734910      0.77681724 
  H      3.94644159     -0.78425808     -0.83687898 




  C     -0.85439202      1.68563917     -0.36326391 
  C     -1.71234651      0.57156895     -0.12297394 
  C      1.48873710      0.78367638     -0.12003378 
  C      1.27938417     -0.65675756      0.20366492 
  C     -0.01113898     -1.26007927      0.32683275 
  C     -1.29011572     -0.77202637      0.19606475 
  C      0.56378187      1.75399660     -0.35401837 
  C     -3.14061480      0.83110182     -0.21475631 
  C     -2.37273202     -1.81997771      0.42451121 
  O      2.77708068      1.09680858     -0.17161068 
  O      2.32762589     -1.30416952      0.36305958 
  O     -1.38797411      2.86594568     -0.64431437 
  O     -3.65784830      1.92692051     -0.47532417 
  H     -3.03803062     -1.54766948      1.24823117 
  H     -1.91997812     -2.77835817      0.67123625 
  H     -2.99143547     -1.96737555     -0.46514929 






  H      3.23891283      0.24595211      0.02701084 
  H     -3.81593197     -0.01150886     -0.03992552 
  H      0.08284370     -2.31234044      0.57117286 







  C      1.32100899      0.26418288     -0.37478702  
  C      1.27503132     -1.26558389     -0.26315958 
  C      0.03045125     -1.79757631      0.20637017 
  C     -1.14395862     -1.07343043      0.23351158 
  C     -1.23059529      0.28569895     -0.23399977 
  C     -0.03861443      0.90398429     -0.74002563 
  O      2.27669274     -1.95204738     -0.49773944 
  C     -2.38789320     -1.77718379      0.71705182 
  C     -2.44957813      1.05112473     -0.32237119 
  O     -3.58777062      0.72138462      0.02760597 
  O      0.03089452      1.94226218     -1.42068726 
  O      2.28173262      0.70199434     -1.32857826 
  C      1.69489141      0.84953305      1.03081984 
  O      2.85009581      0.29511280      1.62104940 
  O      4.68862162     -0.48210547     -0.51191699 
  H      0.87353172      0.68013974      1.73009939 






  H     -2.28945230      2.05868538     -0.74970151 
  H     -2.83054447     -1.24764455      1.56430175 
  H     -2.15493678     -2.80356802      1.01050947 
  H     -3.16159704     -1.78226632     -0.05407308 
  H      1.83497112      1.46301019     -1.74962220 
  H      3.56130334      0.20120437      0.96102703 
  H      0.02730673     -2.84789842      0.47672019 
  H      4.04983114     -1.22147756     -0.51673861 




  C      1.31544095      0.27238757     -0.44239450 
  C      1.26896676     -1.19486812     -0.25018860 
  C      0.06980728     -1.78134729      0.14701800  
  C     -1.13701692     -1.07166703      0.19711175 
  C     -1.22106789      0.27897950     -0.21184467 
  C     -0.02489527      0.91324595     -0.73086785 
  O      2.34144262     -1.92369798     -0.35754406 
  C     -2.35933824     -1.81544666      0.66973084 
  C     -2.44120786      1.05937986     -0.23347677 
  O     -3.56471301      0.70878914      0.13193907 
  O      0.00047277      1.98172078     -1.36409411 
  O      2.25802968      0.68468323     -1.41828891 
  C      1.80144293      0.93920762      1.04519690 
  O      2.96674894      0.48050515      1.49516454 






  H      0.95413742      0.75848951      1.73204013 
  H      1.79523876      2.00842273      0.74573894 
  H     -2.28880013      2.08538671     -0.61438480 
  H     -2.79046559     -1.33459338      1.55137398 
  H     -2.10918695     -2.85159129      0.90845732 
  H     -3.14908486     -1.79251208     -0.08474810 
  H      1.84179221      1.48159255     -1.79497589 
  H      3.87781263     -0.02528555      0.60470743 
  H      0.09257052     -2.83097338      0.41542866 
  H      3.25625638     -1.37169427     -0.37636340 




  C      1.16226593     -0.04795429     -0.98214112  
  C      1.18881948     -1.33768179     -0.49907100 
  C     -0.00017014     -1.88049954      0.04972638 
  C     -1.16943847     -1.14736563      0.13037308 
  C     -1.20336571      0.20473908     -0.33737424 
  C     -0.01271755      0.78131956     -0.91318224 
  O      2.29130145     -2.14375757     -0.53037436 
  C     -2.39159886     -1.80329367      0.73165138 
  C     -2.37263483      1.05537297     -0.28788378 
  O     -3.49068253      0.78525442      0.16136253 
  O      0.12393779      1.96809539     -1.37292856 
  O      2.23187594      0.57561537     -1.59975804 






  O      3.01207510      0.80213915      2.05969664 
  C      1.93463272      1.20509940      1.67293292 
  H      1.00022317      0.94994854      2.20354846 
  H      1.83032420      1.86379817      0.79620664 
  H     -2.18951108      2.05810626     -0.71587995 
  H     -2.75271039     -1.25666992      1.60645557 
  H     -2.15818767     -2.83160957      1.02386019 
  H     -3.22795064     -1.81423397      0.02786833 
  H      1.81388514      1.45014988     -1.81582363 
  H      4.31850864      0.02660594      0.57448182 
  H      0.04264983     -2.89972257      0.41740736 
  H      3.11111898     -1.61114950     -0.55856107 




  C      0.41330517      0.08871090     -0.20328194 
  C     -0.88184378     -0.28298158      0.24161843 
  C      1.15856433     -0.76712725     -1.00694048 
  C      0.62833964     -1.99918700     -1.37605378 
  C     -0.65056107     -2.38070180     -0.94358524 
  C     -1.41335529     -1.54630579     -0.14458297 
  O      2.41159037     -0.44488187     -1.45791220 
  O      1.34079278     -2.84275506     -2.15762872 
  O      0.99437284      1.26314146      0.11336597 
  C     -1.60659284      0.64809196      1.07647815 






  H     -2.60995103      0.34626573      1.41425796 
  C     -2.78777252     -2.00001197      0.29432678 
  H     -3.57178132     -1.31586967     -0.04271847 
  H     -2.86519466     -2.07884881      1.38271306 
  H     -3.00598565     -2.98315735     -0.12373088 
  H      2.64348183      0.43161154     -1.12287824 
  H      2.19054396     -2.42968112     -2.36537576 
  H     -1.02444142     -3.34884992     -1.25423749 
  H      0.35489495      1.76110362      0.68487562 
[FeIII] 
0 4 
  C     38.23926701     38.29629874     29.53710554 
  N     37.51798914     36.53354383     31.20562786 
  H     36.57979369     36.42065883     30.85451949 
  C     38.47794332     37.40109561     30.70591902 
  C     38.04802096     35.87599426     32.27156015 
  H     37.52185157     35.15020117     32.86958055 
  N     39.28494611     36.26706861     32.47751634 
  C     39.56590086     37.21519536     31.51655407 
  H     40.52482129     37.70584044     31.48585394 
  C     43.17144571     38.99031542     34.13308757 
  C     42.29929121     37.89270308     34.72239123 
  O     41.81177984     37.05054528     33.86259073 
  O     42.10233410     37.85427623     35.94139009 
  C     42.35063634     31.20755424     31.36745326 
  N     43.24710579     33.45069629     32.12753254 






  C     42.20717619     32.53510038     32.03066067 
  C     42.80204263     34.54207495     32.79466044 
  H     43.39294733     35.41270229     33.02047687 
  N     41.53826112     34.38048108     33.12648486 
  C     41.15541594     33.13769466     32.66220200 
  H     40.15958826     32.76864523     32.83712342 
 Fe     40.45422521     35.67867455     34.27965033 
  O     41.76393178     35.02188784     35.96638579 
  H     41.91088933     35.86532866     36.42605115 
  H     41.08838887     34.50407100     36.47718862 
  O     39.64345087     33.64057732     36.74668694 
  C     38.90092945     33.66328621     35.75878925 
  O     39.18269509     34.21179155     34.61874976 
  C     37.53237688     33.00691561     35.82810828 
  O     39.47350152     36.73538467     35.34864171 
  H     43.37302269     38.82858090     33.07435629 
  H     44.10751694     39.04958309     34.69209629 
  H     42.65822947     39.94753440     34.25938393 
  H     43.11736403     30.59335687     31.85068902 
  H     42.61405175     31.30528297     30.30919715 
  H     41.40657325     30.66468441     31.42637224 
  H     38.00518255     37.73104235     28.62875809 
  H     39.13480814     38.88665977     29.33901725 
  H     37.41555410     38.99416356     29.72014118 
  H     37.27644531     32.52731764     34.88140651 
  H     36.78976652     33.78715730     36.02249251 









  C     38.00896528     38.60216009     29.69941967 
  N     37.44311767     36.57497726     31.10723864 
  H     36.54072433     36.39738663     30.69423179 
  C     38.31091978     37.60279442     30.76403270 
  C    38.00814300     35.85188438     32.10860738 
  H     37.55700287     34.99686361     32.58628125 
  N     39.18365426     36.35258700     32.42217182 
  C     39.38424709     37.44098206     31.59759418 
  H     40.28446955     38.02884196     31.67266600 
  C     43.41914438     38.92014552     34.22782020 
  C     42.37756387     37.87552887     34.60258657 
  O     41.92761656     37.12994751     33.67064669 
  O     42.02355685     37.80990186     35.80655036 
  C     42.67677952     30.91175014     31.56208238 
  N     43.31056064     33.34787845     31.84365942 
  H     44.20186027     33.28922231     31.37617348 
  C     42.42062681     32.30082291     32.04018472 
  C     42.78370610     34.46959952     32.39942085 
  H     43.25848974     35.43774302     32.40695228 
  N     41.61239275     34.20336176     32.93598990 
  C     41.37437380     32.86052796     32.72218952 
  H     40.46981128     32.39741540     33.08122287 






  O     41.50236339     35.06648185     35.92094104 
  H     41.82624773     35.94452257     36.20268891 
  H     40.74049714     34.84705401     36.49473509 
  O     38.88011645     34.59535533     36.68499048 
  C     38.49125303     33.95855439     35.67381698 
  O     38.91179853     34.15450913     34.48556742 
  C     37.44625394     32.87164224     35.87981002 
  O     39.37128366     37.05835820     35.43679881 
  H     43.66423760     38.88583723     33.16633306 
  H     44.32129016     38.75931581     34.82349839 
  H     43.04003076     39.91218399     34.48621897 
  H     43.58396715     30.48771493     32.00529078 
  H     42.78229310     30.86608781     30.47287584 
  H     41.84086406     30.26930209     31.84161017 
  H     37.88323416     38.13085291     28.71888556 
  H     38.83105670     39.31483774     29.62206095 
  H     37.09824332     39.16945284     29.91861256 
  H     37.13523466     32.42476027     34.93556981 
  H     36.58154758     33.29282079     36.39810905 
  H     37.86155953     32.09724618     36.53044688 
  H     40.14321330     37.52446195     35.81591985 








  C     38.29039775     38.83670376     29.75970800 
  N     37.53658237     36.77152669     31.01303247 
  H     36.64900671     36.67456191     30.54167423 
  C     38.47470056     37.76259298     30.77755892 
  C     37.99765570     35.95779952     31.99438327 
  H     37.46624044     35.10388307     32.38327543 
  N     39.18400406     36.36718042     32.40646501 
  C     39.49047876     37.49087017     31.65574539 
  H     40.41310258     38.02923278     31.79963147 
  O     41.85072243     36.97229884     34.00977936 
  C     43.57033631     31.09423871     32.04199166 
  N     42.31206030     33.04076490     31.02418044 
  H     42.52637202     32.81918015     30.06272176 
  C     42.73306810     32.32422057     32.13438580 
  C     41.56117085     34.08597233     31.44022500 
  H     41.10549373     34.80007754     30.77370156 
  N     41.47280941     34.09040688     32.75946760 
  C     42.19988722     32.99525887     33.20039016 
  H     42.27404820     32.76830220     34.25038761 
 Fe     40.30225156     35.37404145     33.97139581 
  O     41.34696423     34.47121405     35.85400523 
  H     42.05698111     34.85023568     36.38219507 
  H     40.55814752     34.42433131     36.44137962 
  O     38.78087868     34.65033772     36.67645302 






  O     38.69486787     34.25298052     34.48107801 
  C     37.08552476     33.16530788     35.88259347 
  O     39.65143149     36.94327308     35.57106427 
  H     44.52848132     31.29140487     31.55179241 
  H     43.06194389     30.30230089     31.48388474 
  H     43.77916042     30.71432595     33.04216421 
  H     38.17329681     38.42358495     28.75336053 
  H     39.16047797     39.49362371     29.75134665 
  H     37.41096354     39.45129745     29.97460169 
  H     36.64628194     32.85713869     34.93562238 
  H     36.33978036     33.65398027     36.51211032 
  H     37.42898568     32.28031518     36.42529186 
  H     38.94075657     37.55949548     35.36168237 
  H     39.27579006     36.28775687     36.20999533 
  H     42.80309956     36.90259275     33.88383372 








Part XI. Molecular dynamics (MD) simulations 
 
Model Construction: To construct the model of TropC, we used the partial crystal structure 
described in this report and the Modeller software to model the C-terminal region for which no 
density was observed in X-ray crystallography experiments.70 To develop a homology model for 
this region, we submitted the TropC amino acid sequence to the RCSB PDB71 and JPred4 server 
for secondary structure prediction. These programs indicated that thebaine 6-O-demthylase crystal 
structure (PDB ID: 5O7Y, 27% sequence identity, Pymol superalign Cα-RMSD: 4.378) as the 
closest predicted related structure.42, 72 Based on the structure prediction results, residues 307-323 
of the C-terminal region were modeled as a helix.  
 To generate an initial substrate-bound structure for MD simulations, further analysis of the 
RCSB PDB structure revealed that non-heme iron enzyme thymine-7-hydroxylase (T7H) 
possesses structural similarity to the apo crystal structure of TropC (PDB ID: 5C3Q, 28% sequence 
identity, Pymol superalign Cα-RMSD: 3.139).33 The deposited crystal structure of T7H was co-
crystallized with substrate, nickel, and α-KG. In addition, similarities between the native substrates 
of TropC and T7H are evident. They are both small, cyclic substrates with a similar substitution 
pattern of a methyl group ortho to a hydroxyl group. To establish an initial substrate-bound 
structure for MD simulations, we overlaid the TropC coordinates with the T7H substrate, co-
substrate and Fe coordinates. We then computationally replaced thymine with TropC native 
substrate 4.10 and converted the nickel atom to an iron atom to prepare our model for MD 






System Preparation: We submitted the TropC model coordinates to the CHARMM-gui for 
addition of all hydrogen atoms and protons, which were added according to their canonical 
protonation states.73 These protonation states were determined based on the use of the Propka-3.1 
software.74-75 The tautomeric forms of histidine were assigned to maximize hydrogen bonds. To 
obtain an overall electrically-neutral charge model, 47 potassium and 42 chlorine atoms were 
added. A water box was used with periodic boundary conditions, and the particle mesh Ewald 
method was used to describe long-range electrostatic effects. Dimensions of the water box were 
established to fit the largest dimension of the protein plus 10 Å. All water molecules within 2.8 
angstroms of heavy atoms were removed. The final model contained 53,819 atoms. Parameters for 
the substrate were obtained using CGenFF 4.0.76-77 Parameters for iron were obtained from those 
described by Pang and coworkers.78 A restrained active site was used (50 kcal/molÅ2 force 
constant), in which the restraints were based off of crystal structure distances. Included in these 
restraints were a positional restraint on residue Phe213 to more closely resemble that of the 
complimentary residue in 5C3Q to maintain closure of the active site, and restraints based on H-
bonds within the active site. A 5000 step molecular mechanics (MM) minimization was then was 
performed using the steepest decent algorithm using the CHARMM36 force field.79 
MD Simulations 
 Simulations were performed with the OpenMM/CHARMM interface (version c42b1) 
using periodic boundary conditions, particle mesh Ewald for long range electrostatic interactions, 
and a Langevin thermostat (friction coefficient = 5).80 A three-step MD protocol was used to obtain 
the pose described in the main text, which all used a 2 fs timestep. The first phase slowly heated 
the model from 10K to 298 K over 500 ps and included the restrained active site as well as 





were then removed, and temperature was kept constant for an additional 500 ps. The MD 




Figure 4.S34. Tracking H-bond distance between Arg325 and Asp104 throughout the final 
10 ns of sampling (MD).  








Figure 4.S35. Full image of TropC with substrate bound from the final frame of MD 
simulation.  
Residues chosen for alanine screening mutagenesis are shown in blue, substrate 4.10 is shown 







Figure 4.S36. Close-up image of TropC active site with substrate bound from the final 
frame of MD simulation.  
The hydrogen bonding distance between R186 and substrate 4.10 is shown. Residues chosen 
for alanine screening mutagenesis are shown in blue, substrate 4.10 is shown in purple, cofactor 







Figure 4.S37. Close-up image of TropC active site with substrate bound from the final 
frame of MD simulation.  
The hydrogen bonding distance between D100 and R325 is shown. Residues chosen for alanine 
screening mutagenesis are shown in blue, substrate 4.10 is shown in purple, cofactor α-







Figure 4.S38. Close-up image of TropC active site with substrate bound from the final 
frame of MD simulation.  
Residues chosen for alanine screening mutagenesis are shown in blue, substrate 4.10 is shown 







Figure 4.S39. Close-up image of TropC active site with substrate bound from the final 
frame of MD simulation.  
Residues chosen for alanine screening mutagenesis are shown in blue, substrate 10 is shown in 







Figure 4.S40. Observed 2-point binding between the amide backbone nitrogen of F213, 
substrate 4.10 and guanidinium nitrogen of R190 from the final frame of MD simulation.  
Residues chosen for alanine screening mutagenesis are shown in blue, substrate 10 is shown in 
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Chapter 5: Conclusions and Future Directions 
 
5.1 Conclusions  
 The elucidation of biosynthetic pathways in microorganisms and plants has enabled 
annotation of an immense number of enzymes, exposing the untapped synthetic potential of 
biocatalysts from secondary metabolism.1-3 Yet, great effort is required to bridge the divide 
between biocatalyst discovery and the seamless integration of enzymes into the synthetic chemist’s 
toolbox.1-3 Our work actively engages with this challenge to establish and develop novel 
biocatalytic methods for complex molecule synthesis. We seek to harness the power of biocatalysis 
to improve upon current synthetic methods and to build complementary reaction platforms for 
challenging transformations. The search for candidate biocatalysts to fulfill this purpose led to 
non-heme iron (NHI) α-ketoglutarate-dependent (α-KG) dioxygenases, which remain largely 
underutilized as biocatalytic tools.4 These enzymes are known to catalyze a wide variety of 
transformations in a highly selective manner.5 In addition, scalable reaction platforms have been 
developed for NHI enzymes, owing to their simple reaction requirements of inexpensive α-KG 
and ferrous iron. This Chapter summarizes the results of the preceding three chapters describing 
the use of NHI enzymes in the chemoenzymatic synthesis of complex molecules and natural 
products. 
 Reactive intermediates, such as ortho-quinone methides (o-QMs), have been leveraged as 
building blocks in the synthesis of complex molecules.6-9 The efficient and selective generation of 





directly access intermediates in the biosynthesis of secondary metabolites. Taking advantage of 
this catalyst-controlled selectivity, we leveraged NHI dioxygenases CitB and ClaD for site- and 
chemo-selective benzylic C–H hydroxylation of o-phenolic benzaldehydes.10 The resulting 
benzylic alcohol products then underwent an elimination reaction under mild conditions, 
generating o-QM intermediates which were modified through 1,4-addition or [4+2] cycloaddition 
reactions in a modular, one-pot chemoenzymatic process. This reaction platform was applied to 
the synthesis of numerous complex molecules, the natural product (–)-xyloketal D, and the 
labelling of peptides. These transformations were performed on near-gram scale by using whole 
E. coli cells expressing the biocatalyst of interest. Chemoenzymatic generation of o-QMs provided 
several advantages over traditional synthetic methods in that the reactive intermediate could be 
generated in a single vessel with precise control over the site- and chemo-selectivity of the benzylic 
hydroxylation reaction.10 
 We have also utilized chemoenzymatic processes to access a variety of tropolones. 
Tropolones are a diverse class of natural products with a conserved seven-membered aromatic 
ring. NHI enzymes XenC and TropC were leveraged for the direct synthesis of diverse tropolones 
through a two-step enzymatic cascade. Synthesis of these tropolones was achieved on preparative 
scale, allowing isolation of these novel compounds. This cascade reaction was also applied to the 
racemic synthesis of 18-deoxyepolone B, a deoxy form of tropolone natural product epolone B. 
Furthermore, the hetero-Diels-Alderase XenE was shown to catalyze [4+2] reactions in vitro for 
the synthesis of 18-deoxyepolone B, demonstrating the potential to apply hetero-Diels-Alderases 
for synthetic purposes. 
 In addition to the chemoenzymatic synthesis of tropolones, we have explored the 





of TropC, alanine-screening of the enzyme active site and computational analysis of potential 
reaction pathways, we have characterized the TropC ring expansion process as likely a radical 
rearrangement. This new mechanistic proposal is strongly supported by experimental and 
computational evidence as well as literature precedent for one-electron ring expansions in 
tropolone synthesis. 
 The studies described here have led directly to the development and characterization of 
biocatalysts as tools for complex molecule synthesis. Through these efforts, we have established 
and explored the synthetic utility of NHI enzymes and their ability to achieve selective and 
synthetically-challenging reactions. Furthermore, this work directly addresses the knowledge gap 
between enzyme discovery and chemoenzymatic synthesis, enabling integration of NHI 
biocatalysts into synthetic planning.  
5.2 Future directions 
Structural characterization of NHI enzymes CitB and ClaD 
 Through our development of a biocatalytic benzylic C–H hydroxylation platform, we 
characterized the substrate functionalities required for NHI enzymes CitB and ClaD to engage in 
productive catalysis. Although CitB and ClaD are homologs sharing 46% sequence identity, they 
are able to catalyze benzylic C–H hydroxylation on substrates with divergent functionalities, 
allowing them to serve as complementary biocatalysts. In an effort to identify and understand the 
biochemical foundation of these differences, we aim to perform structural characterization of these 
enzymes in collaboration with Prof. Markos Koutmos at the University of Michigan. We anticipate 
that a comparative structural analysis will enable elucidation of the amino acid residues responsible 





enzymes. Furthermore, the development of structural information on this subclass of α-KG-
dependent hydroxylases will enable detailed characterization of the active site architectures which 
deliver site- and chemo-selective oxidation of phenolic substrates. This information is also crucial 
for efforts to characterize and classify homologs of CitB and ClaD, as no structural information is 
available for these functionally-related enzymes. We anticipate that these efforts, paired with 
bioinformatic analyses, will allow the identification of homologous biocatalysts possessing 
complementary substrate requirements, which we envision will broaden the synthetic utility of 
NHI enzyme-catalyzed benzylic oxidation. 
 
Characterization of XenE-catalyzed reaction product and application to chemoenzymatic 
synthesis 
 We have developed a biochemical assay to demonstrate the activity of hetero-Diels-
Alderase XenE in coupling an ortho-tropolinone methide (o-TM) with α-humulene through [4+2] 
reaction to generate tropolone meroterpenoids. Ongoing work aims to develop a preparative scale 
reaction for the isolation of XenE-generated Diels-Alder products and evaluation of the 
enantioselectivity of this reaction. We also aim to further characterize the XenE-catalyzed reaction 
by evaluating the coupling partners, such as other o-TM precursors and humulene derivatives, 
which could be productive substrates in this transformation. For this purpose, we will leverage the 
ability of NHI enzyme XenC to efficiently generate non-natural tropolones, screening these 
products as reactions partners in XenE-catalyzed reactions with α-humulene. In this way, we aim 
to efficiently and selectively generate a variety of tropolone meroterpenoids as potential bioactive 
compounds. In addition, we envision that the efficient and mild nature of a XenE-catalyzed Diels-





for high throughput, selective synthesis and screening of tropolone meroterpenoids. These efforts 
will seek to reduce existing barriers to synthetic access of tropolones, leading to detailed 
exploration of their biological activities and potentially the development of novel pharmaceuticals. 
 
Characterization of hetero-Diels-Alderase XenE 
 In this work, substrates have been identified which are accepted by XenE as partners in the 
Diels-Alder rection. However, little is known about the enzyme active site architecture which 
permits the activity observed in these reactions. We aim to further investigate the biochemical 
characteristics of XenE through structural characterization using X-ray crystallography in 
collaboration with Attabey Rodríguez-Benítez (Prof. Alison Narayan and Prof. Janet Smith). 
Broadly, this analysis will provide architectural details on a previously uncharacterized class of 
enzymes which catalyze highly selective reactions in tropolone biosynthesis. In addition, we 
anticipate that substrate-bound structures will enable a detailed analysis of substrate binding poses 
which impart diastereoselectivity in the resulting reaction.  
 
 The chemoenzymatic approaches presented in this dissertation demonstrate the broad 
potential for biocatalysis to develop novel, streamlined synthetic routes to natural products and 
their analogs. The synthetic utility of these transformations is built upon the selective oxidation 
reactions performed by NHI dioxygenases. This work highlights the advantages offered by NHI 
biocatalysts in the selective synthesis of complex molecules, particularly when combined with 
chemical processes. One would anticipate that, as the number of known biosynthetic enzymes 
continues to increase, the incorporation of NHI dioxygenases in synthetic schemes will grow in a 
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